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Stellingen Voor de detectie van trombose in de kransslagaderen is coronaire angioscopie superieur aan andere beeldvormende technieken. 
Groningen, 18 rnei 1994 
2 De variabiliteit in de interpretatie van angioscopische beelden is een stimulans voor het ontwikkelen van eenduidige definities, betere classificaties, en kwantitatieve angioscopische onderzoeksmethoden. 3 Door de hoge kwaliteit van de huidige coronaire angioscopen ontbreekt elke concurrentie, waardoor perfectionering en verdere technische ontwikkelingen warden vertraagd. 4 Subacute stent trombose is een foutieve benaming, omdat occlusie van een intracoronaire stent soms door intima dissectie ontstaat. 5 De voorspellende waarden van intracoronaire thrombusvorming en intimadissectie voor het ontstaan van restenose na PTCA dienen onderzocht te warden in een prospectieve studie met gebruikmaking van angioscopie en kwantitatieve coronaire angiografie. 6 Een dreigende acute occlusie na PTCA is de meest waardevolle klinische indicatie voor coronaire angioscopie. 7 Het concept van laser thrombolyse dient gecombineerd te warden met de techniek van coronaire angioscopie. 8 Het resultaat van een PTCA verbetert niet door 'even te wachten' na de ingreep. 9 Het door elkaar gebruiken van verschillende lengte-eenheden in de interventie-cardiologie, zoals bij een 3.0 mm ballon op een 2. 7 French catheter over een 0.014 inch voerdraad en het 0.082 inch wijde lumen van een 8 French geleide catheter, getuigt van grate warhoofdigheid bij de beoefenaars ervan. 1 O Door het voortschrijden der techniek komen binnenkort een PTCA-catheter met een profiel kleiner dan zijn voerdraad, en een geleide catheter met een grater lumen dan zijn buitendiameter, op de markt. 11 Ramen blijven namaak-appels. 12 Het mooiste geluid is dat van een luchtgekoelde zescylinder boxermotor. 13 Sommige promovendi, die het opschrijven van hun Stellingen tot werkelijk het allerlaatste moment bewaren, kunnen beter spreken van 'Uitstellingen'. 
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1 [ introduction 
History of coronary angioscopy 
The Cardioscope I The appealing idea to examine a functioning heart by means of direct visualization 
through an optical instrument is more than 80 years old. The first attempts are 
described in a paper by Cutler et al: 1 Exploring the possibilities of intracardiac 
surgery, Lawrence Rhea and LC. Walker tried in 1913 to visualize the interior of a 
canine heart during thoracotomy. Using a rigid tube, similar to a cystoscope 
equipped with a lamp and a knife (Fig 1-1), which they called the 'Cardioscope', their 
efforts were not overwhelmingly successful: not only were they unable to obtain a 
blood-free field of vision, but also, as cited by Harken: 'These workers did not report 
-
FIGURE,., CLEFT> The Cardioscope of Rhea and Walker, anno 
1913. (Reproduced, with permission, from: Cutler CE, Levine 
SA, Beck CS. The surgical treatment of mitral stenosis: 
experimental and clinical studies. Arch Surg 1924;9:689-821. 
Copyright 1924, American Medical Association) 
FIGURE , .2 !RIGHT> The Cardioscope used by Allen and 
Graham, taken apart to show its components: light source, 
rigid tube with lens, and valve knife. The concave lens was 
positioned against the endocardium. (Reproduced, with 
permission, from: Allen DS, Graham EA. lntracardiac surgery­
a new method. JAMA 1922;79:1028-1030. Copyright 1922, 
American Medical Association) 
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their work because of the failure of their animals to live'. 2 However, the idea was sound 
and led in 1922 to animal experiments by Allen and Graham, who imaged the 
endocardium and the mitral valve through their cardioscope. 3 They used a tube with 
a lens mounted at the distal aperture (Fig 1-2), and a small electric light bulb inside, 
and approached the mitral valve through the left atrial appendage. Their efforts to 
visualize the inside of the heart were indeed successful: 'On first thought it would seem impossible to see the interior of the heart in the presence of blood. This is not the case, as will be shown. The endocardium can be seen through the cardioscope as clearly as we see the mucosa of the bladder through the cystoscope, if the lens of the instrument is in contact with the structure to be seen' . These Midwestern surgeons used cardioscopy to try mitral 
valvulotomy techniques under direct visualization. In 1923 the first patient was 
operated with the use of this technique.4 This patient was a 31 year old woman with a 
mitral stenosis, who had undergone two previous, preliminary aborted operations. 
The cardioscope was successfully, though briefly, used during this third procedure. 
Unfortunately the patient died on the operating table, even before the valve had been 
opened. The fatal outcome of this operation was attributed to the anesthesia. 
Nevertheless, such results, as well as the reluctance to perform open thoracotomy in 
that era, precluded a widespread application of the technique in patients. The 
interest in cardioscopy was revived in 1943 by Harken and Glidden,2 and in 1954 by 
Bolton et al.5 The technique that was used was both simple and ingenious: these 
scopes had transparent latex or plastic balloons, filled with saline, attached to their 
distal ends. These balloons displaced the blood in order to visualize the intracardiac 
structures through the transparent balloon material (Fig 1-3). Dwight E. Harken was 
FIGURE 1.3 Cardioscope used by Harken et al with an 
assortment of transparent balloons. (Reproduced, with 
permission, from: Harken DE, Glidden EM. Experiments in 
intracardiac surgery. J Thorac Cardiovasc Surg 1943; 
12:566-572.) 
a pioneer of cardiac surgery, who during the war became very skillful in removing 
foreign bodies from the heart. 6 Before he went to England in 1944 to perform this 
first consistently successful intracardiac surgery, he worked in Boston and managed 
to observe the ventricle and auricle of a dog's heart for as long as 20 minutes, with 
full recovery of the animal. He commented that 'endoscopy (. .. ) has now cam'ed into 
almost all organs. Cystoscopy, ventriculography, peritoneoscopy, sigmoidoscopy, 
thoracoscopy, and gastroscopy have all contributed to direct therapy and to our concepts of 
physiology and pathology. It is not too much to hope that some day corresponding 
contributions may be offered by cardioscopy'. He hardly could have foreseen that one day 
these forecasted contributions would come not only from looking at the interior of 
the heart itself, but indeed from observing the inner surfaces of the surrounding, tiny, 
coronary arteries. His method was later refined by Gamble and Innis. They avoided 
thoracotomy by using a catheterization technique and balloon-tipped fiberoptic 
instruments. 7 
As for all endoscopic devices and applications, a real breakthrough of cardiovascular 
endoscopy could not have taken place without the invention of the optical fiber. The 
principle of internal reflection of light was demonstrated a century ago by the British 
physicist John Tyndall in water flowing out of a reservoir. In 1934, Norman R. 
French patented a 'light-pipe' - a tube with a reflecting inner wall. More recently, in 
the fifties, the American Optical Corporation was the first company to manufacture 
light transmitting fibers consisting of 2 kinds of glass. The subsequent surge of the 
fiberoptic industry led to miniaturization of fibers, increased flexibility, enhanced 
light transmitting properties, and technologies to attach miniature lenses to these 
very small fiberoptic bundles. The attention of endoscopic cardiovascular imaging 
shifted in the meantime from the intracardiac structures to the interior surfaces of 
blood vessels. 
Peripheral angioscopy I Generally, new intracoronary diagnostic and intervention techniques are first applied 
to the peripheral arteries. Successful peripheral employment of such techniques 
subsequently leads to reduction of the size of the devices, and improved mechanical 
FIGURE 1.4 Fiber-optic choledochoscope 
used by Greenstone et al in 1966 for 
peripheral intraoperative angioscopy. 
(Reproduced, with permission, from: 
Greenstone SM, Shore JM, Heringman EC, 
Massell TB. Arterial endoscopy 
(arterioscopy). Arch Surg 1966;93:811-813. 
Copyright 1966, American Medical 
Association) 
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properties such that they are made suitable for the small, mobile, fragile, and 
tortuous coronary vessels. In 1966, Greenstone et al used fiberoptic endoscopes to 
image the abdominal aorta and its major branches of dogs and human cadavers.8 
Their equipment consisted mainly of modified choledochoscopes (Fig 1-4). These 
procedures could only be carried out during surgery. Percutaneous use was 
precluded by the size of the devices and the problems of obtaining a blood free field. 
Gamble and Innis employed a distensible, low-pressure latex balloon in order to 
FIGURE 1-s Early angioscopes and delivery systems 
(Baxter - Edwards) for intraoperative use. 
facilitate clearing of blood from the field of vision, and to peer inside the cardiac chambers and aorta. 7 At that time, however, there seemed to be no practical purpose for angioscopy, and a decade passed without much progress. Towne and Bernhard reported vascular endoscopy in 91 vascular reconstructions, including 42 carotid endarterectomies in 1977.9 Their preferred instrument was a 5 mm right angled choledochoscope , connected to a fiberoptic light source and transmission cable. Still the use of angioscopy remained controversial and anecdotal. The development of specialized optical catheters in the eighties brought a renewed interest in this field. Now the pioneers were at the Cedars-Sinai Medical Center and UCLA School of Medicine in Los Angeles. 10•12 They cooperated closely with industry to produce and test low-diameter angioscopes with increasing fiber count and resolution, as well as appropriate delivery systems (Fig 1-5). This group published a landmark paper in 1985, for the first time clearly documenting the fact that intraoperative angioscopy, performed in peripheral as well as coronary arteries, could actually provide more intravascular detail than angiography. Moreover, this resulted in a change in the surgical procedure in 26% of their patients. 13 Nowadays, peripheral angioscopy is mainly practiced by vascular surgeons, who use the instrument to improve vein graft bypass surgery. 14' 15 During preparation of the vein graft, which remains in situ using this technique, the quality of the veingraft can be inspected and catheter based valvulotomy can be performed with direct visual inspection. 
lntraoperative coronary angioscopy I Although, as described above, the attention for coronary angioscopy was raised in 1985 by Grundfest et al, these principal investigators in the field of angioscopy were not the first to successfully visualize human intraluminal coronary surfaces by means of fiberoptic instruments. Spears reported in 1983 the use of a 1.8 mm Olympus prototype angioscope during coronary artery bypass surgery. 16 After trials in postmortem canine and human coronary arteries, and in vivo intraluminal visualization in dogs, four patients were studied during open heart surgery, using clear cardioplegia fluid to displace blood from the field of view. The angioscope was inserted through a side branch of the vein graft, and advanced across the distal anastomosis into the coronary artery. One of the photographs in this paper was the first to show an in vivo picture of atherosclerotic plaque obtained by a fiberoptic catheter in a human left anterior descending coronary artery. The authors discussed the future application of angioscopy during PTCA and thrombolysis procedures, and speculated that this technique had the potential to better define the pathologic nature of angiographically visible intraluminal filling defects. This was later confirmed by the Cedars-Sinai group. 13 In 1986 they reported in the New England Journal of Medicine that complex plaques or thrombi could be observed with angioscopy in 
11 
patients undergoing bypass surgery. 11 These complex lesions and thrombi had 
not been detected by coronary angiography. They compared the angioscopic findings 
of IO patients with unstable angina to those of patients with stable angina. None of 
the 17 investigated arteries in the IO patients with stable angina had either a complex 
plaque or thrombus, while the vessels of all patients with unstable angina were 
characterized by intracoronary thrombus or an angioscopically complex lesion with 
hemorrhage or ulceration. This important paper thus reflects the first attempt to 
compose angioscopic definitions of unstable angina, and to distinguish unstable from 
stable coronary artery lesions. The authors even went one step further, and 
subdivided the unstable angina patients in a group of 7 patients with angina at rest 
and 3 patients with accelerated angina. The complex plaques were found in the latter 
group, while all intracoronary thrombi were exclusively observed in the patients with 
rest angina, implicating a different pathologic etiology for these two different 
manifestations of unstable angina. The significance of this study was twofold: it 
presented angioscopic evidence that unstable angina and acute myocardial infarction 
may have a similar pathogenesis, and the study gave the impetus to put increased 
efforts in the development of percutaneous coronary angioscopy. 
In contrast to the situation of peripheral angioscopy, intraoperative application of 
coronary angioscopy can be regarded as a first stage in the development of the 
percutaneous technique. Intraoperative coronary angioscopy has now largely been 
abandoned in favor of its percutaneous counterpart. There may be a role for it in the 
preoperative assessment of the quality of internal mammary artery grafts, and for 
evaluation of distal graft anastomoses, 18• 19 and it has been used to assess the results of 
coronary endarterectomy.20 More importantly, intraoperative coronary angioscopy 
has played an essential role in stimulating the development of miniaturized, flexible, 
wire-guided fiberoptic catheters for percutaneous transluminal use. 
Percutaneous coronary angioscopy I Spears and colleagues were not only the first to perform intraoperative coronary 
angioscopy, they also had the premiere of employing fiberoptic imaging catheters 
during cardiac catheterization. 16 They used the brachial approach and a modified 
PTCA guiding catheter with an enlarged lumen to insert a fiberscope in 5 patients with 
totally occluded right coronary arteries. The angioscope was advanced to the distal 
tip, but not beyond the end of the guiding catheter. The Olympus 'Ultra thin' 
fiberscope had an outer diameter of 5 French (1.7 mm), and could not be advanced 
to the distal guiding catheter tip in 2 patients because of insufficient flexibility. In the 
remaining 3 patients, visualization of white atheromatous plaque near the site of 
occlusion was achieved by manual injection of 5 to IO ml of saline through the 
guiding catheter in the artery. 
12 
FIGURE , _, Artist impression of the Microvision angioscope 
with its deflecting guidewire (courtesy of Advanced 
Cardiovascular Systems, Santa Clara, ca, usa). 
13 
As described in the previous section, the larger intraoperative series of angioscopic observations in the same and the next year promised clinical relevance for this new imaging tool. '3• 11 Driven by the notion that coronary angioscopy could evolve as a superior imaging method, several companies like Olympus, Advanced Interventional Systems, Baxter-Edwards, Mitsubishi, and Nihon Kohden tried to overcome the technical problems of making small, high resolution, flexible fiber bundles with appropriate catheter delivery systems that could be used to clear the blood and direct the fiber bundles, and with appropriate video equipment. The leading Japanese optical and electronic industries produced innovative technologies in this field. It was therefore not surprising that important progress in the next years was reported from Japan.21•27 The integrated angioscopy catheter systems had now diameters of 1.1 - 1.7 mm, and either deflectability of the tip or a guidewire lumen to safely engage the coronary arteries. The field of vision was cleared from blood using irrigation channels in the angioscopy catheters or by flushing saline through the guiding catheter. High resolutions were achieved by using fiber bundles containing 2000 - 3200 imaging fibers. These Japanese investigators contributed significantly to pathophysiological insights obtained by coronary angioscopy, especially in the field of intracoronary thrombus formation. An important study by Mizuno et al was published in January 1992 in the New England Journal of Medicine.28 They performed angioscopy in 15 patients with unstable angina, within 48 hours after an episode of chest pain at rest, and in 16 patients with acute myocardial infarction, within 8 hours after the onset of symptoms. They observed that coronary thrombus in patients with unstable angina generally had a grayish-white color, whereas the acute myocardial infarction patients had predominantly red thrombi. The authors speculated that this difference may result from the presence (unstable angina) or absence (AMI) of blood flow in the vessel, and that the difference may account for the contrasting results of thrombolytic therapy in these two syndromes. In the meantime, a usable coronary angioscopy catheter had become available in the United States for clinical evaluation. This 'Microvision' system (Advanced Cardiovascular Systems, Santa Clara, CA, USA) was introduced in 1987, and tested in 1988-1991. 29•36 The key features of the Microvision system were a diameter of 1.4 mm, a distal occlusion balloon, a coaxial guidewire channel, a distal flush lumen, and a 0.2 mm fiber bundle containing 2000 individual fibers. The system further included a special angioplasty guidewire with multiple curves, which deflected the tip of the angioscope when it was rotated or withdrawn (Fig 1-6). Although considerable efforts were put into the clinical applicability of this device, its handling was not ideal because the balloon had to be deflated prior to repositioning of the lens, and the 
14 
obtained pictures left room for improvement. The system was finally withdrawn from further development in 1991. It is very likely that percutaneous coronary angioscopy would have remained a difficult, exclusive toy for a few investigators, with less than 250 reported procedures 16, 24' 29' 34-42 until the end of 1991, if the coronary ImageCath™ system (Baxter Healthcare Corporation, Interventional Cardiology Division, Irvine, CA, USA) had not been introduced. This system, which was introduced for clinical testing in June 1991, through its image quality, as well as its simplicity in setup and handling, made coronary angioscopy practicable during everyday interventional cardiology procedures. More than 3000 of these angioscopes have been used today, almost equally divided over the USA and Europe, 43 so this angioscope has increased the number of performed procedures by a factor of 12 during the last 3 years. Edwards Laboratories, later Baxter Healthcare Corporation, Interventional Cardiology Division, started their angioscopy program in 1983 with the introduction of a 1.5 mm Mini-Flex intraoperative angioscope. The ImageCath product line for peripheral angioscopes was available from 1987. These angioscopes started as simple, though flexible and soft tipped optical catheters. During the following years an occlusion cuff, guidewire compatibility, and a movable optical bundle were added to the design. These peripheral angioscopes were precursors of the current ImageCath coronary angioscope, which finally, through an evolutionary process, could be designed and manufactured by miniaturization of optical fibers and lenses, along with sophistication of catheter technology. Initially, a limited number of centers in the United States and Europe were selected to evaluate this new device. In Groningen, the first angioscopy case, which was also the first in Europe using this particular angioscopy catheter, was performed on September 3, 1991. Coronary angioscopy has now been firmly established as a unique research tool. Today, the subjects of clinical angioscopy studies include the pathogenesis of unstable angina and acute myocardial infarction, PTCA, acute closure post-PTCA, imaging of vein grafts, coronary stenting, laser angioplasty, restenosis, and comparison with other imaging techniques. 44-60 Additionally, there is a growing acceptance of coronary angioscopy as a useful imaging tool to better select the optimal therapeutic strategy during routine coronary angioplasty. 45• 47, 56' 59, 61-63 
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Aims o f  this thesis The primary aim of this thesis is to give an overview of the role coronary angioscopy can play today in the interventional catheterization laboratory. Technical and procedural aspects are highlighted to demonstrate its practical feasibility in routine interventional cardiology. Special emphasis is given to the interpretation of coronary angioscopic images, since this is the ultimate determinant of the scientific and clinical utility of this tool. The efforts of a European working group to make a classification and definitions system for angioscopic observations, as well as the computerized digital angioscopy atlas of this classification system, have been given a central place in this thesis. The current applications and expectations of future developments of coronary angioscopy are discussed, and related to our personal experience of 135 procedures in 100 patients. Five angioscopy related papers are included as appendices of this thesis. The clinical relevance of angioscopy is underscored in the first of these papers: two cases of subacute stent occlusion are described in which angioscopy proved that these occlusions were mainly caused by intimal dissection rather than the suspected stent thrombosis. An observational pilot study, describing the intraluminal changes that occur during the first hour after balloon angioplasty, is presented in appendix II. In appendix 111, one of the main themes of this thesis is presented as a cooperative study by a European angioscopy working group. The 'Ermenonville' classification, as described and evaluated in this paper, which has been published in the European Heart Journal, forms the basis to describe all angioscopic observations in this thesis. A basic comparison of the angioscopic versus the angiographic detection of intracoronary thrombus and intimal dissection is given in appendix IV. Finally, a first clinical pilot study addressing the new intervention of selective laser ablation of intracoronary thrombus, including the use of angioscopy in one of the studied patients, is published as appendix v. 

2 I Coronary Angioscopy - procedural aspects 
The angioscope - technological considerations 
The procedure of coronary angioscopy is a simple one: the operator connects the 
angioscopy catheter to a light source and video camera, introduces the angioscope 
into the coronary artery of interest, starts the motorized saline flush, and inflates the 
occlusion cuff. Because this is essentially all that is needed to get images of the 
coronary artery lumen, it is easy to overlook the huge technological achievements, 
which have made this procedure possible. The various attributes, from light source to 
lens tip, that angioscopes need to function inside the coronary vessels, are discussed 
below. 
O pti cal fi ber bundles I Very thin fibers of glass are flexible: they can be bent without breaking. When light is 
introduced within such a bent fiber, it follows the curves, since it is continuously 
reflected from the inside surface. Optical fibers consist of a core with a high index of 
refraction for light, surrounded by a 'cladding' with a lower index of refraction 
Core, high index of refraction 
FIGURE 2 - 1  Schematic drawing of light 
propagation through an optical fiber. 
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(Fig 2-1). The light beams are internally reflected at the boundary plane between the 
inner core and the surrounding cladding, provided that the angle of incidence is 
sufficiently small. Multiple optical fibers are needed to transmit images. For this 
purpose, the fibers have to be ordered in a so-called 'coherent fiberoptic bundle', 
which means that the bundle is structured in a way that each fiber has the same 
neighbors at both ends of the bundle. 64 Each fiber transmits one picture element 
(pixel), thus fiber bundles with higher pixel densities produce sharper, higher 
resolution, images. 59• 65 This is intrinsically conflicting with the equally important goal 
to make the fiber bundles as small and as flexible as possible. A large diameter of the 
optical fiber bundle means a rigid bundle and incompatibility with the coronary 
arteries. From these considerations it follows that extremely thin individual fibers are 
mandatory to construct a coronary angioscope. The fiber size has come down from 
10-12 µm in peripheral and intraoperative angioscopes to 2.0-3.5 µm in the current 
coronary angioscopes. 1 0• 64' 66• 67 By comparison, the diameter of a red blood cell is 
approximately 7.5 µm. Although the pixel count is the single most important 
determinant of resolution and sharpness, another important fiber bundle related 
factor in image quality is the phenomenon of 'crosstalk' between fibers. The contrast 
of the image is especially affected by this leakage of light from one fiber to another. 
F lex ibility I A coronary angioscope should be very flexible in order to negotiate bends in the tortuous coronary arteries. Wire guided systems must be flexible enough to track over a 0.014 inch (0.36 mm) 'floppy' PTCA guidewire. Interventional cardiologists are nowadays used to work with extremely soft and flexible balloon catheters, mainly made of polyethylene. They expect more or less the same from their intracoronary imaging devices. The flexibility of angioscopes is mainly determined by the flexibility of the optical fiber bundle they contain. One method that has been used to manufacture flexible fiber bundles is to allow the individual fibers to move independently within the bundle. The proximal and distal ends of the fibers of such a fiber bundle must of course be bound together with exactly the same organization pattern. This method has now largely been abandoned because of the vulnerability of these bundles, resulting in breakage of individual imaging fibers during routine use. The remaining option is to minimize the size of the individual fibers in bundles of the 'fused silica' type, with all the individual fibers fused together. These fused silica fiber bundles are too rigid for cardiovascular use unless they have a diameter of less than at least 0.5 mm.64' 67 With their microscopic sized fibers, current coronary angioscopy fiber bundles are quite flexible, although still somewhat stiffer than balloon angioplasty catheters. The distal part of the ImageCath angioscope has a bend radius of less than 4 mm. 
L ens I A distal lens is necessary to focus an image of the vessel interior on the distalaperture of the fiber bundle. These lenses are very tiny, with diameters as small as 0.25 mm. Special methods, using epoxy glues and other mounting techniques, had to be developed to attach these small lenses to the fiber bundles. 1 0• 64• 66• 67 The resolution, i.e. the ability to discern objects, of these lenses is typically higher than the resolution of the imaging fiber bundle, which is limited to its pixel count. Important issues in the design of these lenses are the viewing angle and the object distance. Resolution is a linear function of the object distance. 65 Coronary angioscopes have viewing angles of 50°-55° in water, with the exception of the 5.2 French (r.4 mm) and 2.4 French (o.8 . mm) Olympus scopes, which had 75° and 65° fields of view. The ideal angle, allowing for optimal orientation and lumen visualization, would be 90°, 1 1  like some of the peripheral scopes have. However, wide angle lenses of the Gradient Index ( GRIN) type, which type is used in small caliber angioscopes, 65 would distort the image and introduce color dispersion. The depth of field should be beyond 0.5 mm, to ensure that most of the field of view is in focus. 
1 8  
Guidewire channel 
Light fiber 
Ocular / camera I In addition to an objective at the distal fiber bundle aperture, a proximal lens system, or ocular is needed to focus the obtained and transmitted image on the retina of the eye or, preferably, on the Charge-Coupled Device ( ccn) chip of a videocamera. An ocular eyepiece is available for some scopes, like the Omegascope (Omega Fiberoptic Technologies, London, UK). However, the size of the angioscopic image, determined by the size and the number of pixels, is much too small for comfortable viewing and reliable observations through such an eyepiece. The videocamera serves to magnify the image by a factor of 40. A state-of-the-art miniature ccn camera offers a resolution that exceeds the resolution of the angioscopic image after magnification by a factor of 5-1 0  in the optical coupler, which connects the angioscope to the videocamera. Camera resolution is usually measured in TV lines, which are derived from television test patterns. The OPTX 3000-P camera, which is used with the ImageCath coronary angioscopes, reaches 300 horizontal and 330 vertical lines. Together with a high color fidelity, electronic shutters to eliminate the 'white-out' effect when the scope is close to the vessel wall, and special 'antiblooming' circuitry to prevent smearing effects of bright light, these modem videocamera's are optimally tuned to the optical output of the angioscopes. 
Ill umination I A high intensity light source is needed to illuminate the field of view. Although the optical illumination fibers are efficient light transmitters, more than 99% of the brightness of the light bulb is lost in the housing of this light source and in the optical couplers of light cables and angioscope. The light source of the OPTX system 
FIG U R E  2 - 2  Schematic drawing of the tip of the coronary 
lmageCath™ angioscope, showing the concentric ring of 
produces more than 100000 lux, of which only 45 lux is delivered at the tip of the angioscope. 68 Xenon arc lamps are used to provide such intense light, which also has be as pure white as possible. The ability to emit all of the colors in the visible light spectrum is expressed as the color temperature of the light source. The OPTX 300 light source, which is used with the ImageCath coronary angioscopes, generates a light temperature of 6300 Kelvin. At this light temperature, the evenness of the spectral distribution is sufficient for optimal true color imaging. The light output should be adjustable to give an adequate lighting, but not over-exposure of the image, under various circumstances in different vessel sizes. The light is transported through the angioscope by illumination fibers, which are 1 0-50 times thicker than the fibers in the imaging bundle. They can form a separate light channel, with a separate 
illumination fibers. 
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aperture at the tip as in the ACS Micro Vision angioscope (Fig 1-6), or they can be arranged in a concentric ring around the imaging bundle (Fig 2-2). The latter method has the advantage of relatively wide-angled, uniform lighting of the field, which is crucial for optimal image quality. 
Irrigation I Because blood is almost impenetrable for all visible wavelengths of light, it must be displaced from the space between the lens and the objects of visualization. As discussed in chapter 1, in the past this was attempted by placing the lens in direct contact with the surfaces of interest, or by filling balloons with saline and looking through these balloons. Theoretically, an inert gas can also displace blood in the arteries .69 Smits et al have demonstrated that CO2 gas gives superior imaging, and is safe to use in canine and porcine peripheral arteries. During coronary angioscopy, 
Frc.uRE 1 . 3 Motorized power injector filled with saline. 
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however, co2 gas infusion resulted in mechanical heart failure in all instances, which was fatal in the majority of the investigated pigs and dogs, 70 so it does not seem appropriate to try this in humans. Irrigation with fluids is the method of choice to obtain a clear field of view. In his initial intraoperative experiments, Spears used a special, translucent, perfluorocarbon-containing blood substitute.1 1  Nowadays, saline, sometimes containing heparin, or lactated Ringer's solution is used by most investigators.25' 27• 53• 59• 66• 72 For intracoronary use, this fluid should be warmed to 37°c to prevent precipitation of ventricular arrhythmias. 10 The clear fluid is delivered either through the guiding catheter or through the angioscopy catheter. Manual injection with a syringe is possible when it is infused through the guiding catheter. 25 Due to their limited diameters, irrigation channels of angioscopes have a much higher flow resistance than guiding catheters . Motorized infusion is mandatory to obtain a sufficient flow of saline at the catheter tip. Special rotary pumps were developed for peripheral scopes, and also for the Olympus scopes that were used for the coronaries. 10• 67 A much simpler solution however is available in every cathlab: contrast medium power injectors that are used for ventriculography, aortagraphy, etc possess all the necessary features for irrigation through a coronary angioscope (Fig 2-3) . These power injectors can infuse at pre-programmed, accurately controlled flow rates and injection durations, have programmable pressure limits and built-in warming systems to keep the irrigation fluid at body temperature. Moreover, these power injectors, although indispensable for diagnostic catheterizations, are rarely used during angioplasty procedures, making them readily available to assist angioscopy. We use a Medrad™ Mark V injector, with flow rates between 30 and 60 ml/min. Flushing with these amounts of saline in the coronaries is however usually insufficient to obtain a clear, blood-free field, unless the vessel is occluded from antegrade blood flow proximal to the lens tip. One method is 'wedging' or 'deep­throating' of the guiding catheter, 53 which most interventional cardiologists find somewhat hairy and not a very elegant technique, and which can indeed potentially cause serious intimal dissections. Uchida used a special balloon-tipped guiding catheter. 21 This has the disadvantage of creating a large ischemic area because the vessel is occluded at its origin. To minimize this problem, they also used a telescopic, 
subselective intracoronary guiding catheter system equipped with an occlusion balloon. Without doubt the best solution is to mount an occlusion balloon on the angioscope, just proximal to its tip. This balloon should be as soft and compliant as possible in order to be atraumatic and fully occlusive. This occlusion balloon technique has been used in the Mitsubishi, ACS, Omega, and Baxter angioscopes. 25• 21, 
53
• 
59 An important difference is that the ImageCath has a truly compliant balloon, while the others have used PTCA type, non-distensible balloons. 
The Del ivery Catheter System I A delivery catheter is required to bring the optical fiber and lens tip into the coronary arteries, and to create a blood-free, properly aligned field of view. The Omegascope OM 2/029, through its absence, clearly demonstrates the importance of such a delivery catheter system. Although it is an extremely thin angioscope, with good imaging capabilities by means of 2000 pixels and concentrically arranged light guides in just 0.29 mm overall diameter, its employment is cumbersome because it lacks a dedicated catheter system. Delivery catheters for a coronary angioscope should provide guidewire tracking capability for a 0.014 inch (0.36 mm) PTCA guidewire, a short and compliant occlusion balloon, and should easily fit inside a standard 8 French (2 .67 mm) PTCA guiding catheter with an inner diameter of 0.078-0.084 inch (1 .98-2 . 13 mm). In addition, it is desirable to have some means to steer or deflect the tip so that the lens can be directed toward the vessel lumen. Such a deflection mechanism was present in the Mitsubishi angioscope.25' 28' 53 One version of this scope was equipped with an occlusion balloon. The disadvantage was that the fiber bundle was incorporated in the main catheter shaft. The result was that the catheter tip, although it could be angulated, could not be moved longitudinally in the vessel during imaging. The ACS Microvision angioscope, that was used with some success by a few investigators featured a special, curved, guidewire to deflect the tip.30• 59• 66 This mechanism worked well, but the angioscope, which was based on a PTCA balloon catheter with separate light and imaging bundles (Fig 1-6) encountered some technical problems and failures, and was withdrawn from further development. 21 In the last 3 years, the ImageCath catheter has become the single successful and broadly employed angioscope. With the exception of a tip deflection or steering mechanism, all of the important features discussed above are built into this catheter, which without doubt has been the key to its success. 
F I G U R E  2 . 4 The lmageCath™ diposable angioscopy catheter. 
F I G U R E  2 - s  Tip of the lmageCath angioscope, with fiber 
bundle fully extended. 
FI G U R E  2 - &  Tip of the angioscope, featuring 'GuideRail' 
double monorail guidewire channels, inflated occlusion 
cuff, and atraumatic PVC lens tip. 22 
The lmageCath system As shown in Figure 2-4, the ImageCath angioscope is a disposable dedicated coronary angioscopy catheter. Its optical bundle has a total diameter of o.6 mm, including 3000 imaging fibers with a diameter of 2-3 µm, a concentric ring of 120 µm illumination fibers, and a stainless steel and pvc housing. The objective is a 0.25 mm diameter Gradient Index (GRIN) lens, providing a 55° Field of View, and a Depth of Field beyond 0.5 mm.65 The catheter body is made of polyethylene, and has a 4.5 French (1.5 mm) outer diameter.68 It can be inserted through 8 French (2.67 mm) PTCA guiding catheters, with the drawback of very limited proximal contrast injection capability through the guide because of the relatively large catheter shaft diameter. We recommend guiding catheters with an inner diameter of 0.082-0.084 inch 
(2 .08-2 . 1 3  mm) to allow manual contrast injections, which can be important for accurate placement of the occlusion balloon and lens tip. The angioscope actually consists of 2 coaxial catheters, with the inner catheter containing the imaging bundle. The outer catheter features a low-pressure occlusion cuff at its tip, which is inflated via a small secondary channel. This occlusion cuff is made of Kraton™ (Shell Chemical Corporation), which is a soft, thin, very compliant, elastomeric material. It can be filled with a saline/contrast mixture, and inflated to circa 6 mm. The inner catheter can travel freely inside the outer catheter over a 5 cm trajectory (Fig 2-5) : the fiber bundle, and with it the lens tip, can be probed through the coronary artery by moving the back end in a longitudinal direction. Although the inner catheter can be rotated at its back end, it does not have torque transmission capabilities.The entire catheter assembly feels somewhat rigid, however the thin 1.8 French (o.6 mm) probing imaging bundle has enough flexibility to follow most curves in the coronary arteries. The PVC lens tip assembly has a largest diameter of 4.5 French (1.5 mm), and houses the distal aperture and lens of the imaging bundle, and a short wire channel which can accommodate a 0.014 inch (0.36 mm) guidewire (Fig 2-6). This construction, together with the co-axial double catheter design, enables the operator to probe the fiber bundle over the guidewire while keeping the occlusion cuff inflated. The guide­wire enters a second, 'monorailm type lumen in the outer catheter shaft, exiting again at a 23 cm distance from the entrance. This double monorail system has been termed the 'GuideRail' system, and is designed for rapid exchange of the angioscope for PTCA catheters or other devices and vice versa. Radiopaque markers are mounted on the main catheter shaft just proximal to the occlusion cuff, and within the lens tip assembly. This enables the operator to accurately control the site of occlusion of the 
artery, and to correlate the lens tip position with the obtained intraluminal images. 
The main lumen of the outer catheter, containing the inner catheter, is also used for 
irrigation. The clear fluid exits the catheter just distal to the occlusion cuff. 
The Y-connector at the back end of the catheter contains the proximal irrigation port, 
and an adjustable pressure valve to prevent backflow during flushing and to allow 
longitudinal movement of the fiber bundle (Fig 2-7). 
Connections I An optical (c mount) coupler connects the proximal image bundle aperture to the 
FIGURE 2 . 1  Proximal part of the angioscope: inflation / 
deflation port of occlusion cuff, and Y-connector with 
adjustable pressure valve and irrigation port. 
ccn camera. The image, magnified by a factor of 7.5, is focused by means of an 
adjustment ring. The small 0PTX 3000-P ccn camera is connected to the optical 
coupler (Fig 2-8). The camera contains a 1/2 inch format ccn, which reaches 330 
lines vertical resolution, has a light sensitivity of 5 lux, and an automatic shutter and 
automatic white balance. A new, improved camera will be available in the first half of 
1994. We have had the opportunity to evaluate this new camera, which has a 1/3 inch 
format ccn and offers a resolution of 43ox4 70 TV lines, in 4 patients. As a result of 
this enhanced resolution, as well as its higher light sensitivity, the images appear to 
have a substantial better contrast and color fidelity. A light cable connects the light 
source to the angioscope, with ACMI connectors at both ends. The 0PTX 300-I light 
source features a 300 Watt Xenon ceramic short arc lamp, with continuously 
adjustable light output. 
Second generation lmageCath I A new, improved version of the coronary ImageCath catheter will be available from 
F IGU RE 1 - a  Connections of light cable and CCD camera/ 
optical coupler. 
Is there room for improvement? 
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spring 1994. In October 1993, we have tested a prototype of this new catheter in 3 
patients, with excellent results. The optical properties of the new angioscope have 
remained unchanged, but its handling has been improved by means of changes to the 
proximal Y-connector. This Y-connector now has a pre-set, low friction, silicone 
coated seal, and a Teflon coated hypotube as the part of the fiber bundle that travels 
through this seal. The result is that the fiber bundle can be probed with considerable 
less resistance in the hemostatic valve, resulting in a much better tactile feedback of 
the lens tip to the operator. In addition, the preparation of the angioscope has 
become easier and quicker due to a simplified method of pre-filling the irrigation 
channel and purging the catheter from air. A folded sterile sleeve is pre-attached to 
this new angioscope to rapidly connect the camera and light source (Fig 2-9). 
The ImageCath system has brought angioscopy within reach of every interventionist 
with adequate PTCA experience. The system is user friendly and yields excellent 
images. The fact that it does not have real competitors however has its disadvantages 
too. It has taken the manufacturer nearly 3 years to launch the above described 
FIGURE 2-9 Improved back-end of the second generation 
lmageCath, featuring low-friction preset pressure seal and 
sterile sleeve attached to the connectors. 
FIGURE 2 - 1 0 In a curve, the lens of the angioscope is usually 
directed toward the opposite vessel wall. A curved probing 
fiber bundle can potentially solve this problem in tortuous 
vessels. 
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improved version. Although the optical system still offers state of the art imaging, it could benefit from a wider field of view or improved contrast. In the previous section, it was pointed out that the system has every desirable feature for a coronary angioscope but one: it clearly lacks a mechanism to steer or deflect the lens tip. The main cause for insufficient imaging of the target, and indeed the prevailing reason for rejecting a case when screening angiograms for 'angioscopability', is tortuosity of the artery. Even moderate tortuosity, such as the first curve of the normal Right Coronary Artery (RCA) can cause the angioscope to be directed toward the vessel wall rather than toward the lumen. 53 We have reviewed the 9 unsuccessful imaging attempts of our series of 135 angioscopy procedures. Unsuccessful imaging was defined as visualization of less than two-thirds of the circumference of the vessel wall at the target site. Imaging was inadequate because of a technical failure in one patient, and because of massive collateral flow, obscuring the lumen, in another patient. In the remaining 7 patients, incomplete visualization was caused by an eccentric lens tip position. In all seven cases, the guidewire was seen at the opposite side of the vessel wall. This indicates that the guidewire follows the inner curve of such an artery bend, while the angioscope takes the outer curve in the majority of cases (Fig 2- IO) .  This is not surprising, since a PTCA guidewire is more flexible than the imaging bundle. From this observation it can be deduced that a higher imaging success rate could be obtained with a special, curved version of the ImageCath, as is drawn in Figure 2-10. It is sometimes helpful to bend the fiber bundle before introduction of the angioscope. In our opinion, the ideal ImageCath scope would have a slight curve in the distal fiber bundle, as well as r to r torque transmission capability of the inner catheter. If this could be achieved, for instance by adding a wire braiding to the structure of the inner catheter, it would provide steerability and allow the operator to achieve optimal co-axial alignment while tracking the guidewire. 
FIGURE 2 -1 1 OPTX 300 Xenon light source and elctronics 
housing of OPTX 3000 angioscopy video camera. 
FIGURE 2 - 1 2  Mitsubishi CP50E video copy processor. 
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Video and processing equipment Since angioscopy renders images in full motion, and because a single still frame contains very little angioscopic information compared to a full examination, it is essential to record these moving images for later retrieval and review. The simplest and most obvious way is to connect a video tape recorder to the camera. The camera has a composite-video (BNC connector) and a Super-VHS (v/c connector) output. The European version uses the PAL video standard (A NTSC version of the same camera is used in the United States) . Apart from the light source and the camera electronics (Fig 2-u), it consists of a 14 inch (36 cm) Sony PVM 1440 QM multi-system color monitor and 2 Super VHS videorecorders for recording, and copying or editing of recorded angioscopy procedures. Initially we used Sony u-matic video cassette recorders, but now prefer modem, off-the-shelf, Super-VHS systems because of their significantly lower cost, easier transportability both of recorders and videotapes, and to the naked eye indistinguishable picture quality. A video-mixing panel can be added to the video-chain. This can very conveniently be used to record fluoroscopy (by means of the analog output of digitally enhanced cine angiography systems) and angioscopy simultaneously. A video character generator can be used to store patient data on tape. The production of single still images, although a poor representation of a complete angioscopic examination, is needed for the preparation of manuscripts, for slides, and for other documentation and presentation material. It has long been a problem to rapidly obtain such photo-like pictures. We have evaluated the Polaroid Freeze Frame Video recorder. With some video picture enhancement controls, this device produces slides or photographs of acceptable quality. The main drawback is that these slides and photographs have to be processed, unless the lower quality Polaroid immediate-processing film is chosen. The recent development in dye-sublimation type of full color video printers has largely solved this problem. We now use a low­cost Mitsubishi CPSOE A6 size video copy processor (Fig 2-12) with good results. This processor is easily installed within the video-chain, and accepts composite-video as well as s-video (v/c) input. It offers control over color levels, sharpness, contrast and brightness, and produces a photo-like picture in r¼ minute. Another method to obtain still images or slides is digitalization and enhancement using microcomputers. 
Digital image acquisition and storage The new technology of digital full-motion video opens new possibilities for all kinds of image processing. On a large scale, this technology is used by the film industry, by all kinds of complex medical and other imaging systems, but on a much smaller scale it is now available in personal microcomputers, opening the road to simple digital acquisition, storage, and manipulation of medical diagnostic imaging tools like angioscopy. In 1992, QuickTime™ software was introduced by Apple for their line of Macintosh™* personal computers (Apple Computer, Inc., Cupertino, CA, USA). QuickTime is an extension of the Macintosh operating system, which enables the computer to digitize and record video and sound to its internal memory or storage medium, and to edit, manipulate and playback these digital recordings. 74 Special QuickTime programs, or QuickTime compatible versions of major applications like databases, word processors, and presentation programs are needed to take advantage of this technology. In addition, hardware to digitize the analogous video (and audio) signal is required. Some of the latest Macintosh computers have built-in digitizing circuits and chips, other models need add-on digitizing boards. 
Digital angioscopic recordings I We have applied this QuickTime technology to our angioscopy program.75 Angioscopic digital video recordings can be acquired either off-line from videotape, or directly from the angioscopy camera. The Super-VHS videorecorder, or the 
F IGURE 2 . 1 3  Screenshot of FusionRecorder™ digital video 
recording program. The controls at the bottom can be used to 
play, quick-search, step-search or pause. The program allows 
for simple editing, as well as copying and pasting of video 
fragments or still frames. 
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camera, is connected to the y/c input channel of the image-grabber board or the on­board video of the Macintosh computer .... We have used a Macin�osh Quadra 700 computer with a RasterOps 24 STV image grabber (RasterOps Corp .), and recently a Macintosh Quadra 840 AV model which features a built-in on-board video digitizer. These systems are able to grab an analog s-VHS or Composite-Video signal at 24 bits color depth, providing 'true-color' digitalization (theoretical simultaneous on-screen availability of 16.8 million colors). Special software is needed for recording: we use FusionRecorder™**. This is a small application program which permits the user to record, play back, and edit sound and video (Fig 2-13) . An essential feature for angioscopic recordings is that a rectangular part of the entire screen can be selected prior to recording, so that only this selection will be recorded. Because the angioscopy camera outputs a relatively small angioscopic image, careful selection to exclude the rest of the screen (which remains black) saves massive amounts of storage capacity, and increases the capture rate in frames per second. Single frames, 
* Quicktime™ and Macintosh™ are registered trademarks of Apple Computer, Inc., Cupertino, CA, USA. 
** FusionRecorder™ is a registered trademark of VideoFusion, Inc. 
or parts of recordings, can be copied and pasted as pictures or screen movies into other recordings, or into other application programs. To obtain the highest capture rate, the recordings are first stored in Random Access Memory (RAM), and written to the computer's hard disk after completion of the recording. These digital video recordings consume large amounts of memory. We record our angioscopy runs to windows of, on average, 194x194 pixels (approximately 7x7 cm when viewed on a 36 cm monitor). Recordings of this size, when stored at 24 bits color depth and in uncompressed QuickTime Movie format, occupy about 1.5 megabyte per second. It is advisable to install at least 24-40 megabyte (MB) of internal RAM, and to use high capacity hard drives. In addition to 0.5 MB and I gigabyte (GB) hard disks, we use 3.5 inch 128 MB erasable optical disks for long term storage and transport of our digital angioscopic recordings. Applications such as FusionRecorder offer various, software based, compression algorithms, which dramatically reduce the required memory and disk space. In our tests with angioscopic recordings, however, these algorithms resulted in a substantial loss in image quality, and in a reduced capture rate. Under optimal circumstances, i.e. using the Macintosh 840Av with its powerful 40 MHz 68040 processor, and recording a 194x194 pixel window to RAM, we can reach about 15 frames per second, which renders a fairly smooth running 'movie'. Various third party vendors now offer QuickTime compatible 'CoDec' (Compression-Decompression) boards, which use hardware compression techniques such as Joint Photographic Experts Group (JPEG) compression in specialized chips. With this type of real-time high speed compression, the digital image data are compacted such, that relatively low data transfer rates can be used with minimal loss of image quality. At the present time, these CoDec boards are the only possibility to obtain full-screen (64ox480 pixels or more), full-motion (25-30 frames/sec), and full­color (24 bits color depth) video on these microcomputers. We do not use these CoDec boards because with angioscopy we do not need full screen video, and because these boards have the drawback that they have be installed in every computer that is used to play the digital videorecordings. In contrast, normal QuickTime recordings can be played on almost any Macintosh, which is essential to our project of a digital angioscopy atlas. 
Applications I Our main purpose of QuickTime based digital angioscopy recording has been the development of this digital angioscopy atlas. This work is closely related to the efforts of the European Working Group on Coronary Angioscopy to formulate a classification system for angioscopic observations, and is discussed in chapter 3. Another, practical, application is to store angioscopic recordings within a database containing administrative, clinical and descriptive patient data. Using for instance 
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F IGURE 2 . 1 4  Schematic drawing of coronary segments 
suitable for angioscopy. 
FileMaker Pro™*, each record of the database can have its own (if necessary edited) QuickTime angioscopic recording. Angiographic recordings can also be added to these records, if they are recorded from video or the analog output of digital angiography installations. The obvious advantages are ease of retrieval, compact and reliable storage, and consistence of quality with back-up copying and reproduction. This computer setup also facilitates a rapid and easy production of still frames. To obtain a single frame, a digital recording is retrieved from the angioscopy database in order to select a suitable single frame. Using the 'Copy' command, this frame is then temporarily stored in the Macintosh clipboard to be 'Pasted' into Adobe PhotoShop™** , which is a program for image manipulation. If necessary, the colors and contrast of the picture can be enhanced in PhotoShop. Text and arrows can be added. The image can subsequently be saved in various file formats. The angioscopic images in this book are all reproduced with this technique. Images like these can be saved in the Tagged Image File Format (TIFF) or Encapsulated PostScript (EPS) format. These TIFF or EPS files can be used by the printer's imagesetting equipment. We can also print these enhanced images on the earlier described Mitsubishi video copy processor. Presentation slides can be made by importing such images in one of the available presentation programs such as Aldus Persuasion™*** and MicroSoft PowerPoint™****. These slides are then produced with one of the many available computer film recorders. 
Procedure of coronary angioscopy The actual catheterization procedure of coronary angioscopy, using the ImageCath system, is very simple. A trained interventional cardiologist can learn the required maneuvers during one or two instruction procedures, and be fully familiar with it after a learning curve of about IO procedures. 
Selection of suitable imaging sites I To obtain an optimal imaging success rate, it is important to select the coronary trajects to be visualized carefully. Figure 2-14 shows the parts of the coronary tree that, in general, can be imaged. The proximal r cm of any of the three coronary vessels can not be imaged because of the distance of the occlusion cuff to the field of view in front of the lens tip. The angioscope is especially suitable for the mid 
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* FileMaker Pro™ is a registered trademark of Claris™ Corp. 
** PhotoShop™ is a registered trademark of Abobe Systems Inc., Mountain View, CA, USA. 
* **  Persuasion is a registered trademark of Aldus Corp., Seattle, WA, USA. 
* * * *  PowerPoint™ is a registered trademark of Microsoft Corp. 
segments of the main coronary branches, although occasionally a large side branch can be entered too. Proximal vessels with excessive tortuosity, or for instance a Left Circumflex artery (Lcx) with a sharp take-off from the left main stem, should be avoided because of the main catheter body's inherent stiffness. Forceful cannulation of such a trajectory could result in serious intimal dissection. The site of inflation of the occlusion cuff should be relatively straight to prevent an eccentric, wall directed, field of view. For instance, the very first curve of the proximal RCA can not usually be imaged well. The diameter of the vessel to be imaged should exceed 2.5 mm. Because of the rather severe ischemia that is induced during occlusion and irrigation, the operator should avoid 'last remaining vessels' or patients with extreme left ventricular failure. 
P reparation and setup I After removal from its sterile package, the disposable angioscope is placed on the sterile working area of the fluoroscopy table. Using a 20 ml syringe filled with a 50/50 mixture of saline and contrast, the air is aspirated from the occlusion cuff and its inflation channel (Fig 2-15) . The 1 ml syringe that is included in the package is then connected to the inflation port to perform a test inflation of the cuff. This 1 ml syringe should be filled with 0.5 ml of the same contrast/saline mixture. 
FIGURE l-1 s A 20 ml syringe is used to apirate air from the 
occlusion cuff and its inflation channel. 
The angioscope is then connected to the ccn camera and the light cable, which are covered by a sterile sleeve. The light source is switched on, and the white balance of the camera is set with the lens tip close to a white surface (for instance a sterile gauze). The focusing ring of the optical coupler is adjusted until a sharp image is observed on the monitor. The videorecorder is made ready for recording. The power injector should be filled with prewarmed saline or Ringer's lactate, and is connected by pressure tubing to the irrigation port of the angioscope. The injector is programmed at a flow rate of 30 ml/min and a maximum back pressure of 1 50 psi (ro.6 atm). The Y-connector and irrigation channel are purged from air using these power injector settings. Finally the adjustable pressure valve of the angioscope is set to allow back and forth movement of the fiber bundle without backflow of irrigation fluid. 
P rocedure I Angioscopy can be performed before or after angioplasty, or without intracoronary intervention. A 0.014 inch (0.36 mm) PTCA guidewire, inserted through a 8 French (2.67 mm) guiding catheter, should be positioned as deep as possible in the artery of interest. We prefer the use of a High Torque Intermediate™ (HTI) guidewire (Advanced Cardiovascular Systems, Santa Clara, CA, USA) over very 'floppy' wires to have optimal guidance of the lens tip and to avoid 'wire-trapping' (this is discussed later) in vessels with some tortuosity. The two monorail wire channels of the 
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FIGURE 2-1 6  Position of the angioscope 
during imaging under fluoroscopy. 
FIG URE 2-1 1  <LEFT> Adequate imaging, 
slightly eccentric lens tip position. 
FIGURE 2 - 1 s  (RIGHT> Optimal imaging, 
central lens-tip position (Bull's eye view). 
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angioscope are guided over the proximal end of this wire. Under fluoroscopy, the angioscope is carefully introduced into the coronary artery, and the occlusion cuff, marked by its proximal radiopaque marker is positioned at the selected site (Fig 2-16) . We prefer to introduce the scope with the fiber bundle 2-3 cm extended to negotiate the first bends with maximal trackability. When nearing the imaging site, the fiber bundle is then held in place while advancing the main catheter shaft until the lens tip is back against the main shaft. Under continuous fluoroscopic, ECG, and aortic pressure monitoring, the irrigation is started and the occlusion cuff inflated. The occlusion cuff has a very small volume, and 0.5-0.8 ml usually is a sufficient inflation volume. Even with the 1 ml syringe, care should be taken not to over-inflate. We recommend to start irrigation first, to inflate slowly, and stop inflating as soon as a clear picture starts to form on the monitor. The inflation port can be closed by means of the sliding gate valve. The first images are checked for a correct position of the lens tip. The guidewire, and at least a part of the lumen should be visible (Fig 2-1 7, 2-1 8) .  The occlusion balloon should be deflated and repositioned if, even after gentle probing movements with the fiber bundle, only the vessel wall can be visualized. Small position changes, in the order of a few mm, of the occlusion cuff can often be sufficient to obtain better results. It is useless to try inflation and imaging if the image is not entirely red before irrigation is started: a white or partial white appearance of the image in this situation indicates that the lens tip is placed against the vessel wall and thus too eccentric for image acquisition. As soon as a satisfactory initial image is observed, recording on videotape is started, and the probing fiber bundle is slowly advanced over the guidewire under continuous irrigation. The video recordings will be difficult to review if these fiber bundle 
Lumen Guidewire 
Guidewire Lumen 
movements are too rapid. The irrigation flow rate should be adjusted to a higher setting if the picture is unclear because of the presence of blood despite irrigation, for instance in case of collateral blood flow. We have not used flow rates exceeding 60 ml/min. The combination of proximal occlusion and irrigation produces ischemia to the extent that the imaging duration is usually limited to 30 seconds because of chest pain. After deflation, and allowing time for recovery, the procedure can be repeated, if necessary with a changed catheter position. In our experience one or two of these imaging sequences per procedure are generally enough to obtain all the necessary recordings. 
Probing I As described above, the fiber bundle can be advanced and withdrawn during imaging to inspect the artery over a distance of maximally 5 cm. In the native coronary arteries, this is a very long trajectory, and it is in fact usually limited by the distal curves in the artery rather than the maximum possible fiber bundle extension. In vein grafts, this extension can often be used to its maximum. During this fiber bundle maneuvering, the operator should primarily observe the angioscopic monitor, and only occasionally glance at the fluoroscopic screen - intermittent fluoroscopy may be used - to check the lens tip position. This ensures a safe and atraumatic procedure: the operator is warned to stop probing, or to proceed very carefully, when vision is obstructed by the vessel wall, a plaque, a stenosis, or a thrombus. A stenosis can be crossed with the lens tip if it is not extremely tight. However, a 'Dotter' effect of mechanical catheter dilatation can be observed sometimes on angiography afterward. 
W ire- trapping I Facilitated by its GuideRail system, the angioscope is rapidly removed, and if necessary exchanged for an angioplasty catheter, after completion of the procedure. The fiber bundle should be withdrawn with some care to avoid the phenomenon of wire-trapping,39• 53 which results from a loop formation of the guidewire between the two monorail wire channels of the scope. It can occur when the fiber bundle is withdrawn, and the coils of the guidewire catch on the PVC tip of the angioscope. This problem can potentially cause dissection or may result in an unwanted loss of the guidewire from the vessel, but it can easily be avoided by careful fluoroscopy. Some operators prefer a guidewire with a 30 cm radiopaque tip to avoid wire trapping. When it threatens to occur, it is easily countermeasured by extending the fiber bundle first and then withdrawing it with fluoroscopic control. 
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Experience in 1 00 patients - safety and success From September 1991 until November 1993, coronary angioscopy was performed in our catheterization laboratory in 100 patients (75 male and 25 female, mean age 61.6 years, range 40-86 years) . These patients underwent angioscopy before and/or after PTCA, and in some cases without intervention. The indications to perform angioscopy, and the resulting observations, will be discussed in chapter 4. Below, the safety and the imaging success rate of the procedure are described. 
Safety I All catheterization techniques which include manipulation of guidewires and catheters inside the coronary arteries carry the potential risk of sudden, unexpected complications.76• 77 These complications can be serious to the extent that they cause myocardial infarction, the need for emergency bypass surgery, or death. None of these major complications, which are usually caused by acute coronary artery closure, occurred in our angioscopy patient group. Mortality caused by coronary angioscopy has also not been reported in the literature. The (minor) complications that occurred in our series of 100 patients are listed in table 1. 
TABLE 1 Angioscopy related complications and technical 
problems in 1 00 consecutive patients. 
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Patient Nr Compl ication Consequence 
3 Ventricular fibrillation DC cardioversion 
5 Ventricular fibrillation DC cardioversion 
26 Wire trapping in RCA Scope retrieved together with wire. 
No vessel damage 
42 Angioscope related PTCA balloon inflation with good result 
dissection in CX 
44 Balloon deflation failure Angioscope manipulation to desobstruct 
the inflation channel 
81 Wire trapping in RCA Corrected by manipulation. No vessel damage 
Small intima flap 
Small intima flap 
FIGURE 2-1 !1 Small intima flaps, not visible at the first 
antegrade passage, can sometimes be observed at 








FIGURE 2-20 Average time ± standard deviation to report 
subjective chest pain in 17 patients during angioscopy versus 
PTCA balloon inflation. 
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We have seen angiographic evidence of dissection in one patient. This occurred when trying to cannulate a tortuous part of the LCX with the angioscope. This dissection, which did not result in ischemia or impaired flow, could be treated with a 5 minute inflation of a PTCA balloon catheter at low pressure. Angioscopy related dissection has been reported to result from guidewire looping. 39• 53 Wolff et al have described a case of pseudo-aneurysm formation and dissection resulting in emergency bypass grafting. 78 This was caused by deliberate rapid over-inflation of the occlusion balloon, to rupture an occlusion balloon that could not be deflated. The inability to deflate an occlusion cuff has been encountered incidentally in the ImageCath catheters. It was induced by an eccentric position of the inflated balloon, so that the balloon material covered the single hole of the inflation/deflation channel. We have encountered it in one patient. Gentle longitudinal motion of the entire angioscope while trying to in­flate and deflate with very small volumes should be sufficient to de-block the balloon channel and deflate rapidly, as it was in our single experience with this phenomenon. Although major, angiographically visible dissection seems to result rarely from angioscopy, we have the impression that it more often causes small surface disruptions. In 12 cases, very small, mobile flaps that were not detected at the first pass could be seen at withdrawal or at the second pass of the angioscope (Fig 2-19). These angioscopically observed flaps were indeed very small, and far below the detection threshold of angiography. Much more of these small, but also larger, flaps are invariably seen after balloon angioplasty. It can be assumed that these small disruptions, which are only detectable by angioscopy, can occur with the passage of any type of intracoronary catheter. We have seen ventricular fibrillation in 2 patients (nrs 3 and 5). They occurred during our learning curve, and resulted from excessively long ischemia in the RCA supply area. These incidences of VF were easily cardiovertable. We have noted that chest pain during angioscopy invariably occurs earlier during occlusion, and is more severe than during PTCA. In 16 consecutive patients we have compared the average time to onset of subjective chest pain during angioscopy occlusions and PTCA balloon occlusions (Fig 2-20). During angioscopy, the time to onset of AP was 17± 6.9 seconds (mean ± standard deviation). It took 82±62.2 seconds for the patients to develop chest pain during PTCA, which was a statistically significant difference (Paired t-Test, P=o.0004). This test of subjective chest pain was intended to confirm our impression that it occurred earlier, but is of course not a proof of earlier and more severe ischemia during angioscopy. Nevertheless, it is likely that ischemia is more severe, because the occlusion is more proximal than during PTCA, and, more 
importantly, the remaining oxygenated blood is vigorously flushed from the occluded 
coronary vasculature, counteracting collateral filling. Another contributing cause may 
be that the compliant occlusion cuff blocks the antegrade blood flow entirely, while 
the non-compliant balloon of a PTCA catheter may allow some blood to pass. During 
imaging, the occlusion cuff of the angioscope is inflated in the coronary artery 
proximal to the site of interest. Although it is a soft and atraumatic balloon, there has 
been some concern that this may cause intimal hyperplasia and thus lead to luminal 
narrowing. Clinical occlusion cuff luminal narrowing has until now not been 
reported. Hamon and Lablanche et al have used Quantitative Coronary Angiography (QCA) in 33 patients to demonstrate absence of a decrease in Minimal Luminal 
Diameter (MLD) of the site of inflation of the occlusion cuff at 6 months follow-up 
angiography. 79 
In conclusion, with the absence of major complications in our series of 100 patients, 
and a very low number of reported complications in the literature, angioscopy can be 
regarded as a safe intracoronary imaging procedure. 
Succes I The reported rate of successful angioscopic imaging of any investigator is entirely 
dependent on the used definition of success, on the selection of patients and 
coronary segments, and, to a lesser degree, on the operator's routine and skills. Our 
definition of successful imaging is as follows: a clear field of view of the targeted 
coronary segment, with at least % of the vessel wall circumference of the· target site 
visible. Although the vessel wall, and not the lumen, is the object imaging, this 
definition implies that, at the target site, at least % of the lumen should be visualized. 
Using this definition, we have a 9 1 %  success rate (9 1 of 1 00 patients). Adequate 
imaging was not obtained in 7 patients because the lens tip had an eccentric position 
in the target segment. The result was that less than % of the vessel wall 
circumference was visualized. Thus relevant pathology of the opposite, non 
visualized, side of the inner artery wall may have been missed altogether by 
angioscopy in these patients. One procedure failed because of a leaking Y-connector. 
Since this patient was in a very unstable condition, the procedure was aborted 
instead of using a new angioscope. Finally, in one patient with a severe proximal lad 
stenosis clear imaging was hampered by collateral flow a la!ge diagonal branch. The 
occlusion cuff had to be inflated proximal to the orifice of this branch, while the 
target site was located more distally. We think that this 9 1 %  success rate is 
acceptable, but the number of failures due to an eccentric lens position indicate that 
it could be improved with some means of tip deflecting or steering. Moreover, the 
selection of eligible patients would benefit from such a catheter refinement, since 
considerably more lesions would be suitable for angioscopic imaging. 34 
3 J The interpretation of angioscopic images 
What can be detected? Angioscopy visualizes the inner surface of the coronary artery wall, as well as structures within the coronary lumen. Angioscopic observations are based on the ability to detect differences in colors and contours. In order to describe pathological changes, the observer should be able to recognize the normal appearance of the coronary artery lumen and wall. 
Normal coronary artery I Normal coronary arteries have been characterized by a yellow-white, smooth, non­elevated appearance when inspected by angioscopy. 59• 80 To many observers, the color of normal vessel wall may appear to be gray-white rather then yellow-white. Attempts at description of colors often result in vague terms such as 'yellowish' and 'grayish', which is a clear demonstration of the subjectivity of color interpretation. This was 
Smooth gray vessel wall 
confirmed by the observer panel of the European working group on coronary angioscopy during its meetings (see appendix III). The Kappa values for chance 
Orifice of sidebranche 
FIGURE 3 .1 Normal coronary artery. 
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corrected inter observer agreement on colors were among the very lowest, representing a poor or even absent agreement beyond chance.45 Furthermore, color interpretation is not only subjective, but also seriously influenced by the color representation and settings of the videocamera and monitor. Although it thus appears that the interpretation of colors is subjective and variable, this does not imply that the detection of color changes should be regarded as difficult. Based on the experience of the European working group on coronary angioscopy, we postulate that, in observations with only slight color differences, the detection of the presence or absence of these color changes is both easier and more meaningful than trying to name the actual colors. Pathological changes of the vessel wall that can be detected at angioscopy, are identified for a large part by their different colors, compared to non­diseased parts of the arteries. We therefore propose to identify a normal vessel wall by its uniformity of color, rather than discuss if this color is white, gray, or yellow. Other, equally important features of angioscopically normal arteries are the smoothness of their surfaces and contours, and the absence of protrusions and abrupt diameter changes. Figure 3-1 shows an example of an angioscopically normal coronary artery. 
Thrombus I Angioscopy, mainly because of its ability to discriminate colors of intracoronary surfaces and structures, is an eminent imaging tool to identify intraluminal thrombus.1 7• 28• 36• 42• 6 1 •  62• 80-85 Intracoronary thrombus is usually adherent to the vessel wall (Fig 3-2), but occasionally large, free floating thrombi, that obstruct the antegrade coronary flow, can be visualized. Occasionally, thrombi can be seen that adhere to the coronary guidewire (Fig 3-3). These guidewire thrombi may be caused by detachment from the vessel wall and sticking to the guidewire during its introduction. Theoretically they could also originate on the guidewire (if it remains in the vessel over a prolonged period), due to its inherent thrombogenicity, but until now we have not observed this. 86 The situations in which thrombi may be found in the coronary arteries, as well as the significance of these thrombi, are discussed in chapter 4. Their general appearance is that of an intraluminal mass. This mass, although it adheres to the vessel surface, clearly is a separate structure. The sizes of intracoronary thrombi may vary from small patches on the surface to large, protruding, obstructing masses. Larger thrombi often have some mobility, and undulate in the flowing irrigation fluid. Sometimes, thrombus can be seen to dissolve slowly in the fluid stream. The color of a thrombus may be red, white, or mixed red and white. A red coronary thrombus consists of fibrin, mixed with erythrocytes, leukocytes and platelets, whereas white thrombi only contain a tight fibrin network and platelets.2 1 ' 87 In our opinion, the diagnosis of a purely white thrombus should be made with caution. It can be difficult or impossible to reliably distinguish a white thrombus from a white, mobile, intima flap. A white thrombus, due to its composition of fibrin strands, has a cotton-wool like appearance at angioscopy. The diagnosis can be made with greater certainty if the white thrombus contains red elements, and is in fact a mixed red and white thrombus. 
F I G U R E  3 - l  (LEFT) Mural, mixed red and white thrombus. 
F I G U R E  3 - 3  ( R I G HT> Mixed red and white thrombus, 
attached to the guidewire. 
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White part of thrombus Red/white thrombus 
Mural thrombus Guidewire 
FI G U R E  3 . 4  CLEFT) Yellow atheromatous plaque. 
Atheroma I Atheroma is characterized histologically by an increased width of the intima containing a lipid-rich region, with some discontinuity of the internal elastic lamina. There may be thinning of the underlying media. 88• 89 The presence of lipid deposits within the smooth muscle cells and macrophages gives the atheromatous plaque its pathognomonic bright yellow color at angioscopy (Fig 3-4). In addition, the luminal surface often has elevations or protruding parts, although it may have a smooth contour. In the latter case, we use the angioscopic term of a lining atheroma.45 Not all plaques are yellow: fibrous plaques can have an almost pure white angioscopic appearance . 89 With this white color, it may be discerned from the normal vessel wall mainly by the luminal narrowing, protrusions or elevations it can cause. Unstable atheromatous plaques, with ulceration, tears, fissures, and dissection have been associated with unstable angina.90-92 At angioscopy, these unstable atheromatous plaques are seen as disruptions of the intima, with patchy discolorations, and mobile irregularities (Fig 3-5). Thrombus or wall hemorrhage may also be observed in these ruptured plaques. 
Yellow atheroma Irregular lumen 
FIG U RE 3-s CRIGHT> Unstable atheromatous plaque, 
characterized by patchy colors, intima flaps, and irregular 
lumen shape. 
Lumen Patchy, friable plaque 







3.0 mm lumen 
1.5 mm lumen 
1.0 mm lumen 
0.9 mm lumen 
0.8 mm lumen 
0.72 mm lumen 
0.014" (0.36 mm) wire 
angioscopy system (Fig 3-6). Theoretically, a perfectly round lumen that could contain only one or two 0.014 inch (0.36 mm) wires would have a minimal luminal diameter of o. 72 mm or less , and could thus be considered an important stenosis. Since the remaining lumen of a stenosed segment more often than not has an ellipsoid, irregular or slit-like shape, which makes the area of the stenosis even less for a given number of guidewires fitting in it, a more practical estimation might be to take the theoretical space to cannulate the stenosis with 3 of these guidewires. This method of imaginative guidewire sizing however proved to be of limited value when evaluated by the European working group on coronary angioscopy, because it was associated with a large intra- and inter-observer variability. A rough visual estimation of a narrowing by coronary angioscopy is best carried out by classifying the stenosis only as the presence or absence of a narrowing or total occlusion. A conceivable method for quantifications of luminal diameters is being investigated by Spears et al. 93 
F 1c.unE  3 -&  Numbers of 0.014 inch (0.36 mm) guidewires 
that would theoretically fit inside perfectly round stenoses 
with different diameters. 
A transverse ring of fiberoptically transmitted laser light is emitted from a 'lightwire' at a constant distance from the lens to define measurable cross-sections. Although this method looks promising, it is still too early to predict if it will reach clinical applicability. At the present time, it must be recognized that angioscopy is not an ideal tool for visual estimation or automated quantification of coronary artery narrowings. Quantitative Coronary Angiography (QCA) and Intravascular Ultrasound (IVUS) imaging provide excellent measurement methods, diminishing to some extent a large need for this in angioscopy, which has its own, specific, imaging potential. Nevertheless, angioscopy can be of some additional value for stenosis measurements using angiography or even QCA, because it enables the observer to identify the shape of the remaining lumen and thus predict if the phenomenon of angiographic underestimation of a very irregular shaped stenosis would occur. 
Restenosis I Luminal renarrowing secondary to balloon angioplasty is histologically characterized by proliferation of smooth muscle cells and fibrous tissue. 94•95 This fibrous aspect has been recognized at angioscopy of restenotic lesions by White and co-workers.4 1 • 99 The restenotic lesion has a distinct white, smooth, appearance. 
Dissection I Intimal dissection can occur either in unstable atheromatous plaques90-92 or as part of the working mechanism of angioplasty.97• 100-105 The distinct angioscopic feature of dissection is mobility: thin fragments of dissected intima behave in the irrigation fluid stream like flapping sails in the wind (Fig 3-7). This explains why especially dissection is difficult to reproduce on photographs, and should be judged during the angioscopy procedure, or on video recordings. We have successfully performed post­
PTCA angioscopy in 66 cases. Some degree of dissection was observed 
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FIGURE 3.7 <LEFT> Small, mobile intima flaps. 
FIGURE 3-s <RIGHT> Wall hemorrhage: red discoloration 
within the vessel wall, rather than on its surface. 
Guidewire and lumen Wall hemorrhage 
Small, very mobile flaps Wall hemorrhage following PTCA in 92 % of these cases. Angioscopically visible dissection after PTCA can be divided in 2 types: multiple tiny flaps, in the order of tenths of a millimeter, that can be seen in virtually all post-angioplasty observations, and larger, more severe, surface disruptions, which typically obstruct the visualization of the vessel lumen to some extent. We have learned from our standardization efforts with the European angioscopy working group, that it is not useful to classify angioscopic dissection in more than these two grades. Although coronary angiography generally is considered as the gold standard to demonstrate intimal dissection, 106 it appears that angioscopic dissections are frequently missed by angiography. Although this is particularly true for the above described small flaps, we have found that even large intimal surface disruptions can be totally obscured by angiography in multiple projections. On the other hand, angioscopy, due to its inherent inability to look behind the directly visible surface, can miss large, angiographically detected dissections. In this respect, these two imaging techniques are very much complementary. 61  (appendix IV) 
W all hemorrhage I Subintimal or medial hemorrhage has been reported at histologic examination of coronary artery segments previously treated by balloon angioplasty.96• 100, 101 This hemorrhage can be observed at angioscopy by patches or rings of red discoloration within the artery wall (Fig 3-8). These small wall hematoma can be difficult to distinguish from patches of mural, lining red thrombus, although these thrombi are by definition not located within the wall but on its surface. 
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Foreign bodies I It may sound trivial, but one corpus alienum that should always be observed at angioscopy using the ImageCath system, is the PTCA guidewire over which the lens tip tracks. This guidewire is an important orientation landmark, and shows the direction of the lumen. The angioscope is not properly aligned if it is not visible. As described above, it has some function of reference when trying to estimate the severity of a stenosis. Tiny air bubbles in the irrigation fluid are frequently observed, either floating downstream with the fluid, or sometimes sticking to the wall or the guidewire (Fig 3-9) . They can be recognized by their spherical shape and their light reflection. Coronary stents can be inspected by angioscopy.47' 5 1 ' 59' 108• 109 (Fig 3-10). We have imaged 7 Palmaz-Schatz™ stents Gohnson&Johnson, Warren, NJ, USA) and 2 Strecker™ stents (Boston Scientific, Watertown, MA, USA) . From our experience with the latter type of stent we recommend to avoid inserting the ImageCath angioscope into any stent with wire crossings, since the lens tip assembly can get trapped behind these wire crossings, with the consequent potential hazard of dislocation and embolization of the stent. 
FIGURE 3.9 <LEFTJ Air bubbles sticking to the guidewire. 
FIGURE 3 . 1  o ( R I G HT> Palmaz-Schatz™ coronary stent. 
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Guidewire and lumen 
Air bubbles Stent wires 
Comparison with other coronary imaging techniques Selective coronary arteriography is the traditional and universal technique for imaging of the coronary arteries, and for guidance of intracoronary interventions. 77' 1 10• 1 13 Because it provides ease of use, a high image quality, quantitative analysis tools, and a general anatomic overview ('road-map'), it will remain the single most important means of imaging for diagnostic and interventional catheterizations. Before coronary angioscopy became clinically applicable, the diagnostic imaging arsenal of 
the interventionist was enriched with another new tool: Intravascular Ultrasound (IVUs) imaging.1 14• 1 16 These two coronary imaging modalities will be briefly discussed, and compared to coronary angioscopy. 
Coronary arteriography and QCA I Coronary arteriography provides two-dimensional negative contrast projections of the 
FIGURE 3-1 1 Mural red/white thrombus, which is not visible 
on the angiogram. 
Frc.u RE 3-1 2 Large dissection seen at angioscopy post PTCA, 
which is totally obscured on the angiogram. 
lumina of the coronary arteries. Its advantages are well known and obvious: a rapid overview of the anatomy and stenotic lesions of the major epicardial coronary branches can be obtained with minimal invasiveness and complications. 1 17, 118 It is the worldwide used, gold standard for the diagnosis of coronary heart disease. The disadvantages of angiography are equally well known. The negative contrast image of the lumen tends to mask relatively small, but potentially clinically important, wall surface and intraluminal abnormalities such as atheromatous plaques, intimal dissections, and thrombi (Figs 3-r r  and 3-12).104• 1 19•125 With its superior sensitivity for these specific pathologic findings, angioscopy is a welcome addition to even the most advanced system of angiographic imaging (See appendix IV). Even with quantitative methods, the severity of stenotic narrowings is referenced to adjacent parts of the arteries on the assumption that these are not diseased. This is often an invalid assumption, which could be disproved by angioscopy. The absolute degree and the hemodynamic importance of a coronary stenosis, derived from arteriography, should be regarded with some caution. Nevertheless, computer assisted Quantitative Coronary Angiography (QCA), initially conceived and developed at the Thoraxcenter of Rotterdam, is now firmly established as an accurate and reproducible means for measurements of stenosis parameters such as the percentage of the stenosis diameter and the minimal luminal diameter.126• 121 In summary, angiography provides an anatomic overview and is suitable for quantitative stenosis measurements, while angioscopy on the other hand offers detailed images of the intravascular structures and surfaces of selected segments, thereby detecting important pathologic features that remain obscured by angiography. 
lntravascular ultrasound imaging I IVUS has both longer and more broadly been applied than angioscopy for intracoronary imaging.1 15' 128 In contrast to angioscopy, which largely depends on one manufacturer, there are several commercially available IVUS systems. Most systems use a single, within the catheter tip rotating, echo crystal. The other available technique is that of the dynamic aperture array multi-element electronic system, in which a large number of static crystals are mounted in a circular fashion around the catheter tip. IVUS provides a unique, radial view of the layers of the coronary artery wall. The possibilities of this technique are extensive. It can be used to demonstrate eccentricity of atheromatous plaque in stenoses, which can be quantified in an 
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eccentricity index. 129 This identification of the radial distribution of the plaque can 
have a direct therapeutic value to guide Directional Coronary Atherectomy (DCA), 
aiming at cutting the plaque rather than the opposite, relatively non-diseased artery 
wall. 1 30 rvus allows discrimination between 'hard' and 'soft' plaques. 62' 1 3 1 - 1 33 Hard 
plaques are characterized by a high echogenicity within the plaque and may consist of 
dense fibrous tissue, with or without calcifications. These calcifications are diagnosed 
by their shadowing effects. Probably the most important advantage of rvus over 
angioscopy at the present time is its inherent suitability for quantifications. 
The Minimal Luminal Cross-Sectional Area (MLCSA), the percentage of luminal area 
obstruction, and the plaque area, are examples of vascular parameters that can be 
measured. A recent development is the implementation of software that can 
reconstruct 3-dimensional images from a large number of 2-dimensional cross­
sections. 1 34 Like angioscopy, 1vus is still limited to larger vessels and branches. 
Tight stenoses also can not be imaged properly because of the catheter sizes and 
because of the technique related 'halo' which prevents imaging in the close vicinity of 
the rotating crystal. Compared to angioscopy, rvus gives less information about the 
inner surface of the vessel wall. Another 'weak point' of rvus is the detection of 
intracoronary thrombus, which is much less sensitive and reliable than with 
angioscopy. 62' 80 
With arteriography giving a general overview, QCA providing large amounts of 
quantitative data for numerous studies, rvus visualizing and measuring the vessel wall 
layers and plaques, and angioscopy looking forward within the vessel with superior 
thrombus detection, it can be stated that these state-of-the-art imaging modalities are 
complementary to each other rather than competitive. When combined, they offer an 
almost complete anatomical and pathophysiological picture of human coronary 
arteries. 
Val idation of angioscopic data 
In contrast to the large number of descriptive clinical series, and studies comparing 
angioscopy to other coronary imaging methods, surprisingly little attention has been 
paid to the in-vivo, in-vitro, and histopathologic validation of angioscopic findings. 
There is however one important paper, which was published by Siegel and co­
workers in Circulation in 1991.84 In this study, 70 postmortem human coronary artery 
segments, 9 of them containing artificial thrombi, were subjected to angioscopic, 
rvus, and histologic examination. A peripheral ImageCath angioscope with 6000 
imaging fibers was used. The investigators used a simple angioscopy classification 
TABLE 3. 1 Angioscopy classification system used by 
Siegel et al. 
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Category Angioscopic c lassification 




Stable atheroma Yellow/white color 
Elevated contour 
Smooth conFiguration 
Disrupted atheroma Discontinuity of intima 
Thrombus Red color 
Elevated contour system, derived from the earlier intraoperative coronary angioscopy studies (Table 3-1). 135 Using this angioscopic classification system, as well as an rvus classification, they compared their observations to histology, using well-defined histological criteria. 88' 89 They demonstrated that both imaging techniques, especially when combined, had high agreements with the histological results. Using histology as the reference standard, angioscopy had a sensitivity and specificity that exceeded 95% for all categories except disrupted atheroma, where, like rvus did, it missed some of these disruptions. This yielded a 73% sensitivity of angioscopy for disrupted atheroma. As can be expected, the angioscopic sensitivity for thrombus exceeded that of IVUS (rno% versus 57%). This study has established a first histopathologic basis for angioscopic observations. It can be used as a starting point for imaging correlation and observer agreement studies, like those carried by the European angioscopy working group (see the next section and appendix III) . It has to be kept in mind, that such studies, as well as clinical applications of angioscopy, need more elaborate classification systems than the one used by Siegel et al. Therefore these sophisticated classification systems will also need validation to histology after demonstrating their clinical and research applicability. 
Mizuno et al have studied the formation of artificially induced red, white, and mixed 
thrombi in canine coronary arteries, thereby establishing a first in-vivo validation of 
angioscopically observed thrombus. 136 They inserted copper coils in the left anterior 
descending arteries of I I dogs, and performed serial angioscopic imaging to observe 
the induction of thrombi by these copper coils. They discovered that white, fibrin­
like material formed the first evidence of thrombus formation. This was followed by 
mixed red and white thrombotic masses, which grew to occluding sizes. 
The angioscopically observed white and red thrombus were examined by 
macroscopic photography and microscopy. These photographs were found to closely 
resemble the angioscopic pictures. Microscopy proved that the angioscopically 
observed thrombi contained a fibrinous network. 
Interpretation and classification 
The previous sections of this chapter deal with the various normal and pathological 
intravascular structures that can be observed with angioscopy, and how some of these 
observations have been validated. It is a different question how these angioscopically 
detectable items are actually interpreted in the clinical setting, when patients are 
subjected to this examination for routine care or research purposes. Due to the 
intrinsically qualitative type of imaging technique, and the subjectivity of 
interpretation, it has been an open question if different observers interpret these 
images similarly, and even if the same observer is consistent in his interpretation. 
This question has been addressed by the European Working Group on Coronary 
Angioscopy. 
The European Working Group on As soon as coronary angioscopy was starting to emerge and to spread to an 
Coronary Angioscopy expanding number of interventional cardiology centers, the notion began to grow 
that it was urgently required to combine the insights and opinions of the leading 
investigators, so that a communis opinio on how to interpret the images, as well as a 
common nomenclature and definitions might ensue. In October 1992, we have taken 
the initiative to form a small core group of European angioscopy investigators, who, 
because of relatively short distances and coordinated communications, can meet 
frequently and openly discuss angioscopic recordings, techniques, and research 
efforts. The meetings of this working group are supported by Baxter Healthcare 
Company, Interventional Cardiology Division. This company, recognizing the 
importance of an independent task force, does not have an active participation in the 
contents of the discussions or in the research efforts of the group. Table 3-2 lists the 
current members of this working group. 
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TA B LE 3 .2 List of the members of the European working 
group on coronary angioscopy. 
Name 
Dr. Rene B. van Dijk 
Prof. Dr. Hakan Emanuelsson 
---
Dr. Pim J. de Feyter 
---
Dr. David P. Foley = 
Dr. Damian Franzen 
Dr. Peter den Heijer 
Prof. Dr. Jean-Marc Lablanche 
Dr. Marie-Claude Morice 
---
Prof. Dr. Ivan de Scheerder = 
Dr. Antonio Serra 
Prof. Dr. Patrick W. Serruys 
Institution 
University Hospital, Groningen, The Netherlands 
University of GOteborg, Sweden -
Thoraxcenter, Rotterdam, The Netherlands 
Thoraxcenter, Rotterdam, The Netherlands 
-- --
Universitats Klinikum, KOln, Germany 
University Hospital, Groningen, The Netherlands 
-
HOpital Cardiologique, Lille, France 
Centre de Cardiologie Du Nord, Saint-Denis, France 
U.Z. Gasthuisberg, Leuven, Belgium 
Hospital Clinic I Provincial de Barcelona, Spain 
--= 
Thoraxcenter, Rotterdam, The Netherlands 
The ' Ermenonville' classification I The first meeting was organized on October 14, 1992, in Ermenonville, near Paris. 
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Until now, this working group has gathered four times at various locations. Although more subjects, like the initiation of multi-center studies, were discussed, the main goal of these meetings has been to create a comprehensive and clinically relevant angioscopy classification system. It was later decided to term this 'Ermenonville' classification after the place of the group's first meeting. A classification system that was used in our post-PTCA angioscopy study (appendix n) served as a basis for extensive discussions on the actual form and contents of an optimal coronary angioscopy classification system. From the beginning it was clear that a trade-off existed between the desire to subdivide the angioscopic observations in as many as possible gradings for clinical and research purposes on one hand, and simplicity -with only a few gradings per item - to enhance the scoring reproducibility on the 
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other hand. Generally, items and grades were added and modified during discussion sessions while numerous videotapes of angioscopic recordings were reviewed by the group. The evolving classification system was tested by means of objective evaluation of reproducibility, which generally had a restricting effect on the number of grades per item. Table 1 of appendix III lists the version of the angioscopy classification system that was evaluated in the beginning of 1992. The method of evaluation is also described in appendix III. We composed 2 special videotapes, each of which contained 60 angioscopic examinations recorded at the catheterization laboratory of the University Hospital of Groningen, the Netherlands . The videotapes were edited in a way that half of the recordings on each tape were duplicates of previous ones, reinserted in a pre-assigned random order. The purpose of this was to analyze scoring agreement, not only between observers but also the agreement of repeated scoring by the same observer. In an effort to ensure obj.ectivity and lack of potential bias in reporting by the observers, the videotaped angioscopic recordings were edited and presented without any angiographic or clinical information. It may be argued that such a scenario is not be the most useful setting in which to develop a clinically relevant classification system. However, it was the general opinion of the group members that provision of any other information would lead to unavoidable interpretative reporting and preclude an objective descriptive approach, which was the object of the study. The inter- and intraobserver variability were reported using percentages of total agreement, and Kappa coefficients for chance corrected agreement. These Kappa values were generally very low, which could, at least partially, be attributed to the following factors: (a) too much grades per diagnostic items; (b) lack of clear and unambiguous definitions of the various angioscopic features of interest; (c) the above described method to score angioscopic images without any clinical and angiographic information. Important conclusions were that the presence or absence of dissection and red thrombus was associated with acceptable agreements both within and between observers, that an angioscopy classification system should be as simple and straightforward as possible, that it should include clear definitions, and that efforts should be put into the development of quantification tools for angioscopy. During a meeting of the working group in September 1993, a simplified Ermenonville classification, including a set of definitions, was proposed. This simplified classification is presented in table 5 of appendix III. It must be stressed that a final form of the Ermenonville classification has not yet been reached. With ever increasing angioscopic experience and knowledge, and with continued efforts of the working group to optimize and re­evaluate, the joint report of the European coronary angioscopy working group (appendix III), which has been published in the European Heart Journal, indeed 
TA B L E  3 . 3  Modified Ermenonville classification (see text) 
General 
represents an account of the work in progress of this group. Another important 
consideration is that the classification as reported in appendix III is based on pure, 
unbiased review of videotapes, and should still be adjusted for clinical use. Table 3-3 
shows the latest, more realistic, version of the Ermenonville classification, offering 
more detail, as well as specific pre- and post-intervention gradings. This latest 
Ermenonville classification will be subject to further evaluation studies. Some 
examples of angioscopic images, classified according to this system, are given in 
figures 3-13 - 3-21. 
Image quality Adequate. Visualization of the target allows one or more diagnoses. 
2 Inadequate. Visualization of the target does not allow one or more diagnoses. 
Obtained image of target segment No recognizable image 
Normal vessel 
Narrowing 
Shape of narrowing 
2 Only vessel wall. The lumen is not visible 
3 Incomplete lumen. No circumferential view of the vessel wall. The lumen is visible, but not entirely. 
4 Complete lumen. The lumen is imaged completely. The entire circumference of the vessel wall is 
visualized. 
Normal vessel. Vessel wall appearing uniformly smooth in contour, and of a uniform color. 
There are no abrupt changes in diameter. The lumen is free of intraluminal structures. 
2 Abnormal vessel. There is at least one abnormal structure or discoloration of the inner vessel 
surface or inside the lumen. The target does not meet the definition of normal vessel. 
0 Not assessable / not applicable. 
No or non-significant narrowing. The vessel has no or slight diameter changes. By estimation, 
more than 3 PTCA guidewires (0.01 4") could cross the narrowest part of the vessel. 
2 Significant narrowing. The vessel has a marked decrease in diameter. By estimation, 
2 or 3 PTCA guidewires (0.014")  could cross the narrowest part of the vessel. 
3 Subtotal or total occlusion. Either the guidewire can not cross the narrowing, 
or very little or no lumen remains visible around the guidewire. By estimation, 
none or only 1 PTCA guidewire (0.014") could cross the narrowest part of the vessel. 
0 Not assessable / not applicable. 
Round or elliptical. The remaining lumen inside the narrowing is grossly round or elliptical in shape. 
2 Slit-like. The remaining lumen inside the narrowing has a d istinct slit-like shape. 
3 Complex shaped. The remaining lumen inside the narrowing has any other shape than round, 
elliptical or slit-like. 






O Not assessable / not applicable. 
None. 
2 Lining red thrombus. Red, predominantly mural, non-mobile, superficial mass, adherent to the vessel 
surface, but clearly a separate structure. The thrombus is purely red and contains no white elements. 
3 Protruding red thrombus. Red, intraluminal ,  protruding, mobile or non-mobile mass, adherent to the 
vessel surface, but clearly a separate structure. At least a part of the lumen remains visible. 
The thrombus is purely red and contains no white elements. 
4 Occluding red thrombus. Red, intraluminal, obstructing, mobile or non-mobile mass, 
adherent to the vessel surface, but clearly a separate structure. 
No or a minimal lumen remains visible. The thrombus is purely red and contains no white elements. 
O Not assessable / not applicable. 
None. 
2 Lining white thrombus. White, predominantly mural, non-mobile, superficial mass, 
adherent to the vessel surface, but clearly a separate structure. The thrombus is purely white and 
contains no red elements. 
3 Protruding white thrombus. White, intraluminal, protruding, mobile or non-mobile mass, 
adherent to the vessel surface, but clearly a separate structure. The appearance is shaggy, irregular, 
and cotton- wool-like. The thrombus is purely white and contains no red elements. 
4 Occluding white thrombus. White, intraluminal ,  obstructing, mobile or non-mobile mass, 
adherent to the vessel surface, but clearly a separate structure. No or a minimal lumen remains visible. 
The thrombus is purely white and contains no red elements. 
O Not assessable / not applicable. 
None. 
2 Lining mixed thrombus. Mixed red and white, predominantly mural, non-mobile, superficial mass, 
adherent to the vessel surface, but clearly a separate structure. 
3 Protruding mixed thrombus. Mixed red and white, intraluminal, protruding, 
mobile or non-mobile mass, adherent to the vessel surface, but clearly a separate structure. 
4 Occluding mixed thrombus. Mixed red and white, intraluminal, obstructing, mobile or non-mobile 
mass, adherent to the vessel surface, but clearly a separate structure. 
No or a minimal lumen remains visible. 
TAB L E  3 . 3  (continued) 






2 Lining yellow atheroma. Non-elevated, smooth, yellow discoloration .  
3 Protruding yellow atheroma. Non-mobile, elevated and/or protruding yellow discoloration. 
There may be focal or diffuse narrowing. 
4 Fibrous plaque. White, non-mobile, elevation and/or protrusion. There may be focal or diffuse 
narrowing. 
5 Complicated lesion. Mobile, or non-mobile, patchy colored disGoloration, elevation and/or protrusion. 
Colors may include white, yellow, red, and brown. There may be focal or diffuse narrowing. 
There may be visible cracks or fissures on the luminal surface. 
O Not assessable / not applicable. 
None. 
2 Small surface disruptions. Small, very mobile, structures, which are contiguous with the vessel wall. 
They do not impede the visualization of the lumen. 
3 Large dissection. Visible cracks or fissures on the luminal surface and/or large mobile or non-mobile 
protruding structures, which are contiguous with the vessel wall and of homogenous appearance with 
the vessel wall. They impede visualization of (part of) the lumen. 
O Not assessable, not applicable. 
None. 
2 Present A distinct, demarcated, red, non-elevated discoloration, which is clearly within the vessel wall .  
3 . 1 3  
3 - 1 6  
3 - 1 9  
Guidewire 
Red/white thrombus 
Lumen and guidewire 
Protruding red thrombus 
Lining yellow atheroma 
Gray vessel wall 
3 - 1 4  
3 - 1 7 






Lumen and guidewire 
3 - 1 5  
3 - 1 8 
3 - 2 1  
Mural red thrombus 
White thrombus 
Guidewire and lumen 
lntima flaps 
lntima flaps 
FIGURE 3 . 1 3  Grade 3 narrowing: 
total occlusion, caused by mixed red 
and white thrombus superimposed 
on yellow atheroma. 
FIGURE 3 . 1 4  Grade 2 shape. 
the remaining lumen has a distinct 
slit-like shape. 
FIGURE 3 . 1 5  Grade 2, lining red thrombus, 
which appears to dissolve slowly in the 
stream of irrigation fluid 
FIGURE 3 - 1 6  Grade 3, protruding thrombus, 
recorded by A. Serra, Barcelona, Spain. 
FIGURE 3 - 1 1 Grade 4, obstructing, free 
floating mixed red and white thrombus. 
FIGURE 3 . 1  e Grade 4, obstructing, 
white thrombus. 
FIGURE 3 . 1 9 Grade 2 atheroma: 
lining yellow atheroma. 
FIGURE 3 . 2 0 Grade 4 atheroma: 
white, fibrous lesion. 
FIGURE 3 - 2 1  Grade 3, large dissection. 
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Digital coronary angioscopy atlas Because angioscopy is a purely visual diagnostic tool, it is very obvious that images are needed to help communicate the terms and the definitions of the angioscopy classification system to other physicians who use this tool for clinical or investigational purposes. The European angioscopy working group has in an early stage recognized the idea that an angioscopy atlas would be needed to illustrate the classification and definitions. This atlas would have to contain at least one example of each grade of each of the descriptive and diagnostic items. However, single still pictures obtained by imaging tools such as angioscopy convey only a fraction of the information that is available on the videorecordings. Angioscopic diagnoses (not unlike echocardiography) depend largely on the 3-dimensional shape and the mobility of the observed structures. The method to acquire and store digital angioscopic videorecordings with the use of Macintosh TM computers and QuickTime™ is described in chapter 2. We have used this technology, together with the HyperCard™* authoring and programming environment, to create a digital angioscopy atlas, which features 40 full-color, full-motion angioscopic videorecordings. These recordings are presented on the screen in a window that allows the user to play, re-play, quick-search through the sequence, and scroll forward or backward with single-frame steps (Fig 3-22). A video window of a given recording is surrounded by a complete description of that recording, in general terms as well as according to the classification system. Each grade of each of the diagnostic items is represented by at least one recording. The digital atlas can be used in a 'browse' mode, which allows the user to see the preferred classification of the presented video-runs, or in an interactive mode. In this interactive mode, the user is asked to score the recordings according to the classification system. The given answers are checked against those of the European angioscopy working group, and immediate feedback is given to the user. We have used this atlas/training tool effectively during the First Coronary Angioscopy Course in Groningen, and during the 'Course on intracoronary diagnostic techniques in interventional cardiology' of the European Heart House education and training program. The digital atlas can be used on any Macintosh computer that supports 16-bits or 24-bits depth of color rendition. Because of its large size in terms of storage memory, it is stored on CD-ROM disks for ease of transportation and distribution. 
• HyperCard is a registered trademark of Claris Corporation 
F I G U R E  3 - l l  Screenshot of Digital Angioscopy Atlas. 
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4 [ Cu rrent and futu re app l ications This chapter deals with the investigational and clinical applications of coronary angioscopy. These applications can be divided in angioscopy for documentation purposes and angioscopic guidance of intervention. The indications to perform angioscopy in 100 consecutive patients and the outcome according to the modified 'Ermenonville' classi�cation (Chapter 3), are presented together with discussions on the relevance of such angioscopic observations. To conclude, some views are given on the potential future application of direct angioscopic intervention. 
Coronary angioscopy for documentation The simplest application of angioscopy in interventional cardiology is the recording and documentation of images of the inner surface and contents of the coronary vessels without a direct influence of the angioscopic observations on the interventional procedure itself. In general, this approach will be useful primarily for clinical research purposes. In the following sections, some examples of indications and situations of angioscopy for documentation alone, are described. 
Angioscopic assessment of lesions in The clinical syndrome of unstable angina pectoris has been associated with platelet 
stable and unstable angina aggregation, intracoronary thrombosis, alterations in vasomotor tone, and complicated and ruptured atheromatous plaque. 90-92, 1 37-143 In fact, angioscopy has contributed significantly in recent years to the pathophysiological insights in unstable angina, 1 7• 27• 28• 42• 46• 54• 63• 144 identifying a complex lesion morphology and a high incidence of thrombus in the culprit lesions of patients with unstable angina. It appears that, in unstable angina, most intracoronary thrombi have a white color, as was first demonstrated by Mizuno et al. 28 In 1992, they have called attention to the angioscopic finding of different types of thrombus: gray-white thrombi were predominantly found in patients with unstable angina, while red thrombi were observed in all patients with acute myocardial infarction. Their reported 93 % total incidence of thrombus in unstable angina has been confirmed by some investigators.46• 62 However, most studies report lower incidences (in the order of 60-70%), and, if reported at all, less white thrombus. 54' 63' 144 Since the earlier angioscopes, like those used by Mizuno et al, could not cross stenotic lesions, or even be moved 
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longitudinally inside the vessel during imaging, 25' 28 it can not be excluded that some of the reported white thrombus in their study may have been whitish intimal structures, and that the true incidence of white thrombus in unstable angina may be lower. More importantly however, this landmark paper has opened the discussion on the angioscopic observation of white thrombus, and voiced the concept that the unsuccessful application of thrombolytic drugs in unstable angina 1 39, 1 45- 1 47 may be related to the presence of white rather than red thrombus in this situation. 
PTCA result documentation I There are several reports of angioscopic observations following percutaneous coronary balloon angioplasty. 25' 27' 32' 36' 59' 6 1 ' 67' 72' 84 Intimal tears, flaps, and thrombi are frequently seen in this situation. This is not surprising, since it is well known that PTCA, although it is widely established as an effective therapy for patients with coronary artery disease, causes severe disruptions in the vascular structures and functions. The finding of this post-PTCA damage is in accordance with previous histologic 1 0 1 , 104, 1 05 and ultrasound 1 29, 148' 149 studies. Therefore, in our view, angioscopic examination of dilated lesions can be considered useful only if it yields information that is related to short term and long term angioplasty results. The initial efforts to investigate such relations to short term and long term angioplasty results will be described later in this chapter, together with the description of 66 post PTCA angioscopy procedures. 
Acute myocardial infarction I Acute myocardial infarction is usually caused by a thrombotic occlusion of an atherosclerotic narrowing of one of the coronary arteries. 1 41 ' 1 5° Coronary angioscopy, with its potential for intracoronary thrombus detection, is a promising imaging tool for studies which address the pathophysiology and interventional (thrombolytic) strategies in acute myocardial infarction. Several investigators have established that red thrombus is present in almost all cases of acute myocardial infarction. 28• 35, 42, 63' 1 5 1 Lablanche et al have demonstrated that red thrombus even can be found up to 60 days after clinically and angiographically successful thrombolysis in a large majority of patients. 1 52 In the series of 100 patients that is described in this book, 3 patients were studied after acute myocardial infarction. Red thrombus was seen in the first of these 3 patients, who underwent angioscopy before and after laser thrombolysis (see appendix v). The second patient was studied one week following successful thrombolysis. No thrombus was found in the infarct related artery of this patient. The third patient underwent angioscopy following coronary angiography for suspected failed thrombolysis. A fairly large mural red thrombus was observed in the infarct related vessel, although it was patent at angiography, with TIMI 3 flow and absence of intraluminal filling defects. From the above cited studies, as well as from 
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these 3 patients, it can be concluded that angioscopy provides a unique opportunity and means to document the natural history of acute myocardial infarction, as well as the effects of interventional strategies aimed at restoring patency. Clearly, it can be expected that more angioscopic infarction studies will follow these first examples. 
Restenosis I The response of the coronary vascular wall to balloon dilatation and other angioplasty modalities is presently subject of numerous studies. Luminal renarrowing, occurring in 25-45% of the dilated lesions, remains the 'Achilles heel' of balloon angioplasty.77' 153• 154 Restenosis is the result of a complex process involving platelets, growth factors, endothelial cells, smooth muscle cells, mechanical injury, wall shear stress, and probably other unknown factors. Although many questions concerning the pathophysiological mechanisms of restenosis still are unanswered, it is generally accepted that secondary hyperplasia of the intima is the major mechanism. Endothelial injury may play an important role in the development of intimal hyperplasia leading to re-narrowing of the lumen within the first months after PTCA. 94, 98• 155• 156 Neither mechanical interventions, such as laser angioplasty or atherectomy, nor drug therapy, have so far contributed much to reduce this intima hyperplasia.157-163 Evidence that intracoronary stents may reduce restenosis is presently building up, but the mechanism is probably one of achieving a larger initial lumen rather than preventing intima hyperplasia. 164• 165 Ramee, White, and co-workers have identified a specific angioscopic morphology of the re-stenotic lesion. 36• 41• 59 In contrast to other stenoses, especially those in unstable angina, the restenotic lesions appeared to be smooth, fibrotic, white and unpigmented, and in most cases devoid of thrombus and dissection. Such a lesion would be classified as a grade 4 atheroma ('fibrous plaque') according to the modified Ermenonville classification. 
Other documentation applications I Until now, we have used the angioscope exclusively in vessels that were at least suspected to contain significant coronary artery disease. The main reason was that intracoronary manipulation with a guidewire or any kind of catheter should be regarded as potentially hazardous. To cannulate the coronary arteries with a new imaging device seemed ethically justifiable only if an intracoronary intervention was planned or performed. However, with increasing operator experience, and with proven safety of the device if cautiously handled, angioscopy has now reached a stage where, for selected clinical research purposes, the additional insights that can be obtained in a purely diagnostic setting outweigh the possible objections against using it without planned coronary intervention. Teirstein et al and Ueda et al have 
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performed serial angioscopy to study the gradual neointimal coverage of coronary stents. 108• 109 Jain et al have used angioscopy to study the coronary arteries of cardiac transplant recipients.58 Annex et al have reported yellow and white atheromatous lesions, found at angioscopy of coronary vessels that were angiographically considered to be 'normal' . 166 It is to be expected that patients with minimal coronary artery disease will be enrolled in larger clinical studies, for instance to assess the effects of lipid lowering agents. 
Coronary angioscopy for guidance of interventions In contrast to the appliance for pure documentation, which is useful mainly for research purposes, angioscopy should also be usable to guide intracoronary interventions. In other words, to become an indispensable tool in the interventional cathlab, it should have a specific clinical applicability. In our view, the single most important clinical application of coronary angioscopy, where it can be used to guide the angioplasty procedure, is to use it as a complementary imaging tool during threatened or acute closure after PTCA. This application will be discussed later in this chapter. Angioscopy can also be used effectively pre and post stent implantation. Several authors have reported on the use of angioscopy to guide peripheral and coronary laser angioplasty, both intraoperatively and percutaneously. 11, 13, so, 161- 173 In recent years, the most important type of laser that has been under investigation for coronary laser angioplasty has been the excimer laser, operating at 308 nm wavelength with extremely short pulse durations. 174 Clinical investigators have successfully used angioscopy to assess thermal injury, the shape of the created channels, and the presence of tissue remnants after excimer laser angioplasty.50 Preliminary reports discuss the use of angioscopy before and after Directional Coronary Atherectomy, 175 Rotational Atherectomy, 176 and Transluminal Extraction Atherectomy. 177 Several angioscopy using interventionists have the opinion that angioscopy helps in the selection of the optimal angioplasty device in any situation, for instance after suboptimal PTCA. This assumption, however, has to be confirmed in prospective trials. 
Experience in 1 00 patients - indications and outcome 
Indications I Angioscopy was performed twice during a catheterization - before and after a 
coronary intervention - in 29 of 100 patients. In 3 cases, 3 separate angioscopic 
recordings were made because of multiple interventions in the same patient. Thus, a 
total number of 135 angioscopic imaging procedures were completed in these 100 
patients. The distribution of the studied vessels was as follows: 67 angioscopy 
procedures of the left anterior descending artery, 16 of the circumflex artery, 33 of the 
right coronary artery, and 19 procedures in venous bypass grafts. Table 4-1 lists the 
indications of these 135 procedures. 
TABLE 4 - 1  Indications for angioscopy of 1 35 imaging 
procedures. 
57 
Ind ication Angioplasty performed Nr of procedures 
Undisturbed lesion assessment Pre PTCA 47 
Undisturbed lesion assessment Without intervention 3 
PTCA result documentation Post PTCA 33' 
Serial observations post PTCA Up to 1 hour post PTCA 2 1  (13 included) 
;=.. 
Threatened or acute closure Post PTCA 1 8  
-
Stent result documentation Post stent 5 
-
Subacute stent closure Pre re-intervention 3 
------
Restenosis Pre PTCA 1 
Laser Thrombolysis Pre IT / post IT 2 
Post thrombolysis Without intervention 2 
As can be seen, most angioscopic imaging procedures were done before and/ or after 
coronary angioplasty, to document the atheromatous lesion before the intervention, 
respectively to observe the angioscopic result of the balloon dilatation. The primary 
aims of these procedures were to assess the safety and imaging success rate of 
angioscopy as a new coronary imaging tool, to gain experience in the technique, to 
learn the interpretation of the obtained images, and to seek out where the clinical utility and applicability of angioscopy is highest. These topics have been discussed in previous chapters. The obtained angioscopic recordings in these patients form the basis on which the Ermenonville classification was defined, and the material that was used to evaluate inter and intraobserver agreement by the European angioscopy working group ( chapter 3, appendix III) . A relatively small number of patients underwent angioscopy for specific reasons such as threatened or acute closure after suboptimal PTCA, clinical research, and inspection of coronary stems. 
Outcome I As described in chapter 2, angioscopic imaging was possible in 91 of 100 patients. Of the 135 attempted imaging procedures in these 100 patients, 126 were successful (93 .3%) . This procedure success percentage is slightly higher than the patient success rate, because angioscopy was not attempted post PTCA if had failed prior to angioplasty. All angioscopic recordings were reviewed off-line from videotape. The modified Ermenonville classification was applied to all imaging sequences. Table 4-2 shows the overall outcome of the 126 successful procedures. 
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The image quality obviously was scored as adequate in 100% of this selection of successful procedures. The entire circumference of the vessel wall, and thus the complete lumen of the target area, was visualized in 59% of the procedures . More than 2 thirds of the lumen was visible in the remaining 41% (see success definition, Chapter 2: Experience in 100 patients - safety and success) . Due to the selection of studied patients, the diagnosis of an angioscopically normal vessel was made in only 2%.  Without doubt, one of the most striking observations is the incidence of intracoronary thrombi: red lining, protruding or occluding thrombus was observed in as much as 47% of all procedures. White thrombus was seen in 24%, and mixed red and white thrombus in 13 % of procedures. It has to be stressed that the diagnoses of red, white, or mixed thrombus are not mutually exclusive. The total percentage of angioscopy procedures with one or more observed thrombi of any of these compositions was 67% .  It is evident, even from this heterogeneous collection of angioscopic recordings, that the occurrence of intracoronary thrombus formation is much more frequent than suspected from classical angiographic observations. The incidence, amount, and significance of intracoronary thrombus and other angioscopic diagnoses, in various subgroups of observations, such as in unstable and stable angina, post PTCA, and vein grafts, will be discussed in the following sections. The items atheroma, dissection, and wall hemorrhage each score a relatively high percentage of 'not assessable / not applicable' because these items are intended for 
TA B LE 4-2 Outcome, according to 
the modified Ermenonville classification 























































Adequate I 1 1 00% 
Inadequate jo% 
No recognizable image lo% 
Only vessel wall 10% 
I ncomplete lumen c=)41 % 
Complete lumen � 59% 
Normal vessel �2% 
Abnormal vessel I 1 98% 
Not assessable / not applicable □6% 
No or non-significant narrowing c:==J 54% 
Significant narrowing □25% 
Subtotal or total occlusion □ 15% 
Not assessable / not applicable □ 10% 
Round or ell iptical i==:J 61 %  
Slit- l ike D 7% 
Complex shaped □ 22% 
Not assessable I not applicable l o% 
None c=J 53 %  
Lin ing thrombus CJ44% 
Protruding thrombus 0 3 %  
Occluding thrombus lo% 
Not assessable / not applicable lo% 
None I ! 76% 
Lining thrombus □ 1 2 %  
Protrud ing thrombus 0 1 1 %  
Occluding thrombus 1 1 %  
Not assessable / not appl icable lo% 
None I ! 87% 
Lining thrombus 0 3 %  
Protruding thrombus O s% 
Occluding thrombus 12% 
Not assessable / not applicable CJ49% 
None f2% 
Lining yel low atheroma □ 1 1 %  
Protruding yellow atheroma Os% 
Fibrous plaque □ 10% 
Complicated lesion D 20% 
Not assessable / not appl icable LJ 37% 
None Os% 
Small surface d isruptions □25% 
Large dissection □30% 
Not assessable I not appl icable LJ 37% 
None c=J 5o% 
Present □ 1 3 %  
specific diagnoses in the undisturbed vessel or post angioplasty. As a rule, atheroma was only considered to be applicable before or without intervention, and dissection and wall hemorrhage after coronary angioplasty. 
Undisturbed lesion assessment I As can be seen in table 4-1, 50 angioscopy procedures were performed as so-called 'undisturbed lesion assessments', which means that these lesions were visualized either before PTCA (47 procedures), or as stand-alone procedure without intervention (3 procedures) . In fact, in these last 3 cases, PTCA was initially planned, but abandoned because angioscopy proved that coronary artery disease of the lesions in question was less than angiographically suspected. Table 4-3 shows the relevant angioscopic findings, according to the modified Ermenonville classification, of 4 7 successful undisturbed lesion assessments. 
TA B L E 4 - 3  Findings of 47 angioscopic imaging 
procedures in undisturbed lesions. 
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Not assessable / not applicable □ 1 1 %  
No  o r  non-significant narrowing □ 17% 
Sign ificant narrowing c::J 51 %  
Subtotal or total occlusion □21% 
Not assessable / not applicable □ 15% 
Round or elliptical c:=J 55% 
Slit- l ike 12% 
Complex shaped □20% 
Not assessable / not applicable lo% 
None C=:J64% 
Lining thrombus CJ 36% 
Protruding thrombus lo% 
Occluding thrombus lo% 
Not assessable / not applicable lo% 
None I ! 81 %  
Lining thrombus 04% 
Protruding thrombus □ 15% 
Occluding thrombus lo% 
Not assessable / not applicable lo% 
None I ! 89% 
Lining thrombus 12% 
Protruding thrombus □9% 
Occluding thrombus lo% 
Not assessable / not applicable lo% 
None lo% 
Lining yellow atheroma 06% 
Protruding yellow atheroma □ 17% 
Fibrous plaque D 24% 
Complicated lesion c=J53% 
Guidewlre and lumen 
It is evident that relatively more grade 3 and 4 narrowings were observed than in the overall population. The incidence of thrombus was much lower, and most thrombi were small (grade 2, lining thrombi). When imaging undisturbed coronary lesions, the scoring of atheroma is the most interesting one. For instance, there is some evidence that yellow plaque is associated with significantly lower restenosis rates.178 It may well be that, with increasing insight in the meaning of these different types of atheroma, angioscopy will be used to anticipate the eventual angioplasty results. 
Stable versus unstable angina I In order to demonstrate whether culprit lesions in unstable angina could be angioscopically distinguished from stenotic lesions in stable angina by means of the modified Ermenonville classification, we have analyzed 24 undisturbed native coronary stenoses in patients with unstable angina pectoris, and compared these lesions to those of a control group consisting of 17 patients with stable angina. Unstable angina pectoris was defined as the presence of one or more of the following 3 features: 1) crescendo angina superimposed on a preexisting pattern of relatively stable, exertion-related angina pectoris; 2) angina at rest or with minimal exertion; 
Complicated lesion 
3) new onset angina pectoris, which is brought on by minimal exertion. 179 The classification data were compared between the 2 groups using the Chi-Square test. Table 4-4 shows the items of the modified Ermenonville classification that were compared, and their frequency distributions in the 2 groups. There were no significant differences between the groups in the grading or shape of the narrowings. Although I I  of 24 (45.8%) of patients with unstable angina proved to have lining red thrombus at angioscopy, versus 4 of 17 (23.5%) of the stable angina group, this difference was not significant with this sample size. There was however a significant difference in the incidence of white thrombus: eight (33.3%) of the unstable angina patients had lining (n=2) or protruding (n=6) white thrombus, which could not be demonstrated in any of the stable angina patients. This finding of white thrombus is in agreement to the data of Mizuno and co-workers, although these investigators reported a larger overall incidence of thrombus.28 We found a highly significant difference in the distribution of the atheroma types. A so-called 'complicated lesion' was identified in 20 of 24 (83.3%) patients of the unstable 
FIGUR E  4 . 1  Complicated lesion in unstable angina pectoris. 
Patchy colors, probably caused by yellow and brown plaque, 
red wall hematoma, and some white thrombus. 
angina group (Fig 4-1), versus 3 of 17 (17.6%) patients of the stable angina group. In this small study, the observation of a grade 5 ('complicated') lesion had a sensitivity of 83%, a specificity of 82%, an accuracy of 83%, and a predictive value of 87% for the clinical syndrome of angina pectoris. It is evident that unstable angina is associated with a specific angioscopic lesion morphology, and that the finding of such a morphology is highly predictive for an unstable lesion. Unstable angina is 
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Stable angi na Unstable angina 
TAB LE 4-4 Angioscopic findings 
in 66 cases post PTCA. Narrowing 0 Not assessable / not applicable 5.9 % 1 6.7 % 
p=n.s. No or non-significant narrowing 1 7.6 % 1 2.5 % 
2 Significant narrowing 52.9 % 50.0 % 
3 Subtotal or total occlusion 23.5 % 20.8 % 
Shape 0 Not assessable / not applicable 5.9 % 1 6.7 % 
p=n.s. Round or elliptical 70.6 % 50.0 % 
2 Slit-like 0.0 % 4.2 % 
3 Complex shaped 23.5 % 29.1 % 
Red thrombus 0 Not assessable / not applicable 0.0 % 0.0 % 
p=n.s. None 76.5 % 54.2 % 
2 Lining thrombus 23.5 % 45.8 % 
3 Protruding thrombus 0.0 % 0.0 % 
4 Occluding thrombus 0.0 % 0.0 % 
White thrombus 0 Not assessable / not applicable 0.0 % 0.0 % 
p=0.0296 None 1 00.0 % 66.7 % 
2 Lining thrombus 0.0 % 8.3 % 
3 Protruding thrombus 0.0 % 25.0 % 
4 Occluding thrombus 0.0 % 0.0 % 
Mixed thrombus Not assessable / not applicable 0.0 % 87.5 % 
p=n.s. None 88.2 % 0.0 % 
2 Lining thrombus 5.9 % 12 .5 % 
3 Protruding thrombus 5.9 % 0.0 % 
4 Occluding thrombus 0.0 % 0.0 % 
Atheroma 0 Not assessable / not applicable 0.0 % 0.0 % 
p=0.0004 None 0.0 % 0.0 % 
2 Lining yellow atheroma 5.9 % 0.0 % 
3 Protruding yellow atheroma 35.3 % 4.2 % 
4 Fibrous plaque 41 .2 % 1 2.5 % 
5 Complicated lesion 1 7.6 % 83 .3 % 
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associated with less favorable PTCA results than stable angina. 77• 180 Angioscopy can therefore be applied to obtain an indication of the expected outcome and risk involved before angioplasty attempts. Ultimately, it may even help improve these angioplasty results, because it may enable the operator to better individually select the optimal strategy. 
PTCA result documentation I Angioscopic images recorded after angioplasty are generally easily recognizable: they typically show multiple small, very mobile flaps, and in a large number of cases large surface disruptions as well. This is reflected by the percentages of dissection in table 4-5, which shows the findings of 66 successful post PTCA angioscopy procedures. 
TAB L E  4.s Angioscopic findings in 66 cases post PTCA. 
Narrowing 0 Not assessable / not applicable 12% 
1 No or non-significant narrowing I !80% 
2 Significant narrowing 09% 
Subtotal or total occlusion 09% 
Shape of narrowing 0 Not assessable / not applicable 06% 
1 Round or el l iptical C=::J61% 
2 Sl it- l ike ,lo% 
3 Complex shaped 033% 
Red thrombus 0 Not assessable / not applicable lo% 
1 None i==:]47% 
2 Lin ing thrombus c=J50% 
3 Protruding thrombus �3% 
4 Occluding thrombus lo% 
White thrombus 0 Not assessable / not applicable lo% 
None [==:J68% 
2 Lining thrombus D20% 
3 Protruding thrombus □ 1 1 %  
4 Occluding thrombus 1 1%  
Mixed thrombus 0 Not assessable / not applicable lo% 
1 None I 1 83% 
2 Lining thrombus 05% 
3 Protruding thrombus □9% 
4 Occluding thrombus �3% 
Dissection 0 Not assessable / not applicable lo% 
1 None 08% 
2 Small surface disruptions c=J41% 
3 Large dissection c=J51 %  
Wall hemorrhage 0 Not assessable / not applicable lo% 
1 None I !82% 
2 Present □ 18% 
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F I G U R E 4 - 2 Example of post-PTCA angiogram and serial 
angioscopic images at 0, 15, 30, 45 and 60 minutes post­
PTCA in a single patient (see appendix II). A distinct 
progression in the appearance and size of white intima flaps 
can be seen in this example. 
i1 � . . � 
0 min.  0 min.  15 min.  
� '/l ' f 
30 min.  45 min.  60 min. 
Together with patchy discolorations within or on the vessel surface, caused by thrombi and/or wall hemorrhage, this angioscopic post-PTCA morphology has been characterized as a 'war zone'. When confronted with this extensive visual damage within the coronary arteries, new angioscopists often remark that it is a good thing for PTCA that angiography was invented earlier than angioscopy: probably, few of the early PTCA investigators would have believed that such a mess could lead to clinical success. Not surprisingly, the large majority of lesions were graded as no or non­significant narrowings. Thrombi were detected in larger numbers and higher grades than in the undisturbed lesions. The outcome of the lesions that were observed post PTCA was compared to the outcome of the undisturbed lesions, using the Chi-Square test. It should be noted that this is a comparison between observations within the same patient in only 28 of these cases, and between different patients in the remaining cases. There was a significant lower degree of narrowing post PTCA versus pre PTCA (p=o.0001) . There were higher grades of red (p=o.0046) and white (p=o.0009) thrombus in the post PTCA observations, but mixed thrombus, which had a low incidence in both situations, did not differ significantly (p=o.1824). The angioscopic intracoronary morphology after angioplasty has been addressed by several investigators. 25• 21• 32• 36• 59• 6 1 ' 67' 12• 84 Their reported observations of intimal tears, flaps, and intracoronary thrombi are in accordance with the above described findings in our patient group. The relation of these balloon induced intracoronary changes to early and late PTCA results still has to be investigated. It is conceivable that for instance the presence and magnitude of intracoronary thrombus and intimal dissection will be proven to have a certain predictive value for immediate and long term PTCA results. 
Coronary angioscopy for clinical Angioscopy can play an important role in restenosis research by documenting the 
restenosis research angioscopic images following angioplasty. A possible relationship to restenosis of the magnitude and amount of arterial wall damage and thrombus caused by PTCA should give new insights in the responsible pathophysiological mechanisms. We have undertaken a pilot study, in which we documented the angioscopic changes that occur during the first hour after PTCA (appendix n). Based on this pilot study, a multi-center study is being prepared in the Netherlands. This study will address the relation of angioscopic as well as IVUS observations to angiographic restenosis at 6 months post procedure. An important characteristic of the proposed study is that imaging will take place before and after PTCA (Fig 4-2), as well as at 24 hours after PTCA, enabling us to establish if progressive intravascular changes occur following angioplasty. Starting in the second half of 1994, one hundred PTCA patients will be enrolled by the catheterization laboratories of the University Hospitals of Groningen, 
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Rotterdam, and Maastricht. The endpoints will include the morphologic changes that may take place during the first 24 hours post PTCA, and the angioscopic and IVUS presence and degree of thrombus and dissection, related to primary procedure outcome, acute complications, and luminal re-narrowing at 6 months. 
Vein grafts I Saphenous vein bypass grafts are generally very suitable for angioscopic imaging, since they tend to have long straight segments, and relatively large inner diameters. The ImageCath angioscope, limited by the maximal size of its occlusion cuff, can be used in vessels with diameters up to 4-5 mm. We have performed 18 successful vein graft angioscopies in 9 patients. The indications for imaging were: undisturbed lesion assessment (n=8), PTCA result documentation (n=5), stent result documentation (n=3), and threatened or acute closure (n=2). Vein grafts often exhibit very pronounced pathological features, as is illustrated by the gradings of thrombus, atheroma, and dissection in table 4-6. 





































Not assessable / not applicable lo% 
None □2s% 
Lining thrombus c::==:J 67% 
Protruding thrombus □5% 
Occluding thrombus lo% 
Not assessable / not applicable 1 0% 
None i==::J56% 
Lining thrombus □2s% 
Protruding thrombus □ 16% 
Occluding thrombus lo% 
Not assessable I not applicable lo% 
None c===1n% 
Lining thrombus □ 17% 
Protruding thrombus □ 1 1 %  
Occluding thrombus 10% 
Not assessable / not applicable c:==]55% 
None lo% 
Lining yellow atheroma 10% 
Protruding yellow atheroma lo% 
Fibrous plaque 06% 
Complicated lesion LJ 39% 
Not assessable I not applicable C)44% 
None l o% 
Small surface disruptions □28% 
Large dissection □2s% 
Not assessable I not applicable C)44% 
None □ 17% 
Present LJ 39% 
Lining or protruding red, white, and mixed thrombus was seen in a relatively high number of the inspected venous grafts, which were often severely diseased and degenerated. Almost all sites of undisturbed narrowings that could be scored as atheroma were graded as 'complicated lesions'. These narrowings typically have a patchy, ulcerated, very friable aspect (Fig 4-3). Our observations in vein grafts are consistent with others.56• 18 1  It appears that, like in the native coronary arteries, angioscopy demonstrates more complex morphology, both before and after PTCA, than angiography does. Future studies should address the question how to use this additional information to improve angioplasty results in saphenous vein grafts. 
Threatened or acute closure after PTCA I As stated earlier in this chapter, this particular situation seems to be the one in which angioscopy comes in most useful to actually guide the interventional procedure. 
Friable, mobile structures 
Red thrombus 
F I G U R E 4-3 Angioscopy of vein graft, showing patchy, 
ulcerated, friable lesion. 
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Acute closure at the site of dilatation still is a major potential hazard during or immediately after balloon angioplasty.77' 182' 1 83 It occurs in 2 - 12% of patients undergoing PTCA, and is usually caused by major intimal dissection, intracoronary thrombosis, or a combination of both. Untreated, it can lead to death, acute myocardial infarction, or emergency coronary bypass surgery. In recent years, so­called 'bail-out' strategies have been developed and successfully employed to counteract impending or complete acute coronary occlusions during PTCA. Prolonged inflation with autoperfusion balloons and implantation of coronary stent are the two most commonly used bail-out strategies. 184-189 Bail-out stent implantation results in higher initial procedure success rates than prolonged inflation using autoperfusion balloons, but is associated with significant subacute reclosure rates, usually caused by thrombosis. 47• 190•194 Fischman and Herrman and co-workers have demonstrated that intracoronary thrombus, angiographically detected prior to stent deployment, increases the risk of subacute stent closure because of the inherent thrombogenicity of stents.188• 1 95 Angiography, compared to angioscopy, grossly underestimates the presence of intracoronary thrombus (appendix IV). It is therefore logical to assume that bail-out strategies, and in particular the choice between stent implantation and a more conservative therapy, can be improved by angioscopic examination of the occluded or threatened angioplasty segment. In such a setting, angioscopy can be used to determine whether the obstruction is caused by thrombus, dissection, or both. Based on such angioscopic guidance, the operator should then, if possible, avoid stent implantation, and try to restore patency by means of prolonged balloon inflation and/or thrombolytic therapy. Sassower et al have carried out angioscopy in 2 cases of abrupt closure post PTCA, and found that in one patient the obstruction was caused by extruded plaque material, while the other patient had a large white 
TABLE 4 • 7  Angioscopic diagnosis, and bail-out strategy, 
in 17 patients with acute or threatened acute occlusion 
during PTCA. 
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7 pts: stent implantation 
2 pts: autoperfusion balloon 
Thrombolysis through angioscope 
Autoperfusion balloon 
Adjunctive i.e. thrombolytics Angioscopy confirmed large intimal dissection and absence of thrombus in 9 of these patients. Palmaz-Schatz™ coronary stents Oohnson & Johnson Interventional Systems Corp., Warren, NJ, usA) were implanted in 7 of these 9 pts. Two of these patients with obstructing dissections and absence of thrombus had unfavorable anatomies for stent placement, and were successfully treated with autoperfusion balloon inflations during 20 minutes. Obstructing thrombus, without evidence of dissection, was encountered in 2 of the 17 patients. These 2 patients were treated with infusion of streptokinase through the irrigation lumen of the angioscope (this procedure is described in the section on direct angioscopic intervention, this chapter). The remaining 6 patients proved to have dissection as well as thrombus at angioscopy. They were treated with autoperfusion balloon inflation and adjunctive intracoronary thrombolytic therapy (150000 - 400000 Units of Streptokinase) . A I Oo% procedural success, with fully restored TIMI 3 patency, was reached in these 
17 angioscopy guided bail-out procedures. One patient had a subacute stent reclosure after 5 days, while the other 16 patients remained free from further events until discharge from the hospital. Thus, the overall clinical success rate in this group was 94 % . These data compare favorably to a contemporary group of 97 patients with acute or threatened closure in our cathlab, that were studied by De Muinck et al. 197 
In this prospective non-randomized study, 36 of 97 received a Palmaz-Schatz stent, and 61 patients underwent prolonged autoperfusion balloon inflation. The autoperfusion balloon group had a procedural and clinical success rate of 69%. The stent group had a much higher initial procedure success rate of 94 %, but this was offset by 8 subacute stent occlusions, resulting in a final clinical success rate of 72%. The results of the angioscopy guided bail-out group suggest that angioscopy can play an important role in the selection of treatment strategies for acute or threatened closure during PTCA, and that it potentially can contribute to improve the outcome of such cases. Prospective randomized studies are needed to confirm this hypothesis. Nevertheless, in anticipation of such studies, the opinion seems justified that coronary angioscopy, by providing the ability to discern thrombus from dissection, is a valuable tool to improve the management of abrupt or threatened occlusion during or after coronary angioplasty. 
Coronary stenti ng I Angioscopy can be used to assess the correct deployment, adequate expansion, and possible presence of thrombotic material following stent implantation.44' 198 We have studied 5 patients with freshly implanted stents (Fig 3-10). Three of these stents were delivered in vein grafts, the other 2 in native coronary arteries. Imaging was successful in all 5 patients. At angioscopy, all stents were found to be well expanded, although small intima flaps (grade 2 dissection) were seen to protrude through the gaps between the stent wires in 3 patients. One patient, who had received a Strecker™ (Boston Scientific, Watertown, MA, USA) in a vein graft, even had a grade 3, large, dissection visible within the stent, although the angiographic result was satisfactory. Even more disturbing was the finding of lining red thrombus within the stented area of the vein graft in 2 patients, and a protruding red thrombus in one patient with a Palmaz-Schatz stent in a vein graft. These patients received additional intracoronary infusion of thrombolytic agents. Follow-up was uneventful in all patients. From this limited experience it appears that angioscopic guidance of stent delivery is useful, especially to check for remaining thrombotic or intimal material that may remain undetected at angiography. However, it has to be recognized that intravascular ultrasound imaging probably is superior in assessing the optimal expansion of a stent.44' 199, 200 
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Angioscopy is clinically useful not only during delivery of stents, but also when adverse results are encountered during follow-up, again by providing the ability to discern thrombus from other intraluminal filling defects. Resar and Brinker have described a case where renarrowing inside a coronary stent, 6 weeks after its delivery, proved to consist of intimal hyperplasia, although thrombus was suspected 
FIGURE4-4 Red thrombus in LAD before laser thrombolysis. 
angiographically.51 Similarly, Strumpf et al have reported 2 cases in which thrombolytic therapy was avoided because stent restenosis proved to exist of tissue instead of thrombus.198 We have used angioscopy to determine the cause of subacute stent closure in 3 patients. Although subacute stent occlusion in the literature exclusively has been attributed to thrombosis, 188• 190•195 we discovered that the occlusion was caused by dissection rather than thrombus in 2 of these patients (appendix I). The third patient with subacute stent occlusion appeared to have an occluding mixed red and white thrombus within his stent, and was treated with PTCA and intracoronary thrombolytic therapy. 
L as er thrombolys is I Laser thrombolysis is a coronary laser application, which aims to remove thrombotic material without having ablation effects on the vascular wall or atherosclerotic plaque. 201-204 A first clinical pilot study, assessing the safety and feasibility of this laser device and catheter system, is reported in appendix v of this book. The ImageCath 
FIGURE 4 - 5  The same site as image 30 after laser thrombolysis. 
The vessel wall and lumen are now free from thrombus. 
angioscopy system became available during the course of the laser thrombolysis pilot study. After gaining initial experience with angioscopy, we were able to use it in 1 patient to assess the effect of the laser energy on the observed thrombus. Angioscopy clearly demonstrated that the thrombus was no longer present after laser therapy (Figs 4-4 and 4-5). Although this is of course a very limited experience, it is clear that angioscopy is an ideal imaging tool to detect thrombus and estimate its amount before laser application, and to assess the ablation effects afterward. The necessary energy levels and amount of laser pulses needed for effective ablation can potentially be better defined with the guidance of coronary angioscopy. The laser thrombolysis project is now in a stage where a major redesign of the laser delivery catheters is being carried out. A next clinical study is planned to start as soon as these new catheters are available and have been tested. According to the protocol of this next laser thrombolysis study, angioscopy will be performed pre and post laser application, both to document the therapeutic laser effect and to guide the total amount of laser energy to be delivered. 
Direct intervention through angioscopes 
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One step further for coronary angioscopy, beyond documentation and guidance, would be to use the angioscope as an interventional device. This would have advantages in situations where direct visualization would enhance the definition of the target and thereby improve the results of the intervention. Below, one simple example of direct intervention through an angioscope is presented. More elaborate 
direct angioscopic interventions seem rather far-fetched at the present time, but 
speculation on such possible future applications is appropriate, since the future place 
and acceptation of coronary angioscopy may well depend on it. 
Angioscopic thrombolysis The irrigation lumen of the angioscope can be used to infuse fibrinolytic agents, 
much like infusion catheters for intracoronary thrombolysis. The additional 
Thrombus mass 
Guidewire 
FIGURE4-& Large, occluding red/white thrombus. 
Lumen 
Vessel wall 
FIGURE4 - 7  The same patient after 1 week of intravenous 
heparin infusion. The right coronary artery is now free from 
thrombus. 
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advantage of using an angioscope for this purpose is that the effect of the 
thrombolytics can be observed immediately and almost continuously. It is thinkable 
that, by interrupting the antegrade flow in the treated vessel by means of the 
occlusion cuff, higher local concentrations of the thrombolytic drug, and increased 
exposure of the thrombus to the drug, are reached. We have used this technique in 2 
patients. The first patient had a massive amount of intracoronary thrombus in his 
right coronary artery after PTCA for a minimal inferior infarction and persistent 
unstable angina (Fig 4-6). The Medrad™ power injector was filled with a mixture of 
100 ml saline and 400000 units of streptokinase. Coronary angioscopy was 
performed intermittently, with the occlusion cuff inflated, and irrigation by infusion 
of 30 ml/min of this streptokinase solution. The occlusion cuff was kept inflated after 
each infusion for several minutes to allow stasis of the streptokinase solution. After 
delivery of the entire dose of streptokinase, patency was fully restored. Angioscopy 
still showed extensive lining red thrombus, but substantially less than before the 
procedure. The patient was kept on full-dose, APTT controlled intravenous heparin 
infusion, and angioscopy was repeated at 24 hours and I week post-angioplasty. 
Protruding mixed thrombus had recurred after I day, but the vessel was entirely 
clean and free of thrombus after I week of i.v. heparin therapy (Fig 4-7). The second 
patient had a threatened reclosure after an initially successful recanalization of a 
totally occluded right coronary artery. Angioscopy proved the presence of a grade 4, 
occlusive mixed red and white thrombus. In this case, 500000 units of streptokinase 
were delivered through the flush channel of the angioscope by means of slow manual 
injection with 2 ml syringes. Patency could also be restored in this patient, but 
angioscopic imaging after the procedure had to be aborted because of wire trapping 
(see chapter 2). These two patients illustrate that direct intervention through 
angioscopes, albeit in these cases in a very simplistic form, is feasible. 
Angioscopic laser throm bolysis I The superior target definition and laser effect assessment that angioscopy can provide 
for the new intervention of laser thrombolysis, has already been discussed in the 
section on angioscopic guidance. It would be even a larger step forward, if the 
technologies of laser thrombolysis and angioscopy could be combined to design an 
angioscopic laser catheter. As is discussed in appendix v, the current fluid-core laser 
delivery catheters seem to have major intrinsic disadvantages. Attempts at redesigns 
of these catheters have so far been unsuccessful. In our view, it would seem 
appropriate and logical to direct the resources and energy spent on perfecting the 
fluid-core laser catheters to the development of an angioscopic laser catheter. Such a 
catheter would have the following advantages: r) direct visualization of the target 
before, during, and after the laser procedure without the need for multiple catheter 
exchanges; 2) superior, and controlled, clearance of blood from the target site by 
means of the occlusion cuff and irrigation channel; 3) optimal assessment of 
therapeutic as well as possible unwanted (e.g. thermal) side-effects. The construction 
of such a catheter, which would have to contain an additional fiber bundle to 
transport the laser energy, would not be simple, but also not impossible. This has 
been demonstrated in a paper by Froelich et al. 205 These investigators have reported 
on the use in a canine model of a 5 French (r.67 mm) angioscopic laser catheter, 
which even has a deflection mechanism to aim the laser energy at specific targets. 
Although they do not mention the possible application of such a catheter for 
coronary laser thrombolysis, they have experimented with a similar kind of pulsed­
dye laser, operating at the same wavelength of 480 nm and comparable energy levels 
as the current laser thrombolysis system. It seems that only a slight miniaturization of 
this device would make intracoronary use for laser thrombolysis practicable. 
An angioscopic laser thrombolysis catheter would not only enhance the further 
development and application of laser thrombolysis, it would also give a positive 
impetus to the widespread use of coronary angioscopy. 
Other direct angioscopic interventions? I Other angioscopic interventions, such as the controlled delivery of excimer laser 
energy and instrumentation by atherectomy or ultrasound ablation devices, should 
also be investigated. In this respect, an analogy can be made to other endoscopy 
procedures, such as cystoscopy, bronchoscopy, gastro-duodenoscopy, etc, etc. 
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These procedures became clinically indispensable as soon as instrumentation and 
intervention through working channels was made possible. Therefore, in our opinion, 
the next important step for angioscopy should be to find a way for direct intervention 
through angioscopes. 

s I Sum mary and concluding remarks 
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Attempts to visualize the interior of the functioning heart date back to the second decade of the century. Throughout the following decades, until open heart surgery came along, cardiac surgeons have tried with varying success to employ optical instruments to alleviate valvular operations on the beating heart. The invention and subsequent miniaturization of optical fibers made it possible to manufacture angioscopes, first for intraoperative use, later for percutaneous use in peripheral vessels, and finally for percutaneous visualization of the coronary arteries. In 1991, the breakthrough came for coronary angioscopy when the ImageCath ™ (Baxter Healthcare Corporation, Interventional Cardiology Division, Irvine, CA, USA) system was introduced, opening the way for everyday clinical application during coronary interventions such as PTCA. A coronary angioscope is a complex instrument, which needs a thin, flexible, high resolution imaging fiber bundle, a miniature lens, a specialized illumination system, means for irrigation to clear the field of vision from blood, and an optimal, tuned video system to magnify and record the obtained images. Alternatively, images can be recorded as digital video in modern microcomputers. We use this technique for special purposes, such as an image database, and a 'digital angioscopy atlas'. The angioscopy catheter should be easily exchangeable with standard PTCA catheter equipment, and should thus be movable through a regular PTCA guiding catheter and over a PTCA guidewire. The current ImageCath angioscope meets these requirements, and can be used by every trained interventionist. The procedure of coronary angioscopy is fairly simple, if the segments to be visualized are carefully selected. In general, the mid segments of the large branches are most suitable, as long as they are not excessively tortuous. The angioscope is introduced through a guiding catheter, and over a PTCA guidewire into the vessel of interest. The occlusion cuff, which is a soft, elastic balloon mounted proximal to the opening of the irrigation channel, is inflated, and imaging takes place during continuous infusion of pre-warmed saline at a flow rate of 30 - 45 ml/min. The ImageCath angioscope allows for longitudinal movements of the lens tip over the guidewire, so that a 5 cm trajectory of a vessel can be imaged within one imaging sequence. Although all intracoronary manipulations must be carried out with 
74 
caution, coronary angioscopy is a safe procedure: in the series of rno consecutive patients that is described in this book, we did not encounter major complications caused by angioscopic imaging such as death, emergency bypass surgery, or acute myocardial infarction. Imaging success, defined as a clear field of view of the targeted coronary segment, with at least % of the vessel wall circumference of the target site visible, was reached in 91% of these patients. With angioscopy, various features of the inner vascular surface and the luminal contents of the coronary arteries can be detected. Normal coronary arteries have a uniform color, and a smooth, even, surface without abrupt diameter changes. Intracoronary thrombi are seen as lining or protruding red, white, or mixed red and white masses, that are clearly separate structures from the vessel wall. Atheromatous plaque can be yellow, white and fibrous, or, in the case of unstable plaques, patchy colored and disrupted. Angioscopic observations after coronary angioplasty show a typical pattern of small, very mobile flaps, and often large dissections, which may remain obscured at coronary angiography. Compared to angioscopy, other imaging techniques such as quantitative coronary angiography and intravascular ultrasound imaging have their specific advantages and disadvantages. Compared to these two techniques, angioscopy still lacks means of quantification, but provides superior detection and definition of intracoronary thrombus and dissection, and unequaled impressions of the appearance and colors of the inner vessel surface. The three main coronary imaging techniques are complementary, and ideally should be combined to obtain optimal morphological information on the coronary vascular tree. Efforts to validate angioscopic data have been rather limited. Since a uniform nomenclature and definitions were lacking, we have initiated a co-operative effort of European angioscopy investigators for this purpose. The product of this working group has been termed the 'Ermenonville classification', and is described in chapter 3 and appendix III. Using this classification, the members of this working group reviewed numerous angioscopic recordings in order to calculate intra- and interobserver agreements. Not surprisingly, since angioscopy is a qualitative means of imaging, these agreements were generally very low. There was however a fair agreement on the absence or presence of thrombus and dissection, which are the most important pathological features for the angioscopist to recognize. 
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The indications to perform angioscopy in our series of 100 patients with 135 performed angioscopy procedures include the assessment of coronary lesions before and/or after coronary angioplasty, threatened or acute occlusion after PTCA, imaging of coronary stents, and guidance of thrombolytic therapies. The angioscopic findings were classified according to the modified Ermenonville classification, and are described in chapter 4. The applications of coronary angioscopy can be divided into documentation, guidance of interventions, and direct intervention through the angioscope. Angioscopic documentation generally is performed for research purposes. Undisturbed coronary lesions, and PTCA results can thus be recorded. With angioscopy, the unstable lesion can be identified: in a comparison of 17 patients who had stable angina with 24 patients with unstable angina pectoris, we noted a significantly higher incidence of white intracoronary thrombus and complicated atheromatous lesions in the unstable angina group. Angioscopy can play an important role in the basic research of pathophysiological factors that are involved with restenosis after PTCA. A Dutch angioscopy and ultrasound imaging multicenter restenosis study is being planned. Guidance of interventions serves more practical clinical purposes than documentation. The most useful clinical application of coronary angioscopy is in the bail-out situation: when an acute occlusion after PTCA occurs or threatens to occur, it is of utmost importance to be able to differentiate between thrombus and dissection as the primary cause for this adverse PTCA outcome. Since angioscopy, compared to angiography, provides superior information regarding these 2 diagnoses, the selection of the optimal bail-out strategy is facilitated. Appropriate measures, such as stent implantation, prolonged inflation of autoperfusion balloon catheters, or intracoronary thrombolysis, can be taken based on acute angioscopy for failed PTCA. Similarly, we have used angioscopy to determine the cause of subacute stent occlusion, and found to our surprise that, in 2 cases, it was caused by dissection rather than the expected stent thrombosis. Direct intervention through the angioscope is still limited to infusion of thrombolytic agents through its irrigation channel. In our view, the technologies of angioscopy and laser thrombolysis should be combined to enable imaging and therapy by means of one angioscopic laser catheter. 
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Coronary angioscopy has given us a unique new look inside the coronary arteries. Numerous angioscopy studies are being carried out worldwide, and much more interesting studies will follow. The technology should be refined to reach more parts of the coronary vascular tree, and to further improve the quality of the images. Tools for quantitative measurements, as well as means for delivering therapy through angioscopes, should be developed to further establish its place as a vital tool in interventional cardiology. 
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FIGURE , Coronary angiogram (RAO view) showing subtotal 
occlusion of a Palmaz Schatz stent, with haziness and in­
traluminal filling defects. There was TIMI grade 1 distal flow. 
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Abstract Early occlusion of intracoronary stents has been exclusively attributed to thrombosis. Using intracoronary angioscopy, we have found 2 patients in whom this common and serious complication of coronary stenting was caused by obstructive intima dissection rather than thrombosis. 
Introduction Acute (<24 hours) or subacute (day r-21) occlusion is a major complication of coronary stenting. 1 It can lead to myocardial infarction, emergency bypass grafting or death during the first hours and days after stent implantation. The incidence has been reported to be o.6% to 28%, dependent on the type and material of the dif­ferent 'stents, lesion morphology, and whether the implantation had been elective or in the bail-out situation.2•6 In all cases, acute or subacute closure has been attributed to thrombosis in the stent.2-7 We report 2 patients where intracoronary angioscopy proved the absence of thrombus, and confirmed our suspicion on intima dissection as a primary cause for stent occlusion in these cases. 
Case Reports Stent implantation was performed in our center in 57 patients (27 'bail-out', 30 elective). Of these 57 patients, 9 (12%) suffered from early closure within 6 days following stent implantation. Of these 9 cases of acute or subacute stent occlusion, 3 were elective implantations and 6 were 'bail-out' stent implantations. In the majority ( 7 of 9 cases) of these early stent occlusions, there was never any doubt that they were caused by acute thrombosis in the stent. All these patients had sudden onset of symptoms of acute coronary artery closure, and all angiograms showed abrupt total occlusions inside the stents. Since, as was pointed out, early stent occlusion has been attributed in the literature solely to thrombosis, these 7 patients were treated accordingly with fibrinolytic drug therapy as well as PTCA. This treatment was successful in 5 of these 7 patients, whereas 2 patients underwent subsequent coronary bypass surgery. The 8th and 9th cases of stent occlusion in our center however made us wonder if intraluminal intima flaps rather than thrombus could be the etiology for stent closure. 
gu i dewire 
� 
l nt ima fl ap s 
I I  mural thrombus  wires 
FIGU R E  2 Coronary angioscopy of  the  stented lesion (Palmaz­
Schatz stent): the distal lumen is obstructed by a large, 
protruding intima flap. More proximally, only a small mural 
patch of thrombus is visible. 
FIGUR E  3 Angiogram of total occlusion of the Right Coronary 
Artery. The occlusion is situated at the distal end of the stent. 
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At that time the ImageCath system (Baxter, Edwards us Division, Irvine, CA) had become available. Intracoronary angioscopy is superior to other imaging methods for demonstrating thrombus.s-io We decided to perform angioscopy in these patients, since the outcome of this diagnostic procedure could well be decisive in our therapeutic strategy. These last two cases are described below. Patient G.K. was a 75 year old man, who underwent PTCA of a severe stenosis in his mid-LAD. A large, subtotally occluding dissection was noted immediately following dilatation. Prolonged inflation with an auto perfusion catheter yielded only temporary improvement. Therefore, it was decided to implant a Palmaz-Schatz Qohnson&Johnson, Warren, N.J.) stent, mounted on a 3.5 mm PTCA balloon catheter. The primary angiographic result was excellent. The first days after implantation were uneventful. However, on the 6th day, the patient returned to the catheterization labo­ratory with acute chest pain and electrocardiographic evidence of transmural ischemia. At that time, the patient was still hospitalised, but ambulant and on oral Aspirin, Acenocoumarol (ThromboTest for "?.72 hours within therapeutic range), and Dipyridamol therapy. At angiography, a subtotal occlusion in the stented region was noted (Fig r) .  There was a functional, if not total occlusion (TIMI grade I flow) of the LAD, with longitudinal filling defects inside the stent, which could be either intima flaps or thrombus. The angiographic appearance of the lesion was therefore considered to be compatible with either thrombosis or intima dissection. Angioscopy revealed multiple small and large intimal flaps, which protruded through the gap between the two parts of the articulated Palmaz-Schatz stent, and also at the distal opening of the stent (Fig 2). Only one, small, lining mural thrombus was seen. Based on this finding, it was decided to withhold intracoronary urokinase administration, and to re-dilate the lesion inside the stent with a PTCA catheter in order to tack up the intima. After prolonged inflations at 4 atm with a 3.0 mm balloon, the end result was satisfactory, with fully restored flow. Afterward, the patient remained free from further complications. Patient J.K. was a 54 year old man, who underwent elective implantation of a 4.0 mm Strecker stent (Boston Scientific, Watertown, MA) for the third recurrence of a mid-RCA stenosis. The artery had a pronounced tapering at the site of the lesion. The stent conformed well to this tapering, and the primary result was good. Three hours later, while the patient was still on ACT-controlled, full dose i.v. Heparin, he suffered from acute chest pain, with ST-segment elevations in the inferior leads of his EKG. While waiting for availability of the cathlab, he received r.5 million units of Streptokinase intravenously, without clinical benefit. At angiography, there was an abrupt total occlusion at the distal end of the stent (Fig 3). The occlusion was 
FIGURE 4 Angioscopy of the Strecker stent in the RCA: 
the distal opening of the stent is obstructed by a large 
intima dissection. 
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crossed with a PTCA guidewire. This proved to be difficult, and considerable friction was noted, even when the wire tip was advanced to the RCA bifurcation. Repeated balloon inflations did not result in restoration of flow, or gain in luminal diameter. Contrast injection revealed extraluminal staining, suggestive of a subintimal routing of the guidewire. This subintimal wire passage and contrast staining, together with the failure of both thrombolysis and balloon inflations to restore patency, and with the experience of our previous case, led us to suspect a dissection in this patient as well. Coronary angioscopy confirmed the presence of a large, occluding intimal mass at the distal opening of the stent (Fig 4). There was no thrombus in the stent or at its distal end. Since vessel patency could not be restored, and the patient was considered not to be a candidate for emergency bypass surgery, he sustained a myocardial infarction. 
Discussion Acute and subacute stent occlusion has been attributed exclusively to thrombosis. It must be recognised from all studies regarding stent treatment, that thrombosis plays a major part in this complication. It is without question responsible for the majority of such cases. Nevertheless, we believe from our angioscopic findings in these two patients, that other mechanisms such as dissection must be considered in a subset of patients. Fischman et al have reported that the presence of dissection following stenting is highly predictive for subacute occlusion. 5 It is conceivable that a combination of dissection and thrombosis is responsible for a large number of stent closures. In our first case, the dissection was present before stenting. After distension on a 3.5 mm balloon, the Palmaz-Schatz stent has sizes of the pores between its struts of up to 2 mm, and the gap of the two articulated parts may expand to 5 mm. This may allow fairly large intima flaps to protrude into the lumen. It can be speculated that this relatively short, articulated Palmaz-Schatz stent had provided insufficient coverage of the pre-existent intimal tears and flaps in this patient. This may have led to a progressive dissection during the first days following stenting, with onset of symptoms at day 6 due to increasing flow impairment. The dissection in the second patient, although invisible on the post-stenting angiogram, may have been caused by over-stretching. This vessel had a marked tapering in the stented area. Especially the distal part of the lesion must have been 
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'over inflated' by the 4.5 mm balloon on which the 4.0 mm Strecker stem is mounted. As with any balloon-expandable stent, the proximal and distal parts of the balloon are not covered by the stem. Thus intimal flaps resulting from over­stretching also are not entirely covered by the stem. The angiogram after balloon inflations in the occluded stent showed evidence of a spiral dissection. It can not be excluded that the subintimal routing of the guidewire had caused this dissection. However, the important angioscopic finding of absence of any thrombus in the cul­de-sac of the occluded stem made dissection the probable primary cause. Unfortunately, there was no therapeutic benefit from this observation, since we were not able to restore flow in the vessel. These 2 observations demonstrate that continued intimal dissection after stem implantation can lead to clinically important events, from 3 hours up to 6 days post­procedure. The first case is particularly remarkable because of the long delay between stent placement and the observation of the intimal dissection of the stented vessel. Such 'time-delayed' dissections have not been reported after balloon angioplasty or other intracoronary interventions, and would therefore at first glance appear to be solely related to stenting. On the other hand, progression from angiographically visible, but hemodynamically unimportant dissection, to subacute vessel closure is a well-known phenomenon after conventional PTCA. Furthermore, it must be stressed that our finding of dissection was exclusively an angioscopic diagnosis. This leads to the hypothesis that, in such cases, intima dissection of an extent below the detection threshold of angiography may be present immediately post-procedure, with subsequent progression of the luminal obstruction. Thus it seems that a slow progression of the hemodynamic effects of the dissection in this case was responsible for the late onset of symptoms. Although this report describes only 2 patients with occluding intimal dissections in stented coronary arteries, we feel that the consequences of these observations can have an important impact on treatment strategies and patient outcome. It appears that angioscopy is at the present time the only available tool that can accurately distinguish thrombus from dissection. The false diagnosis of thrombus might expose patients to unnecessary thrombolytic drug therapy, serious morbidity, and extra cost. Proper and timely diagnosis of dissection after stent placement, on the other hand, will promote more accurate determination of prognosis and might expedite the most appropriate therapy. It is generally accepted that coronary angiography has a low sensitivity for detecting intracoronary thrombus. The superior sensitivity of angioscopy for demonstrating thrombus has been established before.8• 10 Our 
observations suggest that, in some cases, conventional angiographic criteria for the diagnosis of thrombus may also be non-specific. This has to be confirmed in larger studies. We conclude that, in case of a stent occlusion, one must be aware of the possibility that it is caused by dissection rather than thrombosis, even when it occurs after a period of hours to several days after the implantation of the stent. The distinction between these two mechanisms can be difficult to make on angiography alone. Our findings underscore the clinical relevance of coronary angioscopy in interventional cardiology. 
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Summary 
Percutaneous coronary angioscopy was used in 13 patients, in a pilot study to assess 
the intracoronary changes that occur during the first hour after balloon angioplasty 
(PTCA). The dilated segment was studied with 4.5 French angioscopes, as well as with 
Quantitative Coronary Angiography ( QCA), immediately after PTCA and at intervals of 
15 minutes up to 1 hour post-PTCA. Significant progression of intimal dissection, as 
well as thrombus formation, could be demonstrated with angioscopy. These 
dissections and thrombi remained undetected with angiography, which only showed 
haziness. Thus, through its superior sensitivity to detect intimal damage and 
thrombus, coronary angioscopy can reveal important intravascular events, which 
apparently occur even after successful PTCA. The relation of such angioscopic 
observations to restenosis will be addressed in a subsequent, multi-center study. 
Introduction 
Percutaneous coronary angioscopy is a new imaging method that has reached a stage 
in its development where it can be safely and easily added to angioplasty procedures 
to provide visualization of the intravascular lumen. It is now possible to examine the 
entire dilated lesion with an extendable, movable fiber bundle and lens. Although 
Percutaneous Transluminal Coronary Angioplasty (PTCA) is widely established as an 
effective therapy in patients with coronary artery disease, 1•3 it is well known that it 
causes severe disruptions and disturbances of the vascular wall.4-s Vasospasm9, elastic 
recoil1°, thrombus formation, 1 1• 12  and intimal tears and dissection 1 1, 13 are changes that 
have been described to occur immediately after PTCA. 
The purpose of this study was to investigate if these changes can be observed by 
means of intracoronary angioscopy, even after clinically and angiographically 
successful PTCA procedures, and, if present, to observe by serial imaging if these 
changes show progression during the first hour following PTCA. This study served as 
a pilot study for a larger, multi-center study, which will address the prognostic 
significance of angioscopic observations like thrombus and dissection for restenosis. 
Angioscopy is especially suitable for detecting thrombus, 14•16 and intimal tears and 
flaps. 12• 15 Quantitative Coronary Angiography (QCA) has been used to assess the 
phenomenon of elastic recoil after PTCA. 10• 11 Thus, quantitative angiography and 
angioscopy were combined to acquire optimal information on the intravascular 
changes that occur shortly after PTCA. 
Methods 
P atients I Thirteen patients who were candidates for elective PTCA were enrolled in this study within 4 months. The lesions that were elected for balloon dilatation had to be located in the mid-section of one of the large epicardial coronary arteries, without excessive tortuosity in those arteries, to be considered suitable for coronary an­gioscopy. Only patients who underwent an angiographically successful PTCA (�20% enlargement of luminal diameter and $50% residual stenosis), without angiographic evidence of dissection, and without the need for Stent placement or prolonged inflation with an autoperfusion balloon, were included. At the time of inclusion, all patients were free of complaints. All patients had given informed consent prior to the 
PTCA procedure. 
Angioscopy system I The ImageCath (Baxter, Edwards us Division, Irvine, CA) angioscopy system is comprised of a disposable angioscopy catheter, an irrigation system, a light source, and a tuned video system. The angioscopy catheter is a 3-lumen catheter with an outer diameter of 4.5 French (1.5 mm), which can be introduced in the coronary arteries through a standard 8 French PTCA guiding catheter, and over a regular 0.014 inch PTCA guidewire. It features a movable optical fiber bundle, which can be moved independently from the catheter over a 5 cm distance, and over the same guidewire. During imaging, warmed physiologic saline (37°c) is infused through a distal irrigation port at a rate of 30-45 ml/min. by means of a Medrad™ power injector. To obtain an optimal clear image during flushing, a Kraton® distensible, low-pressure occlusion cuff is mounted on the catheter shaft proximal to the irrigation port. The 300 Watt Xenon light source generates a light temperature of 6300 Kelvin. At this light temperature, the evenness of the spectral distribution is sufficient for optimal true color imaging. The ½ inch Charged Couple Device ( ccn) camera provides a high resolution, and has an automatic white balance. 
Q uantitative Coronary Angiography I Quantitative angiographic measurements were performed with the ImageComm system (ImageComm Systems, Inc., Santa Clara, CA) . The contrast filled shaft of the guiding catheter, 2-3 cm proximal to its tip, was used for calibration. Minimal Luminal Diameter (MLD), Reference Diameter (RD), and Percentage Diameter Stenosis (%ns) were calculated with the use of well-validated automated contour detection algorithms.18 
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Procedure I Coronary angioplasty was performed for single, discrete lesions in single vessels. The patients were heparinized with 10000-15000 unit's pre-procedure, and 5000 units of heparin at 1 hour. The guidewire was left in place, and the balloon catheter was exchanged for the angioscopy catheter. Angioscopy was performed immediately after PTCA, and next at 15, 30, 45 and 60 minutes after angioplasty (see Chapter 4, Fig 4-2). All angioscopic runs were recorded on videotape. At each sequence, a single recording was obtained while advancing the angioscope through the section of interest, and one while withdrawing the scope, taking less than 5 minutes per sequence. On average, 300 ml of irrigation fluid was delivered to the patient during one hour. Cine-angiograms, taken after intracoronary administration of 0.2 mg. Nitroglycerin and at standardized projection angles for quantitative analysis, preceded each angioscopy session. The guiding catheter and the guidewire were left in situ throughout the procedure, with repeated flushing of the guiding catheter, and continuous pressure monitoring at its tip. The protocol allowed for repeat balloon angioplasty to be performed if a visually assessed stenosis �50% was noticed after the last angioscopy at 1 hour post-PTCA. 
Angioscopy scoring method I Classification systems of angioscopic images which have been used in earlier 
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studies 12• 14• 16• 19• 20 offered insufficient categories and grades to classify the data that can be obtained with the new device. Furthermore, specific parameters were needed to describe the balloon angioplasty effects on the vessel. We therefore used a classifi­cation system with the following items: estimated lumen diameter, dissection (intimal tears and dissection), thrombus and color of thrombus. All items were scored for 2-6 grades or categories (Table I). All videotapes were reviewed by two physicians, who were at that time unaware of the angiographic findings. Luminal narrowing was estimated by angioscopy by visual reference to the 0.014 inch PTCA guidewire that passed through the stenotic lesions. Luminal diameter was classified as grade 2 ('narrowing') if, by estimation, the remaining lumen was comparable to the total circumference of 3 of these guidewires. A larger remaining lumen was classified as grade 1 ('no or minimal narrowing') .  The narrowing was defined as grade 3 ('total occlusion') if no or a minimal lumen remained visible around the guidewire. The angioscopic definition for a thrombus was as follows: 'intraluminal, superficial or protruding mass, adherent to the vessel surface, but clearly a separate structure' . Additionally, if the diagnosis of white thrombus would be made, the appearance of the mass should be shaggy, irregular, and cotton-wool-like. Angioscopic dissection was defined as 'visible cracks or fissures on the luminal surface and/or mobile or non­mobile protruding structures contiguous with the vessel wall and of homogenous appearance with the vessel wall' . 
Angioscopic Lumen Diameter 
1 : No or minimal narrowing 
2: Narrowing, 
3: Total occlusion 
Surface Disruptions 
1: None 
2 :  Small flaps 
3: Large surface disruptions 
Thrombus 
1: None 
2: 1 lining thrombus 
3: Multiple lining thrombus 
4: Luminal thrombus, <1 /3 of lumen 
5: Luminal thrombus, 1 /3 - 2/3 of lumen 
6: Luminal thrombus, 2/3 - 3/3 of lumen 
Color of Thrombus 
0: Not applicable 
1 : Homogeneous 
2: Mixed, multiple colors 
Predominant Thrombus Color 
O: Not applicable 
1: White 
2: Red 
TAB L E  I Classification system and frequency distributions 
of the angioscopic observations dunng the first hour post-
PTCA. The data are presented as numbers of patients and 
percentages. 
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Post-PTCA 1 5  min .  30 m in .  45 m in .  60 m i n .  
5 (38.5 %) 2 (15.4 %) 2 (15.4 %) 
2 (15.4 %) 2 (15.4 %) 
8 (61 .5 %) 1 1  (84.6 %) 8 (61 .5 %) 
6 (46.2 %) 5 (38.5 %) 
0 (0 %) 0 (0 %) 3 (23. 1  %) 
5 (38.5 %) 6 (46.2 %) 
4 (30.8 %) 1 (7.7 %) (7.7 %) 
(7.7 %) 0 (0 %)  
8 (61 .5 %) 9 (69.2 %) 6 (46.2 %) 
4 (30.8 %) 5 (38.5 %) 
(7.7 %) 3 (23.1  %) 6 (46.2 %) 
8 (61 .5 %) 8 (61 .5 %) 
8 (61 .5 %) 6 (46.2 %) 4 (30.8 %) 
2 (15.4 %) (7.7 %) 
3 (23.1  %) 4 (30.8 %) 2 (15.4 %) 
2 (15.4 %) 0 (0 % )  
0 (0 %)  2 (15.4 %) 2 (15.4 %) 
2 (15.4 %) 3 (23. 1  %) 
(7.7 %) 1 (7.7 %) 3 (23.1  %) 
5 (38.5 %) 7 (53 .8  %) 
(7.7 %) 0 (0 %) 2 (15.4 %) 
(7.7 %) (7.7 %) 
0 (0 %)  0 (0 %) 0 (0 %) 
(7.7 %) (7.7 %) 
8 (61 .5 %) 6 (46.2 %) 4 (30.8 %) 
2 (15.4 %) 1 (7.7 %) 
5 (38.5 %) 5 (38.5 %) 5 (38.5 %) 
4 (30.8 %) 4 (30.8 %)  
0 (0 %)  2 (15.4 %) 4 (30.8 %) 
7 (53.8 %) 8 (61 .5  %) 
8 (61 .5 %) 6 (46.2 %) 4 (30.8 %) 
2 (15.4 %) (7.7 %) 
(7.7 %) 0 (0 %) 5 (38.5 %) 
6 (46.2 %) 9 (69.2 %) 
4 (30.8) 7 (53.8 %) 4 (30.8 %) 
5 (38.5 %) 3 (23. 1  %) 
The angioscopy classification system discussed above has been adopted, although in 
a modified version, by the European Working Group on Coronary Angioscopy 
(Den Heijer P, Foley DP, Hillege H, Lablanche JM, Van Dijk RB, Franzen D, 
Morice MC, Serra A, De Scheerder I, Serruys PW. The 'Ermenonville' classification 
of observations at Coronary Angioscopy - evaluation of intra and interobserver 
agreement. Submitted, Eur Heart J) . The intra- and interobserver agreements of 
angioscopic recordings, evaluated by this working group, were considered acceptable. 
The intra- and interobserver agreement for the angioscopic presence of red thrombus 
were found to be 91% and 81%.  For dissection these figures were 87% for 









1 .62 1.85 
Statistical analysis I Both continuous and ordinal data are summarized as means ± SE for simplicity of interpretation. The changes in the study group concerning the angioscopic lumen diameter, dissection and presence of thrombus from baseline (first observations post-PTCA) to 60 min. post-PTCA, were compared at baseline with the Wilcoxon rank­sum test. The changes in thrombus color and the predominant thrombus color at baseline were analyzed using the McNemar-change test. Quantitative analysis parameters were compared using Student's paired t-test. No explicit adjustment was made for repeated measurements, which must be taken into account when interpreting the P values. The individual P values are reported. The strength of pair­wise association between angioscopic diameter grading and QCA derived %ns and MLD was assessed using the Spearman's rank-order correlation coefficient. All analy­ses were performed with SPSS PC+ version 5.0 software. All tests used are two-sided. A two-tailed P value of less than 0.05 was considered to indicate statistical significance. 
Results 
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Posl-PTCA 15 min. 30 min. 45 min. 60 min. 
FIGURE , Mean angioscopic gradings of lesion diameter 
(description of grading: see table I). The numbers are 
presented as mean ± 5.E.M. The P-values represent the 
comparisons to the baseline value immediately post-PTCA 
(Wilcoxon Matched-pairs Signed-ranks Test). 
The frequency distributions of the angioscopic observations during the first hour post-PTCA are presented in table I. The number of patients with an angioscopically visible narrowing at the dilatation site increase at each 15 min interval. At I hour, angioscopic occlusion-defined as no or a minimal lumen visible around the guidewire-was scored in 6 of 13 patients. The frequency distributions of dissection and thrombus also reveal a shift toward more pathologic findings after each interval. The colors of the observed thrombi show a tendency from homogeneous toward mixed and multiple colors, with white becoming predominant over red. Figures 1-3 show the mean values of the angioscopic grading of Lumen Diameter, Dissection, and Thrombus during the first hour post-PTCA. The values at 15, 30, 45 and 60 minutes are compared to the baseline values immediately post-PTCA, to demonstrate any progression in these angioscopically observed changes. Most lesions had some degree of disruption of the vascular inner surface after PTCA, interpreted as grades of intima dissection. Furthermore, there was a significant progression in grading of intima disruption: at baseline immediately post-PTCA the mean value was 1.77±0.17, with a median value of 2.0 ('Small flaps') ;  at 60 minutes a mean of 2.62±0.14 was scored, with a median of 3.0 ('large surface disruptions') . The same trend was ob­served for the occurrence of intracoronary thrombus after PTCA. The colors of the observed thrombi showed a significant shift from homogeneous at baseline toward mixed at 60 minutes (2-tailed p=o.0078), and from red at baseline toward white 
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FIGURE 2 (LEFT> Mean angioscopic gradings of surface 
l'a0,0117 l'aO.OOn 
disruptions (dissection) (description of grading: l'a0.0180 I I see table I). The numbers are presented as mean ., l'a00431 I ± S.E.M. The P-values represent the comparisons ] I l'a0,0033 \.J 2 ., P-0,0051 I to the baseline value immediately post-PTCA t ] I (Wilcoxon Matched-pairs Signed-ranks Test). I \.J Pa0.0180 3 I � 2.34 2.62 � Pa0,7150 i:5 2.38 2.15 e I I FIGURE 3 (R I G HT> Mean angioscopic gradings of 1 .s:: 2 3.77 i 1.77 I- 3.31 thrombus (description of grading: see table I). 2.77 
The numbers are presented as mean ± S.E.M. 1.77 1.85 
The P-values represent the comparisons to the 
baseline value immediately post-PTCA (Wilcoxon Post-PTCA 1 5 min. 30 min 45 min. 60min. Post-PTCA 15 min. 30 min. 45 min. 60min. 
Matched-pairs Signed-ranks Test). 
Immediately post-PTCA 1 5  m in .  30 m in .  45  m in .  60  m in .  
% DS (% ± SD) 3 1 .35 ± 1 8.51 36.39 ± 1 5.63 p=0.233 37.90 ± 10.13 p=0.1 92 39.25 ± 13.86 p=0.097 42.56 ± 1 6.46 p::0.025 
MLD (mm ± SD) 1 .79 ± 0.49 1 .69 ± 0.50 p=0.285 1 .63 ± 0.44 p=0.124 1 .58 ± 0.48 p=0.076 1 .48 ± 0.53 p=0.01 1 
RD (mm ± SD) 2.61 ± 0.34 2.63 ± 0.30 p=0.641 2 .59 ± 0.37 p=0.750 2.56 ± 0.36 p=0.1 01 2.53 ± 0.37 p=0.1 91 
The values at 1'5, 30, 45, and 60 minutes are compared to those obtained Immediately post-PTCA. 
TAB L E  II Quantitative analysis of Percentage Diameter 
Stenosis (% DS), Minimal Luminal Diameter (MLD), and 
Reference Diameter (RD). 
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at 60 minutes (2-tailed p=o.0078) .  White thrombus was present in 69.2% at 60 minutes versus 7.7% immediately post-PTCA. Thus the increase in the total amount of thrombus as seen in figure 4 can be largely attributed to an increasing incidence of white intracoronary thrombus. Angiography revealed only 'haziness' of the lesions. In none of these 13 patients, angiographic criteria for either intima dissection or intra­coronary thrombus were positive on any of the cine-angiograms. Although the diameter grading shows a significant change during this first hour, it must be stressed that this finding is based on an essentially non-quantitative and subjective approach. In contrast, QCA yields objective numeric values of MLD and %Ds. These values are presented in table II. There appeared to be a significant increase in %0s, and loss of MLD at 60 minutes. This can not be attributed to the repeated intracoronary nitrate injections, since the RD does not change. The Spearman correlation coefficients for angioscopic diameter grading versus %Ds and versus MLD are given in table III. Significant correlations were not demonstrated in this study, with a sample size of n=13. Three patients underwent repeat-PTCA at I hour. 
Angioscopic Lumen Diameter versus Percentage D iameter Stenosis 
Immediately 
Spearman correlation coefficient 
Significance 














Angioscopic Lumen Diameter versus Min imal Lum inal Diameter 
Immediately 
Spearman correlation coefficient 
Significance 
TABLE 1 1 1  Spearman correlation coefficients for angioscopic 
diameter grading versus Percentage Diameter Stenosis and 
versus Minimal Luminal Diameter. 
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P=0.063 This study established that coronary angioscopy can reveal important intravascular events after balloon dilatation that remain undetected with coronary contrast angiography. Patients with angiographic evidence of dissection post-PTCA were not included in the study. The angiograms at 15, 30, 45 and 60 minutes of the study group were also free from signs of dissection, although they generally showed some haziness. Only a decrease of MLD, and an increase in percentage of stenosis (%ns) could be demonstrated after I hour with QCA. No post-PTCA angiograms met the angiographic criteria for intravascular thrombus. On the other hand, with coronary angioscopy quite dramatic signs of vascular wall damage, including large intima disruptions and thrombi, could be demonstrated, and put into a grading scale. The finding of this post-PTCA damage is in accordance with previous histologic, 4• 5• 8 ultrasound21-23 and angioscopic1 2• 24' 25 studies, and underscores the relatively low sensitivity of contrast angiography for intravascular abnormalities. Some of these intracoronary changes after successful balloon dilatation proved to show progression in time, from immediately post-procedure to 60 minutes after the PTCA. Dissections were scored more and with higher grades at each subsequent 15 min. interval: grade 3 (large) surface disruptions were present with a frequency increasing from 7.7% post PTCA to 61.5% at I hour. It does not seem likely that the actual process of intimal tearing and dissection would continue after angioplasty. However, it is conceivable that intima flaps, partially detached by the balloon dilatation, but lying flush against the inner vessel surface, may gradually move toward 
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the lumen and thus give the angioscopic impression of increasing occurrence and size of these flaps. These dissections may give the explanation of our finding of a substantial decrease of MLD from 1.8±0.5 mm post-PTCA to 1.5±0.5 mm at I hour. This unexpected luminal diameter loss at I hour is of comparable order as found at 6 months post-PTCA in various restenosis studies, 26-28 and is consistent with the data of Kimura et al,29 but in apparent contrast to studies by Foley et aP0 and Hanet et al, 3 1  who found, in much larger study populations, no loss in MLD at 24 hours post-PTCA. Since, to our knowledge, no previous studies have reported on angiographic and angioscopic appearances at I hour post-PTCA, one must consider the possibility that a transient decrease in luminal diameter during the first hour after PTCA, with subsequent recovery, could be a real phenomenon. However, a more plausible explanation may be that, as discussed above, repeated passages of the angioscopy catheter may have aggravated dissections that had been already present following balloon dilatation. Although angioscopy is a fairly atraumatic over-the-wire procedure, with direct visual control of the co-axial alignment of the lens-tip assembly, it must be recognized that the repeated passage of the angioscopy catheter through the dilated lesion may have produced this progression of the dissections. Thus it can be assumed that this loss in MLD has been caused by the observed progressive intima disruptions, and that it is in fact an artificially induced deterioration of the PTCA result. It must be stressed that these intima disruptions were only observed by angioscopy, with the angiograms revealing only haziness. Angioscopy did not cause any dissection according to angiographic criteria. Based on the findings, but also on the limitations, of this pilot study, a multi-center study is now being prepared in the Netherlands to address the relation of angioscopic observations post PTCA with restenosis. A major difference will be that angioscopy will be performed only once immediately post PTCA, and once at 24 post PTCA. At the present time, a major drawback of angioscopy is the absence of quantitative measurement tools. We used a grading scale for angioscopic diameter estimation, which proved not to correlate to the QCA measurements of Percentage Diameter Stenosis and Minimal Luminal Diameter (table II). It seems that angioscopy underestimated the remaining lumen, since angioscopic total occlusion was scored in 6 of 13 patients at r hour post-PTCA, although no angiographic total occlusion occurred. Angioscopic occlusion was defined as no or a minimal lumen remaining visible around the guidewire. In these 6 cases, large thrombi or dissections obstructed visualization of the lumen, which apparently is not comparable to a functional or angiographic vessel occlusion. These data confirm that, although angioscopy gives a superior insight in intravascular structures and changes, diameter measurements are 
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presently best left to quantitative angiographic methods. Thus, any conclusions concerning the decrease in luminal diameter that we have found in this study are drawn from the QCA measurements rather than the angioscopic data on luminal narrowing. Progressive intra coronary thrombus formation was also observed at angioscopy. The question may arise if this was caused by the unusual situation of a guidewire in the artery for such a period following balloon angioplasty. On the other hand, thrombi were only observed developing on the vessel wall, and not on the guidewire itself. Progressive intima disruptions may have contributed to platelet aggregation on the damaged endothelium. Until now, thrombus formation after PTCA has not been adequately investigated in patients, since the only reliable diagnostic tool for this is coronary angioscopy: angiography gives a gross underestimation of the presence of thrombus.32 Thus it can not be excluded that progressive thrombus formation post­PTCA is a real phenomenon, taking place even in heparinized patients such as in this study. Mizuno et al reported the angioscopic observation of the growth of copper coil induced thrombi in dogs. 33 These thrombi started to develop as white, fibrin-like material, followed by the appearance of mixed red and white material. Our post PTCA observations show the same pattern: we observed small red mural thrombi immediately following the balloon angioplasty, which may have been present before PTCA. The progression in the total amount of observed thrombi could largely be attributed to the emergence of white, and mixed red and white, thrombi during the first hour post PTCA. The diagnosis of thrombus is without question if mixed red and white intraluminal masses are observed. Purely white thrombi, on the other hand, may be difficult to discriminate from white intimal flaps, resulting in a potential lack of specificity in identifying these purely white thrombi. Nevertheless, it can be speculated that such a thrombotic process, on a scale which is too small for angiographic detection, can continue for hours or days after PTCA. The impact of our findings of angiographically unsuspected intima damage and thrombus formation on acute PTCA complications and late results is presently unknown, but in our opinion well worth investigating. We conclude that intracoronary angioscopy, through its superior sensitivity to detect intima damage and intracoronary thrombus, can serve as an important diagnostic tool in larger, multi-center studies addressing factors influencing primary PTCA outcome and restenosis after initially successful coronary balioon angioplasty. 
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Abstract A European coronary angioscopy working group was established to create, and evaluate, a classification system for angioscopic observations. This 'Ermenonville' classification features items such as lumen diameter, shape of narrowing, colors of surface, atheroma, dissection, thrombus, etc. All items provide gradings in 3-5 categories. Inter- and intraobserver agreement on the interpretation of angioscopic images, using this classification system, was studied within the working group. Kappa values for chance corrected intraobserver agreement of the diagnostic items were 0.51-0.67. The mean kappa values for interobserver agreement were very low at 0.13-0.29. The important items of red thrombus and dissection were studied after recoding to being either present or absent. These items proved to have a good intraobserver agreement, and an acceptable interobserver agreement after recoding. Other angioscopic diagnoses should be made with caution. Multicenter angioscopy studies should make use of a angioscopy core laboratory. A set of definitions for coronary angioscopy is proposed, and this working group will re-evaluate observer agreements using these definitions. 
Introduction Coronary Angioscopy is rapidly being established as an important diagnostic and scientific tool in interventional cardiology. 1-6 Since the introduction of a new, 4.5 French flexible coronary angioscope (Baxter, Edwards LIS Div., Irvine, CA, USA) in 1991, more than 800 coronary angioscopy procedures have been performed in 44 European centers. Angioscopy is especially suitable for detecting thrombus,1-9 and intimal tears and flaps. 9, 10 However, a common classification system to describe angioscopic observations is still lacking. Reliability of a classification system has important implications for the validity of conclusions that are drawn from using it. Reliability estimates are made on the basis of intraobserver agreement and/or interobserver agreement. Although it is generally accepted that angioscopy provides more vascular surface detail than can be detected with angiography, it remains to be demonstrated whether different observers report similar visual findings from angioscopic images and further, whether the observations are similarly interpreted. An angioscopy working group, consisting of European interventional cardiologists with ample and continually expanding experience in angioscopy, was established to address these questions. This report describes the first steps of this working group to 
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create a classification system for angioscopic observations, and to evaluate intra- and interobserver agreements using this classification system. 
Methods Through a process of discussion while reviewing high quality videotapes of angioscopic recordings, the working group has established a consensus on a first, preliminary classification system for angioscopic observations. Table I shows the classification system, which underwent various modifications during these discussions, to reach its present form. The classification system contains 2 parts. The first part consists purely of descriptive items without any clinical interpretation, such as image quality, estimated lumen diameter, and a description of the vessel surface and its colors. In the second part, diagnostic items are given as pathophysiological interpretations of the angioscopic observations, by items such as atheroma, dissection, and thrombus. Each item in this classification can be given a score ranging from o to 2-5. Two working group meetings were organized for the main purpose of evaluating intra- and interobserver agreement on angioscopic observations. The first meeting took place in October 1992 in Ermenonville, France, and the second meeting was held in January 1993 in Amsterdam. The working group decided to name its angioscopy classification system to Ermenonville, the place of their first meeting. During both meetings, discussion sessions preceded the actual observer agreement scoring sessions. These discussion sessions served the purpose of defining angioscopic features of diseased coronary arteries before and after intervention, and seeking to reach consensus on these features. An additional goal was to assess the effect of group discussion and consequent modification of the Ermenonville classification system on the interobserver variability. For each of the 2 scoring sessions, a special videotape was made, which contained 30 recordings of angioscopic examinations, each with a duration of ½ - 1½ minutes. The angioscopic images were all recorded at the Dept. of Cardiology, University Hospital Groningen, The Netherlands. These recordings were selected from images obtained in 62 patients (44 male, 18 female, mean age 60.4 years, range 40 - 76 years), who all underwent coronary angioscopy pre- and/or post-PTCA. The edited videotapes contained only angioscopic recordings without any angiographic images or additional clinical or procedural data. Each recording was repeated once in 
TABLE I Coronary Angioscopy 
classification system. 
Descriptive items Categories 
Image quality Adequate 
2 Inadequate 
Obtained image of target 1 No recognizable image 
2 Only vessel wall, lumen not visible 
3 Vessel wall, lumen incomplete 
4 Vessel wall, complete lumen 
5 Central lumen visualization 
Lumen d iameter 0 Not assessable, not applicable 
No or minimal narrowing 
2 Narrowing 
3 Total occlusion 
Shape of narrowing 0 Not assessable, not applicable 
Round or ell iptical 
2 Slit-like 
3 Complex shaped 
Vessel surface description 0 Not assessable, not applicable 
Smooth 
2 Non-mobile protruding irregularities 
3 Mobile protruding irregularities 
4 Both mobile & non-mobile protr. irr. 
Colors of surface Homogenous color 







Diagnostic items Categories 
Atheroma 0 Not assessable, not applicable 
None 
2 Lining atheroma 
3 Protruding atheroma 
Dissection 0 Not assessable, not applicable 
1 None 
2 Small surface disruptions (flaps) 
3 Large dissection 
4 Large mobile flap(s) 
Red thrombus 0 Not assessable, not applicable 
None 
2 1 l ining thrombus 
3 Multiple l ining thrombus 
4 Protruding thrombus 
White thrombus 0 Not assessable, not applicable 
None 
2 1 l ining thrombus 
3 Multiple l ining thrombus 
4 Protruding thrombus 
Mixed red/white (pink) thrombus 0 Not assessable, not applicable 
None 
2 1 l in ing thrombus 
3 Multiple l ining thrombus 
4 Protruding thrombus 
a pre-assigned random order to calculate intraobserver agreement. During each of the 2 sessions, the same 6 physicians, who were all participants of the angioscopy working group, individually reviewed the videotapes, and completed a single classification form for each recording (table 1) . 
Statistics I The inter- and intraobserver variation were assessed with percentage of total agreement and with unweighted Cohen' Kappa coefficients. 1 1  Kappa is a parameter of the agreement between 2 or more observations in excess of the chance agreement. As this study deals with more than two observers, an unweighted group Kappa 12 was utilized as well, offering a measure of the average agreement between all pairs of observers in excess of the average chance agreement. An overview of the application of Kappa statistics to this study is given in the appendix. Additionally, the parameters lumen diameter, atheroma, dissection, red thrombus, white thrombus, and mixed thrombus were recategorized and dichotomized. The Kappa coefficients and percentages of positive and negative agreements of these parameters were re-computed after this operation. 
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Resu lts To assess intraobserver agreement for each parameter 360 observations in each session (60 paired recordings and 6 observers) were available. Table II lists the intraobserver agreement on all angioscopic observation items of both scoring sessions in Ermenonville and Amsterdam. These agreements are presented first as uncorrected total agreement percentages, and secondly as chance corrected Kappa values. The lowest value of uncorrected intraobserver agreement was 51.4 % for obtained image in the Ermenonville scoring session, and the highest value was 95.0% for brown surface color in the Amsterdam session. The chance corrected Kappa values range from 0.29 for gray surface color in the Ermenonville scoring session to 0.90 for brown surface color in the Amsterdam scoring session. However, these extreme values are not the most meaningful, since obtained image is a relatively unimportant item, and gray and brown surface color have low incidences of occurrence. Generally, intraobserver agreement was satisfactory, with most items scoring a total agreement exceeding 75%, and a Kappa value between 0.40 and o. 70. Among all possible angioscopic diagnoses, red thrombus and dissection are probably the most important items. In the 2 scoring sessions, we found a 75.4 % - 82.2% intraobserver agreement, and Kappa values of 0.57 - 0.60 for red thrombus. Intraobserver agreement on dissection was 76 .3% - 77.0%, with Kappa values of 0.57 - 0.67. 
TABLE II lntraobserver total replication 





Shape of narrowing 
Vessel surface description 
Colors of surface 
(homogenous vs. patchy) 
Colors of surface, white 
Colors of surface, gray 
Colors of surface, yellow 
Colors of surface, brown 
Kappa 
Colors of surface, pink 








































Ermenonvi l le Amsterdam 
78.1 % 83 .9 % 
0.57 0.60 
51 .4 % 61 .7 % 
0.30 0.38 
66.5 % 77.7 % 
0.50 0.58 
80.1  % 73 .1  % 
0.62 0.58 
64.4 % 72.2 % 
0.50 0.59 
80.0 % 87.8 % 
0.60 0.60 
75.0 % 73.3 % 
0.48 0.43 
69.4 % 72.8 % 
0.29 0.50 
78.9 % 90.0 % 
0.51 0.70 
94.4 % 95.0 % 
0.90 
81 . 1  % 
0.71 
84.4 % 76.7 % 
0.57 0.65 
77.3 % 77.0 % 
0.63 0.51 
77.0 % 76.3 % 
0.57 0.67 
82.2 % 75.4 % 
0.57 0.60 
97.2 % 84.2 % 
0.60 0.57 
92 .8 % 83 .1  % 
0.51 0.53 
109 
These Kappa values represent a fair to good agreement beyond chance (see appendix). In general, diagnostic parameters appear to be more reliable than the descriptive parameters. Similarly, comparison between the observers revealed the same difference in favor of the interpretive items (table III), although overall the Kappa's were substantially lower than the intraobserver values, ranging from poor to fair agreement beyond chance. For red thrombus we calculated an interobserver agreement of 49.7% - 71.1%, and for dissection of 48 .6% - 53.1%. Table IV shows the results of the Amsterdam scoring session, when a re-categorized version of the 6 most important items of the classification system was used. For these calculations, these items were considered as being either present or absent, whereby cut-off points were applied with the intention of identifying clinically relevant positive findings as 'present'. Thus, for luminal diameter a cut-off point between grades 1 (no or minimal narrowing) and 2 (narrowing) was used. For dissection, the categories 1-2 (none and small flaps) and 3-4 (large dissection and large mobile flaps) were clustered. We had observed that there was wide variability in the interpretation of small, patchy surface discolorations, with frequent classification as actual thrombus by some observers and no abnormality by others. Therefore, in this table, red, white and mixed thrombus was counted to be present only in case of a grade 4 (protruding thrombus) score. The observed agreement, not corrected for chance, exceeded 85% for all observations on thrombi. However, the Kappa values are all in the category of poor chance-corrected agreement. The observed agreement is separated into P-pos and P-neg. These data indicate that high values of Kappa are associated with P-neg and P-pos values which are of comparable magnitude to each other, and also to the value of the observed agreement. 
Discussion It seems likely that coronary angioscopy will play an increasingly important role in interventional cardiology. Its role may be directed toward either documentation, for the purpose of prospective research, or guidance during the intervention itself. 13-15 We have established a European coronary angioscopy working group in order to develop and evaluate a classification system that can be used to systematically describe angioscopic findings, as well as to encourage, guide and coordinate multicenter clinical trials. The classification system in its present form, as shown in table 1, proves to be suitable for routine clinical use and selected clinical angioscopy studies. However, it must be emphasized that this is merely a preliminary classification, and that the work of refining and adding other items is still in progress. 
TA B LE 1 1 1  lnterobserver total replication 





Shape of narrowing 
Vessel surface description 
Colors of surface 
(homogenous vs. patchy) 
Colors of surface, white 
Colors of surface, gray 
Colors of surface, yellow 
Colors of surface, brown 
Colors of surface, pink 








































Ermenonvi l le Amsterdam 
61.3 % 58.9 % 
0.28 0.09 
42.1  % 41.8 % 
0.18 0.10 
43.8 % 58.0 % 
0.19 0.24 
64.6 % 53.5 % 
0.32 0.27 
42.4 % 52.1 % 
0.21 0.30 
62.3 % 77.4 % 
0.23 0.22 
49.6 % 50.2 % 
-0.04 0.05 
64.0 % 43 .1  % 
0.13 -0.03 
70.0 % 75.8 % 
0.30 0.24 




77.3 % 38.4 % 
0.52 0.07 
52.4% 59.8 % 
0.13 0.15 
53.1 % 48.6 % 
0.27 0.30 
71.1 % 49.7 % 
0.29 0.21 
92.7 % 66.4 % 
0.02 0.05 
85.1% 69.7 % 
0.07 0.07 
TABLE 1v Intra- and interobserver Kappa values 
and other indices of agreement of the recoded 
items of the Amsterdam scoring session. 
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n = number of compared observations, Agreement = Total percentage observed agreement, 
Kappa = kappa value ,  P-neg = Proportion of negative agreement, P-pos = Proportion of positive agreement As our data show, a detailed interpretation of angioscopic images is subject to an acceptable intraobserver variability, but a large interobserver variability. Although this finding may seem somewhat disconcerting, in our opinion it does not necessarily reflect negatively on the clinical utility of coronary angioscopy, but should rather be regarded as an impetus to develop quantitative angioscopic measurement tools, for instance for luminal dimensions, 1 6  or colorimetry. It is relevant to recall well-known studies in the seventies, which revealed unexpectedly poor agreement in the interpretation of coronary angiograms. 17' 18 These observations did not prevent the 
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increasingly widespread acceptance of the clinical usefulness of coronary an­
giography, but they certainly played an important role in the development of 
Quantitative Coronary Angiography. 1 9 Our study demonstrates that the angioscopic 
diagnosis of thrombus and dissection is associated with the highest intra- and 
interobserver agreements. This in itself is an important conclusion, in agreement with 
previous studies which have shown a high sensitivity of angioscopy, compared with 
angiography, for intravascular thrombus formation and intimal dissection.4• 20• 2 1  
There are several factors which may play a role in the low Kappa values that we 
found for most of the other angioscopic features. In an effort to ensure objectivity 
and lack of potential bias in reporting by the observers, the videotaped angioscopic 
recordings were edited and presented without any angiographic data and without any 
knowledge of the patients, their clinical status, and the examined vessel and its 
'angioscopic target lesion'. During everyday clinical angioscopy, the knowledge and 
use of such data may well have a positive influence on the reliability of angioscopic 
data. The absence of cine-angiograms during these sessions made it difficult for the 
observers to define the 'target' lesion as the substrate for description. Probably the 
most important factor contributing to the poor agreement both within and, 
especially, between observers would seem to be the lack of clear and unambiguous 
definitions of the various angioscopic features ?f interest. We consider this to be the 
single most important contributory factor to the poor interobserver agreement. This 
is not surprising as the likelihood of agreement in subjective impressions is clearly 
dependent on availability of tangible reference points. The National Heart Lung and 
Blood Institute of the USA and the American Heart Association and American College 
of Cardiology classifications of angiographic features of dissection and lesion type 
provided such a reference for investigators in that field and thus an international 
language of angiography.22•24 A similar approach is urgently required in angioscopy to 
coin an international angioscopic language. The working group now considers it her 
first priority to establish such definitions, and to re-evaluate observer agreements 
using these definitions. On the basis of the findings of the group, a 'simplified 
Ermenonville classification', with proposed definitions, is presented in table v. 
Examples of angioscopic images, classified according to this system, are given in 
figures 3-13 - 3-21 of chapter 3. Such photographic still-frames have the drawback 
that not all features observed on the real-time, moving angioscopic images, can be 
adequately reproduced, since they lack the third dimension of depth. Software for a 
computerized atlas and training program with digital video recordings of angioscopic 
images has been developed for enhanced illustration of the Ermenonville 
classification system, and to help investigators use the classification system and 
TABLE v Coronary angioscopy simplified 
classification and definitions. 
definitions. 25 The hypothesis that training and learning effects play an important role in the optimal assessment of angioscopic images is supported by the finding that intraobserver agreement was higher in all but 5 of the 17 factors studied at the Amsterdam session, compared to the Ermenonville session. The Ermenonville session was prior to the Amsterdam session, and considerable additional individual angioscopic experience was gained by all observers in the interim, which apparently had a positive influence on the replication reliability. 




























Vessel wall appearing uniformly smooth in contour, and of a uniform color. 
There are no abrupt changes in diameter. The lumen is free of intraluminal structures. 
None. 
Lining atheroma. Non-elevated yellow or white discoloration. 
Protruding atheroma. Non-mobile, elevated and/or protruding yellow or white discoloration .  
There may be focal or diffuse narrowing. 
Not assessable, not applicable. 
None. 
Small surface disruptions. Smal l ,  very mobile, structures, which are contiguous with the vessel wall. 
They do not impede the visualization of the lumen. 
Large dissection. Visible cracks or fissures on the luminal surface and/or large mobile or non-mobile 
protruding structures, which are contiguous with the vessel wall and of homogenous appearance 
with the vessel wall. They impede visualization of (part of) the lumen. 
Not assessable, not applicable. 
None. 
Lining thrombus. Red, predominantly mural, non-mobile, superficial mass, 
adherent to the vessel surface, but clearly a separate structure. 
Protruding thrombus. Red, intraluminal, protruding, mobile or non-mobile mass, 
adherent to the vesselsurface, but clearly a separate structure. 
Not assessable, not applicable. 
None. 
Lining thrombus. White, predominantly mural, non-mobile, superficial mass, 
adherent to the vessel surface, but clearly a separate structure. 
Protruding thrombus. White, intraluminal, protruding, mobile or non-mobile mass, adherent to the vessel 
surface, but clearly a separate structure. The appearance is shaggy, irregular, and cotton-wool-like. 
Not assessable, not applicable. 
None. 
Lining thrombus. Mixed red and white, predominantly mural, non-mobile, superficial mass, 
adherent to the vessel surface, but clearly a separate structure. 
Protruding thrombus. Mixed red and white, intraluminal , protruding, mobile or non-mobile mass, 
adherent to the vessel surface, but clearly a separate structure. 
Not assessable, not applicable. 
None. 
Present. A distinct, demarcated, red, non-elevated discoloration, which is clearly within the vessel wall. 
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Small intraluminal structures and minute discolorations may either be difficult to 
detect for some observers, or give rise to more differing and inconsistent 
interpretations. Therefore an additional analysis was performed for the items luminal 
narrowing, atheroma, dissection, and red, white and mixed thrombus, in which these 
items could only be scored as being either absent or present. For this purpose, the 
original gradings were recategorized such that only substantial abnormal findings 
were considered to give a positive score. Table IV shows that protruding red thrombi 
and large dissection can be detected with acceptable intra- and interobserver 
agreement, although the interobserver Kappa values have still low values. In this 
particular case Kappa values are probably not the best choice for gaining insight into 
the measure of interobserver agreement, as the uncorrected interobserver agreement 
percentages illustrate: the exceptional distribution of the assessments exerts a major 
influence on the Kappa values. 26• 27 In these cases, a factor which can be in part held 
responsible for the low Kappa values, the so-called 'Kappa-paradox', can be 
demonstrated. A typical example is given by the Kappa value for interobserver 
agreement on white thrombus in table IV. The low Kappa value of o. ro is in apparent 
contradiction with the high agreement score of 84 %, and can partially be explained 
by the low prevalence of large white thrombi, causing an uneven distribution of the 
possible scores. In such cases other indices like P-pos and P-neg give a better insight 
into the strength of interobserver agreement. P-neg and P-pos represent the 
probability on negative and positive agreements between random observers, and are 
thus comparable to the well-known concept of sensitivity and specificity. These 
figures reveal fair to good agreement for red thrombus and the absence of thrombus, 
and for dissection and the absence of dissection. 
Conclusions 
With coronary angioscopy, intraobserver agreement for the presence of a substantial 
red thrombus or dissection is good. The interobserver agreement for these diagnoses 
can be considered to be acceptable. Other angioscopic diagnoses should be made 
with caution. Descriptive items in a classification system reach lower observer 
agreements than pathophysiological interpretations. Due to the inherently subjective 
nature of angioscopy, for clinical purposes, an angioscopic classification system 
should be as simple as possible, containing 'diagnostic' rather than descriptive items. 
Multicenter angioscopy studies should make use of a central angioscopy core 
laboratory to minimize the problem of interobserver variability. Quantitative 
angioscopy measurement tools should be developed to assist in clinical research. 
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Finally, to establish a set of clear and unambiguous definitions is the most urgent next step in the rapid evolution of this device as a powerful diagnostic tool in interventional cardiology. A preliminary definition system is given in this paper. Further refinement of these definitions, and additional analysis of angioscopic observer agreement using these definitions will be carried out, and reported, by this coronary angioscopy working group. 
Appendix Estimates of reliability in terms of reproducibility are provided by tests of concordance such as KappaI I  and correlations. The unweighted Kappa coefficient,28 which measures agreement beyond that expected by chance, was used to evaluate intra- and interobserver reliability for nominal scaled parameters, such as the colors of the vessel surface. The unweighted Kappa was used because it represents a measure of the frequency of exact agreement rather than a measure of the degree of approximate agreement. The same coefficient was used for angioscopic parameters which could be addressed as ordinal scaled, such as the lumen diameter. The magnitude of weighted Kappa may be arbitrary. To avoid this arbitrariness, unweighted Kappa coefficients were used. Unweighted Kappa statistics consider all differences of observer agreement to be equally important, and its values to be in the range from -1 to +1. The Kappa statistic is +1 if there is complete agreement between two observers. The Kappa equals o if observed agreement is equal to that expected by chance alone. If observed agreement is less than chance agreement then Kappa has a negative value. The magnitude of Kappa can be divided in arbitrary categories: Kappa values below 0.40 represent a poor agreement beyond chance, values between 0.40 and 0.59 represent fair agreement, those between 0.60 and 0.74 good agreement, whereas values greater than o. 75 may be taken to represent excellent agreement beyond chance.28 Kappa offers a single statistical summary for a study of concordance. However, imbalances in the distributions of marginal totals can produce two types of paradoxes26' 21 when the variability of observations is expressed with the Kappa coefficient and the proportion of observed agreement (PO) . Kappa can be low despite relatively high values of PO, and Kappa values will sometimes be increased, rather than decreased, by departures from symmetry in the vertical and horizontal marginal 
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total of the concordance table. This problem can be resolved by a recoding of the parameter in a 2x2 concordance table, and by citing separate indices, analogous to sensitivity and specificity, for the positive and negative agreements found in an observer variability study. The proportion of positive agreement in case of positive diagnosis can be designated as P-pos., and the proportion of negative agreement as P-neg. P-pos and P-neg indicate consistency of the two observers when going in the opposite directions of positive and negative decisions. The distinction will help a reader decide about the persuasiveness of the individual results. If needed, it will also help the investigator to design further work in an effort to decrease the observers' disparities in the positive direction, negative direction or both directions. A second contribution of the P-pos and P-neg value is that they can explain and 'eliminate' the Kappa paradoxes. These indices are demonstrated in the recategorized dichotomized parameters lumen diameter, atheroma, dissection, red thrombus, white thrombus, and mixed thrombus. 
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Abstract 
Objectives I This study was undertaken to compare coronary angioscopy with angiography for the 
detection of intimal dissection and intracoronary thrombus. 
Background I It has been demonstrated previously that coronary angioscopy provides more 
intravascular detail than cine-angiography. Both imaging methods have to be 
compared directly to assess the additional diagnostic value of angioscopy. 
Methods I The angiograms and videotapes of 52 patients who had undergone angioscopy were 
reviewed independently, by 2 blinded observers. Classical angiographic definitions 
were used for dissection and thrombus. Angioscopic dissection was defined as visible 
cracks or fissures on the luminal surface and/or mobile protruding structures that are 
contiguous with the vessel wall. Angioscopic thrombus was defined as a red, white, or 
mixed red and white, intraluminal mass. 
Results I Angiography and angioscopy were in agreement in 40.4 % of cases on the absence of 
thrombus, and in 11.5% on the presence of thrombus. No less than 25 (48.1%) of 
angioscopically observed thrombi remained undetected at angiography. Using 
angioscopy as the standard, although the specificity of angiography for thrombus was 
100%, sensitivity was very low at 19%. Angioscopic dissection was present in 
40 patients (76.9%) versus angiographic dissection in 15 patients (28.8%). With 
regard to dissection, there was no correlation between the two imaging methods 
(r
cp
=o. 15, P=o.29). 
Conclusions I Coronary angiography underestimates the presence of intracoronary thrombus and 
should no longer be used for that purpose. Angioscopy and angiography are 
complementary techniques for detection and grading of intimal dissections. 
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Introduction 
Coronary angioscopy is a relatively new tool for imaging of the vascular inner surface 
and intraluminal structures of the coronary arteries. 1•3 The recent introduction of an 
operator friendly, wire guided, high resolution coronary angioscopy system has led to 
an increasing acceptance of this imaging method for clinical and investigational 
purposes. 4-s From the beginning of its clinical application, it has been recognized that 
angioscopy provides more intravascular detail than can be detected with angiography. 
The presence of intracoronary thrombus and intimal dissection have been clearly documented in angiographically unremarkable vessels. 9-15 Coronary angiography, on the other hand, is accepted as the gold standard for imaging of the coronary arteries, and is irreplaceable for routine patient care in diagnostic and interventional cardiology. However, with the increasing availability of angioscopy and its potential for rapid and comprehensive direct visualization of the coronary lumen, the definition of intracoronary thrombus and intimal dissection by angiography must be questioned. The purpose of this study was to compare and contrast imaging information obtained in 52 patients undergoing PTCA, using a combination of angiography and angioscopy, with specific attention to the detection of intracoronary thrombus and intimal dissection. 
Methods 
Patients I At the catheterization laboratories of the University Hospital Groningen, the Netherlands and the Thoraxcenter, Rotterdam, the Netherlands, 52 patients (mean age 60.5 years, range 40 - 76 years) underwent coronary angioscopy before (15 patients) or after (37 patients) coronary balloon angioplasty (PTCA). 
Coronary angioscopy I Angioscopy was performed with the ImageCath TM system (Baxter, Interventional Cardiology Division, Irvine, CA) . Visualization of the coronary lumen is facilitated by low pressure inflation of a proximal cuff (maximal diameter 6 mm) and continuous flushing of prewarmed normal saline at 40 ml./minute through the irrigation channel of the angioscope. Specific features of the angioscope include a mobile fiber bundle allowing 5 cm longitudinal movement after cuff inflation. All angioscopic images were recorded on Super-VHS videotape. 
Coronary angiography I Coronary angiography was performed according to the normal routine of both cathlabs, with multiple projections of the treated coronary artery segments both pre­and post-PTCA. The angiograms were recorded at 12.5 - 25 frames per second on cinefilm. 
Data acq uisition and definitions I The angioscopy videotape recordings were reviewed in a pre-determined, random order by 2 interventional cardiologists with ample experience in angioscopy. The presence of dissection and thrombus was scored with the use of a classification system to provide grading scales for these diagnoses (table 1). Presence of thrombus 
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TABLE r Angioscopy classification system 
for thrombus and dissection. 
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was subclassified as red, white, or mixed red and white. The angioscopic definition 
for a thrombus was as follows: 'Red, white, or mixed red and white, intraluminal, 
superficial or protruding mass, adherent to the vessel surface, but clearly a separate 
structure'. A white thrombus should fulfill the additional criterion of a shaggy, irregu­
lar, and cotton-wool-like appearance. Angioscopic dissection was defined as 'visible 
cracks or fissures on the luminal surface and/or mobile protruding structures that are 
contiguous with the vessel wall, and of homogenous appearance with the vessel wall'. 
These definitions and classifications of thrombus and dissection are part of an 
angioscopy classification system that was developed and evaluated by the European 
Working Group on Coronary Angioscopy (Den Heijer P, Foley DP, Hillege H, 
Lablanche JM, Van Dijk RB, Franzen D, Morice MC, Serra A, De Scheerder I, 
Serruys PW. The 'Ermenonville' classification of observations at Coronary 
Angioscopy - evaluation of intra and interobserver agreement. Submitted, Eur Heart 
J). The intra- and interobserver agreements of angioscopic recordings, evaluated by 
this working group, were considered acceptable. The intra- and interobserver 
agreement for the angioscopic presence of red thrombus were found to be 91% and 
81%. For dissection these figures were 87% for intraobserver agreement and 73% for 
interobserver agreement. 
Dissection 0 Not assessable, not applicable 
1 None 
2 Small surface disruptions (flaps) 
3 Large dissection 
Red thrombus 0 Not assessable, not applicable 
None 
2 1 lining thrombus 
3 Multiple lining thrombus 
4 Protruding thrombus, < 1 /3 of lumen 
Protruding thrombus, 1 /3-2/3 of lumen 
6 Protruding thrombus, 2/3-3/3 of lumen 
White thrombus 0 Not assessable, not applicable 
1 None 
2 1 lining thrombus 
3 Multiple lining thrombus 
4 Protruding thrombus, < 1 /3 of lumen 
Protruding thrombus, 1 /3-2/3 of lumen 
6 Protruding thrombus, 2/3-3/3 of lumen 
Mixed red/white thrombus 0 Not assessable, not applicable 
None 
2 1 lining thrombus 
3 Multiple lining thrombus 
4 Protruding thrombus, < 1 /3 of lumen 
Protruding thrombus, 1 /3-2/3 of lumen 
6 Protruding thrombus, 2/3-3/3 of lumen 
TA BLE II Modified NHLBI classification 
of angiographic dissection. 
The cine-angiograms were scored off line by the same observers in blinded fashion in a different, random order. Intimal dissection was defined as intraluminal filling defects, extravasation of contrast material, or linear luminal density staining, and categorized according to modified National Heart, Lung and Blood Institute criteria (table 11). 16-1 9  Angiographic evidence of intracoronary thrombus was defined as the presence of an intraluminal central filling defect or lucency, surrounded by contrast material seen in multiple projections, and with absence of calcifications within the defect.20 








Small radiolucent area within the l umen of the vessel disappearing 
with the passage of contrast material 
Fil l ing defect parallel to the l umen of the vessel disappearing with 
the passage of contrast material 
Dissection protruding outside the lumen of the vessel persisting after 
passage of the contrast material 
Spiral shaped fil l ing defect with normal runoff of the contrast material 
in the antegrade flow 
Spiral shaped fil l ing defect with delayed runoff of the contrast material 
in the antegrade flow 
Persistent luminal filling defect with delayed runoff of the contrast material 
in the distal vessel 
Filling defect accompanied by total occlusion 
Statistical analysis I The angioscopic and angiographic absence, presence, or degree of dissection and thrombus was scored by consensus of the 2 observers. If they differed in their judgment, consensus was reached by the opinion of a third, independent observer. The observers were blinded to all patient data, allowing for independent, unbiased review of angioscopic images and angiograms. 
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Cross tables were made to compare angioscopic and angiographic scores. Correlations were calculated using the Spearman rank-order correlation coefficient rs, and the Phi coefficient for 2x2 tables (rep) .  These correlations were computed using the SPSS statistical package, version 5.01. Statistical significance was set at the 
5% level (p<o.05). 
Resu lts Coronary angioscopy revealed both intracoronary thrombus and dissection in many angiographically unremarkable vessels. 
lntracoronary thrombus I All intraluminal filling defects, fulfilling the criteria for thrombus, that were observed with angiography were confirmed by angioscopy as representing intracoronary thrombus. The angioscopic score of thrombus versus the absence or presence of thrombus at angiography is presented in table III. Angiographic evidence of thrombus was reported in only 6 cases. Angioscopy on the other hand revealed 31 (59.6%) cases of intracoronary thrombus, varying from a single lining thrombus to large occluding thrombi. Table IV shows the absence or presence (angioscopy: grade 2 or more) of thrombus in a 2x2 cross-table. There is agreement between angiography and angioscopy on 21 cases (40.4%) with regard to the absence of thrombus, and on 6 cases (11.5%) with regard to the presence of thrombus. However, no less than 25 (48.1%) of angioscopically observed thrombi remained undetected at angiography. Compared to angioscopy, there were no false negative angiographic thrombus observations. There was a weak, but significant correlation between angiographic and angioscopic presence or absence of thrombus (rcp=o.30, P=o.03). A typical example 
TAB LE I I I  Angioscopic Thrombus Grade 
versus Angiographic Thrombus. 
of intracoronary thrombus formation, detected by angioscopy but obscured by angiography, is presented in figure 3-r r of Chapter 3. Angiography: Thrombus absent Angiography: Thrombus present 
TABLE 1v Angioscopic versus Angiographic Thrombus. Angiography: Thrombus absent Angiography: Thrombus present 
124 
Angioscopic Thrombus Grade 
1 2 3 4 
21 7 1 1  4 
(40.4%) (13 .5%) (21 .2%) (7.7%) 
3 
(1 .9%) (5.8%) (1 .9%) 













Sensitivity and specificity I Based ori these findings, as well as on previous publications, 9' 14' 2 1-23 angioscopy can be 
regarded as the most reliable means of in-vivo detection of intracoronary thrombus. 
Accordingly, to enhance the interpretation of our figures, we used angioscopy as the 
standard to calculate the sensitivity and specificity of angiography for thrombus. 
Although the specificity of angiography for thrombus was 100%, sensitivity was very 
low at 19-4%. The positive predictive value was 100%, the negative predictive value 
45. 7%. It can be argued that the angiographic criteria for thrombus (intraluminal 
filling defect surrounded by contrast in multiple projections) allow only detection of 
larger, luminal space occupying thrombi.24 Thus we recalculated these parameters 
counting only protruding thrombi (grade 4 or more) as a positive angioscopic 
thrombus observation, disregarding mural, lining thrombi. This had only a minor 
influence on the outcome: sensitivity of angiography for thrombus, using angioscopy 
as the standard: 22.2%, specificity 90.7%, positive predictive value 33.3%, negative 
predictive value 84.8%. 
TABLE v Angioscopic Dissection Grade versus 




Type A dissection 
Angiography: 
Type B dissection 
Angiography: 
Type D1 dissection 
1 0  9 1 8  
(19.2%) (1 7.3%) (34.6%) 
1 2 
(1 .9%) (3 .8%) 
2 9 
(3 .8%) (17.3 %) 
1 
(1 .9%) 
Dissection I Table v represents the comparison of angiographic and angioscopic dissection. 
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Type A, B, and DI dissections were seen with angiography in this population. There 
appeared to be no relation to angioscopic intimal dissection grade (Spearman 
correlation coefficient 0.21, P=o. 14). The parameters were dichotomized to test 
whether the angioscopic presence or absence of dissection had a relation to any type 
of angiographic dissection (table VI). These data show angioscopic dissection in 
40 patients (76.9%) versus angiographic dissection in 15 patients (28.8%), again 
without any correlation (r
cp
=o.15, P=o.29). There were 2 cases of angiographic 
dissection that were not detected by angioscopy. Surface disruptions are typically 
TABLE v1 Angioscopic versus Angiographic Dissection 
seen with angioscopy after balloon angioplasty, 4, 12 as was the case in all post PTCA observations in this study. Small surface disruptions, like small thrombi, may easily be missed with angiography, and may not have clinical consequences. These small flaps may even be regarded as the 'normal' aspect of the vascular wall following balloon angioplasty. For this reason, the analysis was repeated, comparing only large angioscopic dissections to all types of angiographic dissections, but again did not yield a significant correlation between the 2 imaging methods (rcp=o.23, P=o.rn). Figure 3-12 of chapter 3 shows an example of a dissection found with angioscopy, which was not visible on the angiogram. 






1 0  27 
(1 9.2%) (51 .9%) 
2 13 
(3.8%) (25.0%) 
Discussion Contrast cine-angiography is accepted as the standard imaging method of the coronary arteries. Although angiography provides indispensable anatomic information, and has set the standard for quantifying stenotic lesions, 25 both before and after PTCA26, it can be questioned if it still should be regarded as a sufficient means of imaging for studies which require a reliable detection of intracoronary thrombus and intimal dissection. The value of such angiographic studies must be open to question, particularly if they address the sequelae of intracoronary thrombus.21-31  
Implications I Adequate angioscopic evaluation of intracoronary thrombus can have an impact on routine patient care as well, for instance, in the determination of the optimal management in cases of suboptimal PTCA result or acute reclosure. All 9 patients in this study with protruding thrombi (grade 4 or more) at angioscopy were treated with adjunctive intracoronary thrombolysis. Sassower et aP2 and Knopf et al8 have identified the clinical relevance of reliable angioscopic thrombus detection during coronary angioplasty in cases of abrupt closure, unstable angina, and acute myocardial infarction. We have previously reported 2 cases of subacute stent 
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occlusion where angioscopy helped to distinguish dissection from thrombosis as the primary cause. 33 This study was undertaken to objectively compare the usefulness of angioscopy and conventional angiography for detection of intracoronary thrombus and intimal dissection. Contrasting conclusions may be drawn from the findings regarding these respective diagnoses. The sensitivity and specificity of angiography for thrombus detection clearly indicate that angiography underestimates the presence of thrombus. The vast majority of angioscopically observed thrombi remain obscured at angiography. For dissection, on the other hand, angiography and angioscopy appear to be complementary imaging techniques. There were 2 cases where angioscopy missed the dissection although it was evident on the angiogram. Both were type B dissections, with a filling defect parallel to the lumen which must have remained hidden from angioscopic view. 
Limitations I Our study has the limitations of a retrospective investigation. Not all types of dissection were present in this group consisting of both pre PTCA and post PTCA lesions. As a result, a positive correlation between angiographic dissection type, and angioscopic dissection grade, may not be excluded but may merely not have been confirmed with this limited number of 52 paired observations. We found a considerable angiographic underestimation of thrombus. This may in part result from the strict angiographic criteria for thrombus. More liberal criteria undoubtedly would result in increased sensitivity at the cost of a much lower specificity. Another problem, which may result in inaccurate estimation of angiographic sensitivity and specificity for thrombus and dissection arises from the difficult angiographic distinction between these 2 diagnoses. Thrombi may have been misinterpreted as dissections and vice versa. In 5 of 6 cases of angiographic thrombus, dissection was present as well. There were 4 cases of angiographic thrombus which correlated with angioscopic lining thrombus. Because lining, mural thrombus not very bulky, in general, it would not be detected by angiography,24 so it is highly probable that the luminal filling defects that were observed in these cases were caused by concomitant dissection. In fact there proved to be a large angioscopic dissection (grade 3) in 3 of these 4 cases, and small surface disruptions (grade 2) in one patient. Thus an even lower angiographic sensitivity for thrombus may have been found if a different pa­tient group, with intracoronary thrombus but without dissection, had been studied. 
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Intra Vascular Ultrasound Imaging (IVUs) is another new imaging tool for intraluminal structures (as well as for vascular wall properties). Although not having 
ideal properties for thrombus detection, rvus has the potential for superior imaging of intimal dissection. 34-37 Future studies should address the combined use of all available coronary imaging techniques. 
Conclusions I Coronary angiography considerably underestimates the presence of intracoronary thrombus and should no longer be used for this purpose. In studies which require reliable detection of thrombus, coronary angioscopy is the imaging tool of choice. Angioscopy and angiography are complementary techniques for detection and grading of intimal dissections. 
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Abstract Laser Thrombolysis is a new, experimental, catheter based intervention aimed at selectively removing intracoronary thrombus. This first clinical study was performed to assess the feasibility and safety of laser thrombolysis, as well as its potential therapeutic place in acute myocardial infarction. Eighteen patients with acute myocardial infarction, who were either non-candidates for, or failures on, intravenous fibrinolytic therapy were included for treatment with laser thrombolysis followed by balloon angioplasty. As a result of catheter and technical failures, the laser was actually fired in only 12 patients. Improvement in TIMI flow from grade 0-1 to grade 2-3 was observed in I O  of these 12 patients after laser application. The overall results of 18 patients were: increase in TIMI grade flow from 0.33 ± 0.49 after wire passage to 1 .28 ± 1 . 23 (P=o.0051) after attempted laser application, and to 2.67 ± 0.97 after PTCA (P=o.0004) . Two patients with previous infarctions died from left ventricular failure despite successful laser thrombolysis. One patient died during emergency bypass surgery after a failed recanalization attempt. Perforation or laser related dissection did not occur. The concept of selective laser thrombus ablation seems to be safe and feasible, but substantial improvements of the laser delivery catheters are needed. Laser thrombolysis is not an effective stand alone therapy in acute myocardial infarction, but other possible applications warrant further research and development efforts for this potentially useful interventional tool. 
Introduction Acute myocardial infarction (AMI) is usually caused by coronary thrombosis, superimposed on atherosclerosis of the coronary arteries. 1• 2 The management during the first hours of myocardial infarction is directed at attempts to restore the blood flow in the occluded coronary artery. In the large majority of patients, this is attempted by means of intravenously administered fibrinolytic drugs. 3-6 Intravenous thrombolysis may be followed later by coronary angioplasty (PTCA) .7• 8 However, thrombolytic drug therapy is associated with angiographic reperfusion rates of only 70-80% or lower, with significant reocclusion rates,1-10 and with bleeding complications. Direct mechanical recanalization of the infarct artery by means of a primary PTCA, without fibrinolytic drugs, has been established as an effective alternative therapy. 11• 12 Recent data indicate that mortality and ·left ventricular function preservation resulting from primary PTCA are at least comparable to fibrinolytic drug therapy. 13- 1 5  New, catheter-based, thrombolysis techniques can 
optical fiber 
potentially improve the clinical outcome after AMI, especially if they are combined with primary PTCA. Based on in-vitro and in-vivo experiments, 1 6• 17 Gregory et al have demonstrated the feasibility of selective coronary thrombus ablation using a pulsed dye laser, and a contrast filled, fluid-core catheter to transmit the laser energy to the thrombus18• 1 9  intracoronary thrombus can be selectively ablated due to selective absorption by Hemoglobin, and energy levels well below the ablation thresholds for endothelium or atherosclerotic plaque. This first clinical study was performed to assess the feasibility and safety of laser thrombolysis, as well as its potential therapeutic place in acute myocardial infarction. 
Methods 
L aser thrombolysis sy stem I The laser thrombolysis system (Baxter, Interventional Cardiology Group, Irvine, CA) is comprised of a Dymed™ model 3010 pulsed dye laser (Dymed Corporation, Marlboro, MA), a laser delivery catheter system, and a Medrad™ power contrast 
l•floncatheter contrast fluid thrombus 
injector. The flashlamp pumped pulsed dye laser operates at a wavelength of 480 nm, and produces I microsecond pulses at a frequency of 1 - IO Hertz, with a maximum energy output of 400 milliJoules per pulse. The laser delivery catheter uses the 
Ftc.URE , Schematic drawing of the fluid core principle. 
principle of fluid core laser light transmission (Fig 1) : the laser energy is launched from a single optical fiber into a stream of iodinated contrast fluid in the lumen of the Teflon catheter, at a distance of 15 cm. proximal to its tip. The energy is then transmitted to the distal catheter opening through internal reflection. 18 This method offers the potential of a simple catheter system, and has the advantages of clearance of blood from the target site, a continuously refreshed and atraumatic surface for light interaction with the target thrombus, as well as immediate fluoroscopic visualization of the therapeutic laser effect. The Medrad power injector is connected to the proximal Y-connector of the catheter, and allows for a constant infusion of contrast fluid at a low flow rate. The Medrad is interconnected with the laser to enable firing of the laser only when the Medrad is injecting. The laser light is represented by the arrows, and travels by means of total internal reflection, initially through the optical fiber, and next through the contrast fluid. The index of refraction for light of this contrast fluid exceeds that of the Teflon catheter, resulting in internal reflection at the boundary plane between these two media. 
P atients and study design I This feasibility study was carried out as a parallel study of a two-center Investigational Device Exemption (IDE) Application study in the USA. 20 The same protocol, which was approved by the u.s. Food and Drug Administration (FDA), was used because the purpose of our participation was to provide supportive data for this two-center study. Included were patients with an acute myocardial infarction within 
133 
6 hours from the onset of symptoms, who were non-candidates for intravenous thrombolytic therapy because of contra-indications for fibrinolytic drugs, and who had a total occlusion (defined as Thrombolysis In Myocardial Infarction grade o or I flow) at angiography of their infarct related vessel, persisting even after passage of a 
PTCA guidewire through the occlusion. Additionally, patients in a life threatening condition such as cardiogenic shock could be included in case of failure on conventional thrombolytic therapy. These patients constituted a separate 'high-risk' group, and laser thrombolysis was allowed as a possible last resort. From a total of 
35 patients who underwent coronary angiography upon admission to the hospital for 
AMI, 17 patients were excluded because of an open infarct related vessel before or after wire passage. Thus 1 8  patients (14 male, 4 female, mean age 58.6 years, range 
38 - 78 years) were included in the study. Eleven of these 1 8  patients were included in the high-risk group, while 7 patients could be included in the 'standard-risk' group as non-candidates for intravenous thrombolysis. This feasibility study was approved by the Medical Ethical Committee of the University Hospital Groningen, The Netherlands, and all patients were included after written informed consent. 
Catheteriz at ion procedure I Acute coronary angiography was performed with minimal delay after admission to the hospital. Ten thousand Units of heparin were administered intravenously. The occluded infarct related vessel was cannulated with a 0.014 inch PTCA guidewire, inserted through a standard 8 French guiding catheter. If the vessel remained occluded (Thrombolysis in Myocardial Infarction grade o or I flow) after this wire passage, the patient was considered suitable for a laser thrombolysis attempt. After calibration, the laser catheter was connected to the Medrad injector and filled with contrast medium. The optical fiber, connected to the laser source, was inserted in the laser catheter. The catheter assembly was then advanced over the guidewire by means of a separate, short, distal monorail-type wire channel. The catheter tip was positioned against the coronary artery occlusion. All procedures started with a 
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IO second contrast infusion at a rate of 0.3 ml/min through the laser catheter without firing the laser, to exclude reperfusion effects of contrast injection alone. Subsequently, contrast infusion was started at the same rate, with simultaneous firing of the laser in bursts of IO seconds at a repetition rate of 3 Hz. The bursts were repeated until a significant increase in flow was observed, or no further improvement was expected. In this patient group, 150 - 1 001 pulses were delivered per patient. The energy output level of the laser was initially set to 80 mJ per pulse (fluence 
1 1 . 1  J/cm2),  and increased to 100 mJ per pulse( fluence 14.0 J/cm2) if considered necessary. These energy levels were chosen, because Gregory et al had observed effective thrombus ablation without histologic evidence of thermal vessel wall injury 
in a canine study 19  at the same wavelength of 480 nm and at comparable energy 
levels, and the damage threshold of normal artery wall is at least a factor of 8 higher. 1 1  
This study, together with its u.s. counterpart, was the first human study with a new 
laser therapy, in the treatment of potentially life threatening myocardial infarction. 
Thus it was considered mandatory to offer the patients, who had to undergo an 
invasive procedure for this study, the optimal chance on continued and full restored 
patency of their infarct related vessels. Therefore, the laser catheter was exchanged 
for a PTCA balloon catheter to dilate the underlying stenosis immediately after the 
laser thrombolysis attempt. Coronary angioscopy, becoming available late in the 
course of this study, was performed in one patient with the ImageCath™ system 
(Baxter, Interventional Cardiology Group, Irvine, CA) to assess intracoronary 
thrombus before and after laser ablation (see chapter 4, figures 4-4 and 4-5). Full­
dose i.v. heparin infusion was continued for 24 hours, and acetylsalicilic acid, 300 mg 
daily, was started and continued for 6 months. Follow-up coronary angiography was 
performed after 6 months, or earlier in case of recurrent angina pectoris. 
Analysis I All relevant angiograms were recorded in multiple projections. Coronary blood flow 
distal to the target site was expressed as Thrombolysis in Myocardial Infarction 
(TIMI) grade. 2 1 Quantitative angiographic measurements were performed with the 
ImageComm system (ImageComm Systems, Inc., Santa Clara, CA) . The contrast 
filled shaft of the guiding catheter, 2-3 cm proximal to its tip, was used for 
calibration. Percentage Diameter Stenosis (%ns) was calculated for the angiograms 
taken prior to laser thrombolysis, post laser thrombolysis, and post PTCA with the .use 
of well-validated automated contour detection algorithms. 22 TIMI grade flow and 
quantitative coronary angiography parameters are presented as mean ± Standard 
Deviation. The Friedman 2-way ANOVA test was used to assess the presence of 
difference in TIMI flow and %ns between the measurements taken post wire passage, 
post laser, and post PTCA. The parameters were compared, and significance was 





TIMI flow grade 
Post wire passage Postlaser thrombolysis PostPTCA 
FI G U R E  2 Thrombolysis In Myocardial Infarction (TIMI) grade 
flow of the infarct related arteries of 12 patients who received 
laser therapy. TIMI flow is indicated after passage of a 
guidewire, after laser thrombolysis, and after balloon 
angioplasty. 
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Results The relevant data of the 18 patients who entered the study are presented in table I .  The overall results show an increase in  average TIMI grade flow from 0.33 ± 0.49 after wire passage to 1.28 ± 1.23 after (attempted) laser application, and to 2.67 ± 0.97 after PTCA. These differences were statistically significant (Friedman 2-way AN0VA: P<o.001, Wilcoxon: post laser vs. post wire: P=o.0051; post PTCA vs. post laser: P=o.0015; post PTCA vs. post wire: P=o.0004). The mean percentage of stenosis decreased from 94.50% ± 8.26% after wire passage to 85.83% ± 15.73% after laser attempt, and to 33.78% ± 26.61% after PTCA (Friedman 2-way AN0VA: p<o.001, Wilcoxon: post laser vs. post wire: P=o.0069; post PTCA vs. post laser: p=o.0051; post PTCA vs. post wire: P=o.0004). Laser success percentage, expressed as an increase in TIMI flow grade to 2 or 3, was 55.6% (IO of 18 patients) .  The overall procedure suc­cess rate was 88.9% (16 of 18 patients), with TIMI 3 flow in all of these 16 successful recanalizations. In 6 of 18 patients it proved to be impossible to deliver the laser energy at the target site. These failures were caused by the inability to advance the laser catheter over the wire to the occlusion site in 4 patients. Due to its diameter and its materials, this prototype Teflon catheter was relatively rigid compared to PTCA balloon catheters, and it had a sharp edged, abrupt distal tip. Even moderate tortuosity in the proximal part of one of the main branches could generally not be ne­gotiated without risking serious damage to the intima. There were 2 technical failures due to energy loss in a malfunctioning optical connector, resulting in no or minimal laser light output from the catheter. As a result of these catheter and technical failures, the laser was actually fired in only 12 patients. Improvement in TIMI flow from grade 0-1 to grade 2-3 was observed in IO of these 12 patients after laser application. The laser thrombus ablation resulted in full reperfusion to TIMI 3 flow in only 3 patients (Fig 2). Three patients died during hospitalization. All 3 were included in the high-risk group. Two of these patients died from left ventricular failure, despite successful laser and PTCA recanalization. Both patients had a history of multiple infarctions and were in sustained cardiogenic shock before the procedure. Patient 7 had a patent infarct related artery at angiography 1 day after the procedure. One patient died during emergency bypass surgery. He underwent a laser thrombolysis and PTCA attempt to recanalize a proximal LAD occlusion after failed i.v. thrombolysis. Because this attempt was not immediately successful, and because of concomitant disease in his circumflex artery, as well as a critical clinical condition, he was referred for immediate surgery, but could not be weaned from cardiopulmonary bypass. Autopsy 
Nr Age Sex Indication for LT Group Time IRV Laser TIMI %D5 Nr Max TIMI %D5 TIMI %D5 F.U. Remarks 
(or contra- to LT fired pre- pre- pulses Energy post- post- post- post- Angio 
indication for LT LT LT LT PTCA PTCA 
thrombolvsis} 
1 56 M Failed HR 4h 40' RCA Yes 1 82 718 1 06 mJ 3 68 3 16  6 m: IRV Free of complaints at 6 months 
thrombolysis patent 
2 61 M Unstable blood HR 2h 30' LAD Yes 1 87 572 80 mJ 2 82 3 14 1 m: IRV CABG for 3-vessel disease 
pressure patent 
3 46 F Failed HR 6h 50' LO< Yes 0 100 608 80 mJ 2 89 3 28 6 m: IRV Free of complaints at 6 months 
thrombolysis patent 
4 68 M Duodenal SR 5h 45' AL Yes 0 100 497 87 mJ 0 100 3 18  2 w: IRV Free of complaints at 6 months 
occluded 
5 59 M Retinal bleedings SR 4h 10' RCA Yes 1 83 624 1 01 mJ 3 85 3 26 6m: IRV Laser failure, PTCA success. Free of 
patent complaints at 6 months 
6 53 M Gastric ulcer SR 1 h  10' RCA. Yes 0 100 1 001 1 00 mJ 2 88 3 30 2 m: IRV 2-vessel disease, CABG 
patent 
7 61 M Failed HR 3h 10' RCA Yes 0 100 587 81 mJ 2 78 3 48 1 d: IRV Died (LV failure, multiple infarctions) 
th ram bolysis patent 
8 38 F Vaginal blood SR 5h 00' LAD Yes 0 100 675 1 03 mJ 2 87 3 19  - Refused F.U. Angio; free of complaints 
loss at 6 months 
9 77 M Extensive CPR HR 4h 1 5' LAD No 0 100 - - - - 0 100 - Failure to reach occlusion; also PTCA 
failure 
10 50 M Failed HR 6h 38' RCA No 0 100 - - - - 3 24 6 m: IRV Technical failure: laser connector 
thrombolysis patent malfunction 
1 1  54 M Extensive CPR HR 2h 30' LO< No 0 100 - - - - 3 51 6 m: IRV Failure to reach occlusion with laser 
patent catheter 
12 78 M Failed throm - HR 6h 20' RCA Yes 1 79 390 85 mJ 3 68 3 10 6 m: IRV Free of complaints at 6 months 
bolysis, shock patent 
13 72 M Failed HR 4h 15 '  LO< No 1 89 - - - - 3 33 6 m: IRV Technical failure: laser connector 
thrombolysis patent malfunction 
14 73 F Leg-surgery 5 SR 3h 30' LAD No 0 100 - - - - 3 16  6 m: !RV Failure to reach occlusion with laser 
days prev. patent catheter 
15 47 M Hemoptysis SR 4h 00' LO< Yes 1 81 901 1 07 mJ 2 45 3 12  - Died after 3 months from lung 
carcinoma 
16 47 F Vaginal blood SR 5h 50' LAD No 0 100 - - - - 3 35 - Failure to reach occlusion with laser 
loss catheter 
17 67 M Failed throm - HR 6h 00' LAD Yes 0 100 307 80 mJ 2 66 3 28 - Died (LV failure, multiple infarctions) 
bolysis, shock 
18 48 M Failed throm - HR 5h 25' LAD Yes 0 100 600 1 00 mJ 0 100 0 100 - Failure on LT and PTCA; died during 
bolysis, shock CABG 
LT =Laser Thrombolysis; IRV=lnfarct Related vessel; TIMI= Thrombolysis In Myocardial Infarction grade flow; %DS = Percentage Diameter Stenosis; 
PTCA=Percutaneous Transluminal Coronary Angioplasty; F.U. Angio= Follow-Up angiogram at 6 months; CPR=Cardio Pulmonary Resuscitation; HR=High Risk; 
SR=Standard Risk; RCA=Right Coronary Artery; LAD=Left Anterior Descending artery; LCX=Left Circumflex Arterv; CABG=Coronarv Arterv Bvoass Grafting 
TAB L E  I Baseline and procedural data of 18 patients included 
in the Laser Thrombolysis pilot study 
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revealed severe diffuse atherosclerosis of all main branches, and large infarcted areas in the entire left ventricle. There was no evidence of thermal or other laser related arterial damage. There were 2 cases of intimal dissection resulting from manipulation with the prototype laser catheter. These dissections were successfully treated with prolonged PTCA balloon inflations. There were no laser energy related dissections or perforations. Follow-up angiography, performed at 6 months in 8 of 18 patients, showed patent infarct related arteries in all cases, but restenosis (�50% loss of initial 
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luminal diameter increase) in 4 of 8 patients. Of these 4 patients, 2 underwent repeat PTCA at 6 months. Follow-up angiography, performed earlier (1 day to 2 months) in 4 patients for clinical reasons, revealed a reocclusion in I patient, and patent infarct related vessels in the remaining 3 patients. One patient died during follow-up from a malignant bronchial tumor, 2 patients underwent elective CABG for multivessel disease. The remaining IO patients were free from cardiac events at 6 months post procedure. 
Discussion The concept of laser thrombolysis is based on 2 new ideas: the selective ablation of intracoronary thrombus without affecting the surrounding vessel wall or atheromatous plaque, 19 and the use of contrast medium to replace optical fibers in the distal part of a delivery catheter for the transport of laser light. 18 The results of this feasibility pilot study, which was the first clinical laser thrombolysis investigation in Europe, in our opinion demonstrate that the former of these 2 ideas, i.e. that of laser thrombus ablation, is feasible. The fluid core catheter on the other hand proved to be cumbersome. Apart from technical laser connector failures, which were easily corrected through a catheter design modification, this laser catheter accounted for failures to reach the occlusion site in 4 patients. Moreover, complete restoration of flow to TIMI grade 3 could only be attained in 3 patients with laser alone. The inability to cross a stenosis and to reach distal parts of the arteries for additional thrombus ablation played a decisive role in these suboptimal results, where in the majority of patients TIMI 2 flow was reached because of incomplete thrombus removal. This study, which was designed to conform to FDA demands for the first human use of a new laser treatment, had the serious problem of difficult inclusion criteria. As a result, the treated patients generally were in a very poor clinical condition, which without doubt had a negative influence on the overall results, and also resulted in a high in-hospital mortality. This is confirmed by the u.s. counterpart of this study by Gregory et al, who treated a much more stable patient group and thus reported a 94 % success rate without mortality or other complications. 20 This latter study however was selective in its inclusion of patients to the extent that only 16 patients were studied in 2 hospitals in a I ½  year period, indicating how distant laser thrombolysis still is from clinical applicability. Although we found evidence of effective thrombus ablation in terms of improved antegrade coronary flow in IO of 12 
FIGURE 3 A Coronary angiogram (LAO view) of the right 
coronary artery of patient 6 after passage of the guidewire, 
showing a proximal total occlusion. 
FIGURE 3B Angiogram taken during laser application, 
with contrast infusion through the laser catheter. 
Faint opacification occurs, but multiple luminal filling 
defects are still present, suggesting large amounts of 
intracoronary thrombus. 
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laser treated patients, and an overall procedure success of 16 of 18 patients, it is highly improbable that a comparable outcome would not have been reached by PTCA as stand alone therapy without laser intervention. It can be speculated that a possible exception is formed by patient 6 of our study: this patient had a massive amount of thrombus, which filled the major part of his right coronary artery up to its bifurcation. Combined treatment with laser (roor pulses) and balloon inflations resulted in restored patency in a situation where PTCA alone might have failed (Fig 3). In the light of the suboptimal results, it has to be stressed that this study was intended merely as a safety and feasibility pilot study, carried out in a patient group that was, in retrospect, not very suitable for assessing this laser's true therapeutic potential. Nevertheless, safety was demonstrated by the absence of complications attributable to the application of the laser energy itself, although the mechanical properties of the laser catheter caused dissections in 2 patients. Feasibility of laser thrombus removal was demonstrated by the apparent effect of the laser energy on TIMI flow grade in the 12 patients who were actually laser treated. This was further substantiated by the angioscopic observation in one patient of complete absence of thrombus after laser ablation. One factor in the moderate recanalization potential in our study may be that relatively low energy levels were used. The fluence may have been substantially lower than the expected r r  - 14 J/cm2 due to transmission loss in the catheter, and divergence of the laser light beam at the catheter tip. The large margin of safety17' 19 would justify experiments with higher laser energy levels. The single most important factor contributing to the mediocre results has been the laser delivery catheter system. Although the fluid core concept is simple and elegant, the prototype catheters were stiff and traumatic, with insufficient length and poor trackability and pushability. Moreover, the choice of suitable materials for the catheter shaft is very limited by the optical properties that they should possess for internal light reflection. The Teflon catheter tip had sharp edges. A required inner luminal diameter of 1 .o millimeter for contrast injection, and an eccentric wire lumen may be prohibitive in creating catheters with profiles, smoothness and flexibility that are comparable to PTCA catheters. This seems to be confirmed by the fact that attempts in the last 2 years to build a redesigned, improved fluid core laser catheter have been without success. We believe that the fluid core laser thrombolysis catheter design should be abandoned in favor of a more conventional, multifiber system. One, in our view promising, approach would be to combine the technologies of the current ImageCath TM coronary angioscopy catheter and the laser thrombolysis system. A special angioscope with a suitable laser light channel would have the same advantage as the fluid core catheter of a clear target without intervening blood, by 
F I G U RE 3C The post-laser angiogram 
reveals restored patency, although flow 
was TIMI grade 2. In the mid part of the 
RCA 2 narrowings remain. These were 
successfully dilated. 
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means of its occlusion cuff and irrigation lumen. Furthermore, with the proven superiority of angioscopy, compared to angiography, for thrombus detection, 23-26 it would offer a superior target definition and therapeutic effect assessment. Recently, Froelich et al have reported on the feasibility of a 5 French laser-angioscope-catheter connected with a pulsed-dye laser operating at similar energy levels as used in our study, and at the same wavelength of 480 nm.21 In our view, even with an optimal laser catheter system, laser thrombolysis will not find a p I lace as a first choice therapy in acute myocardial infarction. It seems to be an unrealizable task to try to surpass, or even match the excellent results of immediate PTCA in AMI. 13- 15 Possible future applications of laser thrombolysis by means of a reliable delivery catheter would potentially include: adjunctive therapy in AMI with failed thrombolysis and/or failed PTCA (for instance with the presence of large amounts of thrombus), vein graft thrombosis, and thrombotic complications of PTCA. The high incidence of intracoronary thrombus reported in recent angioscopy studies24• 25-30 justifies further development of laser thrombolysis as a therapeutic tool in interventional cardiology. 
Conclusion This first clinical application of laser thrombolysis in myocardial infarction demonstrated, in a study with patients in critical clinical conditions, who could not be treated with i.v. thrombolytic drugs or who had failed to reperfuse on such therapy, that the concept is feasible. Furthermore that laser energy from a pulsed dye laser at 480 nm. wavelength can safely be delivered in the coronary arteries at the energy levels used in this study without causing laser related complications. However, to meet clinical applicability, the therapeutic effectiveness of laser thrombolysis must increase. Although the concept of laser thrombus ablation seems to be worth to pursue further, the concept of the fluid core, contrast medium filled, laser delivery catheter system proves to be troublesome. In our view, a special angioscopic multifiber delivery system should be developed. This study, and the possible applications of laser ablation of intracoronary thrombus, make continued investigation and development of this potentially useful interventional tool warranted. 
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Dutch sum mary - Nederlandse samenvatting 
Al sedert het begin van deze eeuw hebben onderzoekers pogingen gedaan het 
inwendige van een levend en werkend hart zichtbaar te maken met behulp van 
optische instrumenten. Aanvankelijk was het doel hiervan de moeilijke klepoperaties 
bij kloppend hart te verlichten. Door de uitvinding van optische glasvezels in de 
vijftiger jaren, en door een verregaande miniaturizering van deze glasvezeloptiek in de 
daaropvolgende decaden, kwam angioscopie - het van binnen bekijken van 
bloedvaten - binnen handbereik. Met de voortschrijdende techniek werd na intra­
operatief gebruik ervan vervolgens percutane angioscopie in perifere bloedvaten 
mogelijk, en tenslotte zelfs percutane angioscopie van de kransslagaders. 
De doorbraak naar klinisch toepasbare coronair angioscopie kwam in 1991. In dat 
jaar werd het ImageCath™ (Baxter Healthcare Corporation, vs) systeem 
gemtroduceerd. De eenvoudige bediening en de goede beeldkwaliteit van dit systeem 
maken angioscopie tijdens coronaire interventie procedures zoals PTCA tot een 
gemakkelijk in te zetten en uiterst waardevol extra diagnosticum. 
Een coronaire angioscoop is een complexe catheter, waarvan de eigenschappen 
waaraan hij moet voldoen in hoofdstuk 2 worden beschreven. Essentiele 
componenten van een angioscopie systeem zijn een extreem dunne, flexibele 
glasvezelbundel met 2000-3000 afzonderlijke vezels, een miniatuur lens, een systeem 
waarmee het bloedvat kan worden afgesloten en waarmee het ondoorzichtige bloed 
kan warden weggespoeld met fysiologische zoutoplossing, en tenslotte optimale, op 
dit doel speciaal afgestemde, video opname- en weergaveapparatuur. Door ons 
werden mogelijkheden en toepassingen onderzocht om, met modeme 
microcomputers, angioscopiebeelden ook als 'digitale video' op te nemen. Met een 
zorgvuldige selectie van patienten en te onderzoeken coronaire segmenten is 
angioscopie eenvoudig uitvoerbaar, en het succespercentage hoog. Het meest 
geschikt zijn de middengedeelten van elk van de drie grote takken van het 
coronairsysteem. Vaten met een meer dan normale tortuositeit kunnen echter beter 
vermeden worden. De angioscoop wordt door een normale PTCA geleide catheter, en 
over een stuurbare PTCA voerdraad, naar de te bekijken segmenten geleid, waama een 
elastisch, atraumatisch afsluitballonnetje met lage druk wordt opgeblazen. Vervolgens 
wordt het bloed voor de lens weggespoeld met behulp van verwarmd fysiologisch 
zout, dat door een speciaal irrigatiekanaal met 30 tot 45 ml/min wordt geinfundeerd. 
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De lens tip van de ImageCath angioscoop kan tijdens het proces van beeldvorming 
door de kransslagader heen en weer bewogen worden, zodat een traject van maximaal 
5 cm tijdens een opname in beeld kan worden gebracht. lntracoronaire manipulatie, 
met wat voor catheter ook, moet met uiterste voorzichtigheid betracht worden. Dit in 
aanmerking nemende kan coronaire angioscopie beschouwd worden als een veilige 
procedure. In dit boek worden 100 patienten beschreven die angioscopie 
ondergingen. Hierbij deden zich in het geheel geen emstige complicaties als gevolg 
van de angioscopie procedure voor. Het succespercentage, gedefinieerd als het 
percentage patienten bij wie tenminste tweederde van de omtrek van het te 
onderzoeken gedeelte van het bloedvat kon worden afgebeeld, bedroeg 91%. 
De beschrijving van de diverse waamemingen die met angioscopie kunnen gedaan 
begint met die van het normale kransvat. Door de angioscoop bekeken wordt de 
normale vaatwand gekenmerkt door een uniforme kleur, en een glad oppervlak 
zonder abrupte veranderingen in diameter. Een intracoronaire thrombus -
waarschijnlijk de belangrijkste angioscopische bevinding - wordt gezien als een 
murale of in het lumen uitpuilende massa, vaak rood maar ook mogelijkerwijs wit of 
gemengd wit en rood van kleur. Atheromateuze plaque kan geel of wit zijn, of, indien 
het een onstabiele plaque betreft, een schakering van kleuren vertonen, veroorzaakt 
door disrupties en hematomen. Het angioscopisch onderzoek van een segment 
aansluitend aan coronaire angioplastiek ervan toont onveranderlijk een patroon van 
vaatwand beschadigingen die in beeld komen als kleinere of grotere intima-flappen. 
Overigens blijven deze op het angiogram vaak onopgemerkt. Evenals angioscopie 
hebben andere coronaire beeldvormende technieken hun specifieke voor- en nadelen. 
Vergeleken bij angiografie en intravasculaire echografie ontbeert angioscopie nog de 
mogelijkheid tot het kwantificeren van waamemingen, maar biedt het een superieure 
detectie van intracoronaire thrombus en intima dissectie. Idealiter zouden deze drie 
technieken voor coronaire beeldvorming gecombineerd moeten worden teneinde 
optimale morphologische informatie over het kransvatsysteem te verkrijgen. 
Pogingen angioscopische waamemingen te valideren zijn tot op heden slechts in 
beperkte mate ondemomen. Wij hebben een Europese angioscopie werkgroep 
opgericht, met als doel uniforme angioscopische beschrijvingen en definities op te 
stellen en te evalueren. Door de leden van deze Europese werkgroep werden talloze 
angioscopische videobeelden bekeken om intra- en interobserver variabiliteit te 
berekenen. Het classificatie systeem dat door deze groep werd ontwikkeld en 
geevalueerd speelt een centrale rol in dit boek, en wordt beschreven in hoofdstuk 3 
en appendix III. 
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In hoofdstuk 4 wordt ingegaan op de indicaties en toepassingen van coronaire angioscopie. Deze kunnen verdeeld worden in documentatie, begeleiding van interventies, en interventies via de angioscoop. In het algemeen dient documentatie voornamelijk het doel van klinisch onderzoek. Zo kan angioscopie gebruikt worden in de research naar factoren die een rol spelen bij het ontstaan van restenose na PTCA. Voorts blijkt het mogelijk te zijn met behulp van angioscopie de onstabiele coronaire laesie te definieren: 24 patienten met onstabiele angina pectoris hadden significant meer witte thrombus, en meer complexe atheromateuze laesies dan een groep van 17 patienten met stabiele angina pectoris. Met het begeleiden van interventies heeft angioscopie een klinisch nuttig toepassingsgebied. In onze ogen de belangrijkste toepassing hierbij is die tijdens een acute occlusie of dreigende acute occlusie na PTCA. Omdat hierbij met angioscopie beter dan met andere beeldvormende technieken het onderscheid gemaakt kan worden tussen thrombus en dissectie, wordt de keuze van de juiste 'bail-out' strategie (zoals stent-implantatie, langdurige inflatie van een autoperfusieballon, of intracoronaire toediening van thrombolytica) geoptimaliseerd. Directe interventie via de angioscoop is nog beperkt tot het toedienen van thrombolytica door het irrigatielumen. Naar onze mening moeten de mogelijkheden tot angioscopische interventie nader onderzocht worden. Een in potentie zeer veelbelovende toepassing zou die van laser thrombolyse via een speciale angioscopie catheter zijn. Het is een voor de hand liggende gedachte de technologieen van angioscopie en laser thrombus ablatie te combineren. Vijf publicaties waarbij angioscopie een rol speelt zijn als appendices in dit proefschrift opgenomen. In de eerste hiervan wordt de klinische relevantie van deze afbeeldingsmethode onderstreept: bij 2 patienten met een subacute stent occlusie bleek dit beeld veroorzaakt te zijn door obstructieve intima dissecties. Dit in tegenstelling tot de verwachtte stent thrombose. In appendix II zijn, in een observationele studie, de intraluminale veranderingen welke zich binnen het eerste uur na PTCA afspelen, vastgelegd in een aantal seriele waarnemingen. De 'Ermenonville' classificatie, het product van de Europese angioscopie werkgroep, wordt gepresenteerd in appendix III, waarbij tevens een eerste basis wordt gelegd voor de inter- en intraobserver validatie van angioscopische waarnemingen. Een basale vergelijking tussen de angiografische en angioscopische detectie van intracoronaire thrombus en intima dissectie is beschreven in appendix rv. Een eerste klinische studie aangaande de nieuwe interventie van laser thrombolyse, waarin bij een der patienten angioscopie werd verricht om het effect van de laser te beoordelen, is tenslotte te vinden in appendix v. 
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the technical parts of the first chapters. I sincerely hope that this book may contribute to the further acceptance and development of the angioscopic vision that these friends have. The members of the European working group on coronary angioscopy have demonstrated an unequaled European unanimity, and have, without complaining, spent long hours looking at moving vessels in dreadful places like Paris, Amsterdam and Monte Carlo. Closer to home, I am indebted for the help I received in my own hospital. Koos Meuzelaar kept on digging up (he may even have reached the floor of his working room) traces of cardioscopy and angioscopy in the prehistoric past of cardiac surgery. The cathlab secretaries Jantje, Ria and Joke have sent numerous letters and faxes, Annelies Kwant knows and reaches everybody, Milou Pentinga has assisted with the laser thrombolysis project and the angioscopy database, and Rudie van der Meer, our in-house camera-man, has made the photographs for this book. Bart de Graaf has created an efficient cathlab environment in which ever increasing numbers of PTCA procedures still leave time for organization and publication of research. The nursing staff of our cathlab is simply the best any interventional cardiologist can hope for, and especially Johan Meijer has taken up a special professional interest in angioscopy. I really would not want to forget to name anyone who in one way or another has played a part. Therefore I would like to think that this thesis, like so many before it, is a tribute to the Thoraxcenter of Groningen. 
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